IT202000007234A1 - Compounds with fungicidal activity, relative agronomic compositions and use for the control of phytopathogenic fungi - Google Patents
Compounds with fungicidal activity, relative agronomic compositions and use for the control of phytopathogenic fungi Download PDFInfo
- Publication number
- IT202000007234A1 IT202000007234A1 IT102020000007234A IT202000007234A IT202000007234A1 IT 202000007234 A1 IT202000007234 A1 IT 202000007234A1 IT 102020000007234 A IT102020000007234 A IT 102020000007234A IT 202000007234 A IT202000007234 A IT 202000007234A IT 202000007234 A1 IT202000007234 A1 IT 202000007234A1
- Authority
- IT
- Italy
- Prior art keywords
- group
- compound
- alkyl group
- groups
- hydrogen atom
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims description 452
- 239000000203 mixture Substances 0.000 title claims description 55
- 230000000855 fungicidal effect Effects 0.000 title claims description 34
- 241000233866 Fungi Species 0.000 title claims description 19
- 230000003032 phytopathogenic effect Effects 0.000 title claims description 17
- 230000009418 agronomic effect Effects 0.000 title description 2
- -1 penta or hexa-atomic Chemical group 0.000 claims description 115
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 86
- 125000003118 aryl group Chemical group 0.000 claims description 62
- 125000004400 (C1-C12) alkyl group Chemical group 0.000 claims description 49
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 49
- 125000004641 (C1-C12) haloalkyl group Chemical group 0.000 claims description 35
- 229910052757 nitrogen Inorganic materials 0.000 claims description 35
- 229910052760 oxygen Inorganic materials 0.000 claims description 33
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 32
- 239000001301 oxygen Substances 0.000 claims description 32
- 125000006710 (C2-C12) alkenyl group Chemical group 0.000 claims description 31
- 229910052717 sulfur Inorganic materials 0.000 claims description 31
- 125000000623 heterocyclic group Chemical group 0.000 claims description 30
- 125000004642 (C1-C12) alkoxy group Chemical group 0.000 claims description 29
- 239000001257 hydrogen Substances 0.000 claims description 29
- 229910052739 hydrogen Inorganic materials 0.000 claims description 29
- 238000002360 preparation method Methods 0.000 claims description 29
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 25
- 125000005842 heteroatom Chemical group 0.000 claims description 25
- 150000003462 sulfoxides Chemical class 0.000 claims description 25
- 239000011593 sulfur Chemical group 0.000 claims description 25
- 150000001204 N-oxides Chemical class 0.000 claims description 24
- 229910052799 carbon Inorganic materials 0.000 claims description 22
- 229910052701 rubidium Inorganic materials 0.000 claims description 22
- LQDARGUHUSPFNL-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)-3-(1,1,2,2-tetrafluoroethoxy)propyl]1,2,4-triazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(COC(F)(F)C(F)F)CN1C=NC=N1 LQDARGUHUSPFNL-UHFFFAOYSA-N 0.000 claims description 21
- 239000005840 Tetraconazole Substances 0.000 claims description 21
- 239000000417 fungicide Substances 0.000 claims description 21
- 150000003457 sulfones Chemical class 0.000 claims description 21
- 239000005730 Azoxystrobin Substances 0.000 claims description 19
- WFDXOXNFNRHQEC-GHRIWEEISA-N azoxystrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1OC1=CC(OC=2C(=CC=CC=2)C#N)=NC=N1 WFDXOXNFNRHQEC-GHRIWEEISA-N 0.000 claims description 19
- 239000002904 solvent Substances 0.000 claims description 19
- XCGBHLLWJZOLEM-UHFFFAOYSA-N 3-(difluoromethyl)-N-(7-fluoro-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1-methyl-1H-pyrazole-4-carboxamide Chemical compound CC1CC(C)(C)C(C(=CC=2)F)=C1C=2NC(=O)C1=CN(C)N=C1C(F)F XCGBHLLWJZOLEM-UHFFFAOYSA-N 0.000 claims description 18
- 125000002618 bicyclic heterocycle group Chemical group 0.000 claims description 18
- HZRSNVGNWUDEFX-UHFFFAOYSA-N pyraclostrobin Chemical compound COC(=O)N(OC)C1=CC=CC=C1COC1=NN(C=2C=CC(Cl)=CC=2)C=C1 HZRSNVGNWUDEFX-UHFFFAOYSA-N 0.000 claims description 18
- 125000005843 halogen group Chemical group 0.000 claims description 17
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 17
- 239000005869 Pyraclostrobin Substances 0.000 claims description 16
- TWFZGCMQGLPBSX-UHFFFAOYSA-N carbendazim Chemical compound C1=CC=C2NC(NC(=O)OC)=NC2=C1 TWFZGCMQGLPBSX-UHFFFAOYSA-N 0.000 claims description 16
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 15
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 15
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 15
- 229910052794 bromium Inorganic materials 0.000 claims description 15
- 239000000460 chlorine Substances 0.000 claims description 15
- 229910052801 chlorine Inorganic materials 0.000 claims description 15
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 14
- 229910052731 fluorine Inorganic materials 0.000 claims description 14
- 239000011737 fluorine Substances 0.000 claims description 14
- ZMYFCFLJBGAQRS-IAGOWNOFSA-N (2S,3R)-epoxiconazole Chemical compound C1=CC(F)=CC=C1[C@]1(CN2N=CN=C2)[C@@H](C=2C(=CC=CC=2)Cl)O1 ZMYFCFLJBGAQRS-IAGOWNOFSA-N 0.000 claims description 13
- 125000004432 carbon atom Chemical group C* 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 13
- 125000006615 aromatic heterocyclic group Chemical group 0.000 claims description 12
- 241000196324 Embryophyta Species 0.000 claims description 11
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 11
- 239000005752 Copper oxychloride Substances 0.000 claims description 10
- 239000005820 Prochloraz Substances 0.000 claims description 10
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims description 10
- HKMOPYJWSFRURD-UHFFFAOYSA-N chloro hypochlorite;copper Chemical compound [Cu].ClOCl HKMOPYJWSFRURD-UHFFFAOYSA-N 0.000 claims description 10
- CMRVDFLZXRTMTH-UHFFFAOYSA-L copper;2-carboxyphenolate Chemical compound [Cu+2].OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O CMRVDFLZXRTMTH-UHFFFAOYSA-L 0.000 claims description 10
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 10
- TVLSRXXIMLFWEO-UHFFFAOYSA-N prochloraz Chemical compound C1=CN=CN1C(=O)N(CCC)CCOC1=C(Cl)C=C(Cl)C=C1Cl TVLSRXXIMLFWEO-UHFFFAOYSA-N 0.000 claims description 10
- RYAUSSKQMZRMAI-ALOPSCKCSA-N (2S,6R)-4-[3-(4-tert-butylphenyl)-2-methylpropyl]-2,6-dimethylmorpholine Chemical compound C=1C=C(C(C)(C)C)C=CC=1CC(C)CN1C[C@H](C)O[C@H](C)C1 RYAUSSKQMZRMAI-ALOPSCKCSA-N 0.000 claims description 9
- WKBPZYKAUNRMKP-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)pentyl]1,2,4-triazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(CCC)CN1C=NC=N1 WKBPZYKAUNRMKP-UHFFFAOYSA-N 0.000 claims description 9
- XTDZGXBTXBEZDN-UHFFFAOYSA-N 3-(difluoromethyl)-N-(9-isopropyl-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl)-1-methylpyrazole-4-carboxamide Chemical compound CC(C)C1C2CCC1C1=C2C=CC=C1NC(=O)C1=CN(C)N=C1C(F)F XTDZGXBTXBEZDN-UHFFFAOYSA-N 0.000 claims description 9
- 239000005738 Bixafen Substances 0.000 claims description 9
- 239000005740 Boscalid Substances 0.000 claims description 9
- 239000005758 Cyprodinil Substances 0.000 claims description 9
- 239000005762 Dimoxystrobin Substances 0.000 claims description 9
- 239000005778 Fenpropimorph Substances 0.000 claims description 9
- 239000005779 Fenpyrazamine Substances 0.000 claims description 9
- 239000005783 Fluopyram Substances 0.000 claims description 9
- 239000005784 Fluoxastrobin Substances 0.000 claims description 9
- 239000005788 Fluxapyroxad Substances 0.000 claims description 9
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 9
- 239000005867 Iprodione Substances 0.000 claims description 9
- 239000005799 Isopyrazam Substances 0.000 claims description 9
- 239000005805 Mepanipyrim Substances 0.000 claims description 9
- 239000005810 Metrafenone Substances 0.000 claims description 9
- 239000005813 Penconazole Substances 0.000 claims description 9
- 239000005818 Picoxystrobin Substances 0.000 claims description 9
- 239000005842 Thiophanate-methyl Substances 0.000 claims description 9
- 239000005845 Tolclofos-methyl Substances 0.000 claims description 9
- 239000005857 Trifloxystrobin Substances 0.000 claims description 9
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 9
- LDLMOOXUCMHBMZ-UHFFFAOYSA-N bixafen Chemical compound FC(F)C1=NN(C)C=C1C(=O)NC1=CC=C(F)C=C1C1=CC=C(Cl)C(Cl)=C1 LDLMOOXUCMHBMZ-UHFFFAOYSA-N 0.000 claims description 9
- WYEMLYFITZORAB-UHFFFAOYSA-N boscalid Chemical compound C1=CC(Cl)=CC=C1C1=CC=CC=C1NC(=O)C1=CC=CN=C1Cl WYEMLYFITZORAB-UHFFFAOYSA-N 0.000 claims description 9
- 229940118790 boscalid Drugs 0.000 claims description 9
- HAORKNGNJCEJBX-UHFFFAOYSA-N cyprodinil Chemical compound N=1C(C)=CC(C2CC2)=NC=1NC1=CC=CC=C1 HAORKNGNJCEJBX-UHFFFAOYSA-N 0.000 claims description 9
- WXUZAHCNPWONDH-DYTRJAOYSA-N dimoxystrobin Chemical compound CNC(=O)C(=N\OC)\C1=CC=CC=C1COC1=CC(C)=CC=C1C WXUZAHCNPWONDH-DYTRJAOYSA-N 0.000 claims description 9
- UTOHZQYBSYOOGC-UHFFFAOYSA-N fenpyrazamine Chemical compound O=C1N(C(C)C)N(C(=O)SCC=C)C(N)=C1C1=CC=CC=C1C UTOHZQYBSYOOGC-UHFFFAOYSA-N 0.000 claims description 9
- KVDJTXBXMWJJEF-UHFFFAOYSA-N fluopyram Chemical compound ClC1=CC(C(F)(F)F)=CN=C1CCNC(=O)C1=CC=CC=C1C(F)(F)F KVDJTXBXMWJJEF-UHFFFAOYSA-N 0.000 claims description 9
- UFEODZBUAFNAEU-NLRVBDNBSA-N fluoxastrobin Chemical compound C=1C=CC=C(OC=2C(=C(OC=3C(=CC=CC=3)Cl)N=CN=2)F)C=1C(=N/OC)\C1=NOCCO1 UFEODZBUAFNAEU-NLRVBDNBSA-N 0.000 claims description 9
- SXSGXWCSHSVPGB-UHFFFAOYSA-N fluxapyroxad Chemical compound FC(F)C1=NN(C)C=C1C(=O)NC1=CC=CC=C1C1=CC(F)=C(F)C(F)=C1 SXSGXWCSHSVPGB-UHFFFAOYSA-N 0.000 claims description 9
- ONUFESLQCSAYKA-UHFFFAOYSA-N iprodione Chemical compound O=C1N(C(=O)NC(C)C)CC(=O)N1C1=CC(Cl)=CC(Cl)=C1 ONUFESLQCSAYKA-UHFFFAOYSA-N 0.000 claims description 9
- CIFWZNRJIBNXRE-UHFFFAOYSA-N mepanipyrim Chemical compound CC#CC1=CC(C)=NC(NC=2C=CC=CC=2)=N1 CIFWZNRJIBNXRE-UHFFFAOYSA-N 0.000 claims description 9
- AMSPWOYQQAWRRM-UHFFFAOYSA-N metrafenone Chemical compound COC1=CC=C(Br)C(C)=C1C(=O)C1=C(C)C=C(OC)C(OC)=C1OC AMSPWOYQQAWRRM-UHFFFAOYSA-N 0.000 claims description 9
- IBSNKSODLGJUMQ-SDNWHVSQSA-N picoxystrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1COC1=CC=CC(C(F)(F)F)=N1 IBSNKSODLGJUMQ-SDNWHVSQSA-N 0.000 claims description 9
- QGHREAKMXXNCOA-UHFFFAOYSA-N thiophanate-methyl Chemical compound COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC QGHREAKMXXNCOA-UHFFFAOYSA-N 0.000 claims description 9
- OBZIQQJJIKNWNO-UHFFFAOYSA-N tolclofos-methyl Chemical compound COP(=S)(OC)OC1=C(Cl)C=C(C)C=C1Cl OBZIQQJJIKNWNO-UHFFFAOYSA-N 0.000 claims description 9
- ONCZDRURRATYFI-TVJDWZFNSA-N trifloxystrobin Chemical compound CO\N=C(\C(=O)OC)C1=CC=CC=C1CO\N=C(/C)C1=CC=CC(C(F)(F)F)=C1 ONCZDRURRATYFI-TVJDWZFNSA-N 0.000 claims description 9
- PXMNMQRDXWABCY-UHFFFAOYSA-N 1-(4-chlorophenyl)-4,4-dimethyl-3-(1H-1,2,4-triazol-1-ylmethyl)pentan-3-ol Chemical compound C1=NC=NN1CC(O)(C(C)(C)C)CCC1=CC=C(Cl)C=C1 PXMNMQRDXWABCY-UHFFFAOYSA-N 0.000 claims description 8
- KWLVWJPJKJMCSH-UHFFFAOYSA-N 2-(4-chlorophenyl)-N-{2-[3-methoxy-4-(prop-2-yn-1-yloxy)phenyl]ethyl}-2-(prop-2-yn-1-yloxy)acetamide Chemical compound C1=C(OCC#C)C(OC)=CC(CCNC(=O)C(OCC#C)C=2C=CC(Cl)=CC=2)=C1 KWLVWJPJKJMCSH-UHFFFAOYSA-N 0.000 claims description 8
- MNHVNIJQQRJYDH-UHFFFAOYSA-N 2-[2-(1-chlorocyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl]-1,2-dihydro-1,2,4-triazole-3-thione Chemical compound N1=CNC(=S)N1CC(C1(Cl)CC1)(O)CC1=CC=CC=C1Cl MNHVNIJQQRJYDH-UHFFFAOYSA-N 0.000 claims description 8
- 239000005735 Benalaxyl-M Substances 0.000 claims description 8
- 239000005780 Fluazinam Substances 0.000 claims description 8
- 239000005782 Fluopicolide Substances 0.000 claims description 8
- 239000005800 Kresoxim-methyl Substances 0.000 claims description 8
- 239000005804 Mandipropamid Substances 0.000 claims description 8
- 239000005824 Proquinazid Substances 0.000 claims description 8
- 239000005825 Prothioconazole Substances 0.000 claims description 8
- 239000005837 Spiroxamine Substances 0.000 claims description 8
- 239000005839 Tebuconazole Substances 0.000 claims description 8
- CJPQIRJHIZUAQP-MRXNPFEDSA-N benalaxyl-M Chemical compound CC=1C=CC=C(C)C=1N([C@H](C)C(=O)OC)C(=O)CC1=CC=CC=C1 CJPQIRJHIZUAQP-MRXNPFEDSA-N 0.000 claims description 8
- 239000006013 carbendazim Substances 0.000 claims description 8
- UZCGKGPEKUCDTF-UHFFFAOYSA-N fluazinam Chemical compound [O-][N+](=O)C1=CC(C(F)(F)F)=C(Cl)C([N+]([O-])=O)=C1NC1=NC=C(C(F)(F)F)C=C1Cl UZCGKGPEKUCDTF-UHFFFAOYSA-N 0.000 claims description 8
- GBOYJIHYACSLGN-UHFFFAOYSA-N fluopicolide Chemical compound ClC1=CC(C(F)(F)F)=CN=C1CNC(=O)C1=C(Cl)C=CC=C1Cl GBOYJIHYACSLGN-UHFFFAOYSA-N 0.000 claims description 8
- ZOTBXTZVPHCKPN-HTXNQAPBSA-N kresoxim-methyl Chemical compound CO\N=C(\C(=O)OC)C1=CC=CC=C1COC1=CC=CC=C1C ZOTBXTZVPHCKPN-HTXNQAPBSA-N 0.000 claims description 8
- QXJKBPAVAHBARF-BETUJISGSA-N procymidone Chemical compound O=C([C@]1(C)C[C@@]1(C1=O)C)N1C1=CC(Cl)=CC(Cl)=C1 QXJKBPAVAHBARF-BETUJISGSA-N 0.000 claims description 8
- FLVBXVXXXMLMOX-UHFFFAOYSA-N proquinazid Chemical compound C1=C(I)C=C2C(=O)N(CCC)C(OCCC)=NC2=C1 FLVBXVXXXMLMOX-UHFFFAOYSA-N 0.000 claims description 8
- PUYXTUJWRLOUCW-UHFFFAOYSA-N spiroxamine Chemical compound O1C(CN(CC)CCC)COC11CCC(C(C)(C)C)CC1 PUYXTUJWRLOUCW-UHFFFAOYSA-N 0.000 claims description 8
- PFFIDZXUXFLSSR-UHFFFAOYSA-N 1-methyl-N-[2-(4-methylpentan-2-yl)-3-thienyl]-3-(trifluoromethyl)pyrazole-4-carboxamide Chemical compound S1C=CC(NC(=O)C=2C(=NN(C)C=2)C(F)(F)F)=C1C(C)CC(C)C PFFIDZXUXFLSSR-UHFFFAOYSA-N 0.000 claims description 7
- 235000010469 Glycine max Nutrition 0.000 claims description 7
- 239000005816 Penthiopyrad Substances 0.000 claims description 7
- 240000003768 Solanum lycopersicum Species 0.000 claims description 7
- 241001360088 Zymoseptoria tritici Species 0.000 claims description 7
- OIPMQULDKWSNGX-UHFFFAOYSA-N bis[[ethoxy(oxo)phosphaniumyl]oxy]alumanyloxy-ethoxy-oxophosphanium Chemical compound [Al+3].CCO[P+]([O-])=O.CCO[P+]([O-])=O.CCO[P+]([O-])=O OIPMQULDKWSNGX-UHFFFAOYSA-N 0.000 claims description 7
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 7
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 7
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims description 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 7
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 claims description 6
- 125000006479 2-pyridyl methyl group Chemical group [H]C1=C([H])C([H])=C([H])C(=N1)C([H])([H])* 0.000 claims description 6
- 239000005746 Carboxin Substances 0.000 claims description 6
- 244000068988 Glycine max Species 0.000 claims description 6
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims description 6
- XQJQCBDIXRIYRP-UHFFFAOYSA-N N-{2-[1,1'-bi(cyclopropyl)-2-yl]phenyl}-3-(difluoromethyl)-1-methyl-1pyrazole-4-carboxamide Chemical compound FC(F)C1=NN(C)C=C1C(=O)NC1=CC=CC=C1C1C(C2CC2)C1 XQJQCBDIXRIYRP-UHFFFAOYSA-N 0.000 claims description 6
- 239000005834 Sedaxane Substances 0.000 claims description 6
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 6
- 150000001412 amines Chemical class 0.000 claims description 6
- GYSSRZJIHXQEHQ-UHFFFAOYSA-N carboxin Chemical compound S1CCOC(C)=C1C(=O)NC1=CC=CC=C1 GYSSRZJIHXQEHQ-UHFFFAOYSA-N 0.000 claims description 6
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 6
- 239000003085 diluting agent Substances 0.000 claims description 6
- 229910052702 rhenium Inorganic materials 0.000 claims description 6
- XERJKGMBORTKEO-VZUCSPMQSA-N (1e)-2-(ethylcarbamoylamino)-n-methoxy-2-oxoethanimidoyl cyanide Chemical compound CCNC(=O)NC(=O)C(\C#N)=N\OC XERJKGMBORTKEO-VZUCSPMQSA-N 0.000 claims description 5
- SOUGWDPPRBKJEX-UHFFFAOYSA-N 3,5-dichloro-N-(1-chloro-3-methyl-2-oxopentan-3-yl)-4-methylbenzamide Chemical compound ClCC(=O)C(C)(CC)NC(=O)C1=CC(Cl)=C(C)C(Cl)=C1 SOUGWDPPRBKJEX-UHFFFAOYSA-N 0.000 claims description 5
- 239000005726 Ametoctradin Substances 0.000 claims description 5
- 241000123650 Botrytis cinerea Species 0.000 claims description 5
- 240000008067 Cucumis sativus Species 0.000 claims description 5
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 claims description 5
- 239000005756 Cymoxanil Substances 0.000 claims description 5
- 235000011430 Malus pumila Nutrition 0.000 claims description 5
- 235000015103 Malus silvestris Nutrition 0.000 claims description 5
- 239000005809 Metiram Substances 0.000 claims description 5
- 241000736122 Parastagonospora nodorum Species 0.000 claims description 5
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 5
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 5
- 239000005863 Zoxamide Substances 0.000 claims description 5
- GGKQIOFASHYUJZ-UHFFFAOYSA-N ametoctradin Chemical compound NC1=C(CCCCCCCC)C(CC)=NC2=NC=NN21 GGKQIOFASHYUJZ-UHFFFAOYSA-N 0.000 claims description 5
- 125000003277 amino group Chemical group 0.000 claims description 5
- 235000013339 cereals Nutrition 0.000 claims description 5
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 5
- RONFGUROBZGJKP-UHFFFAOYSA-N iminoctadine Chemical compound NC(N)=NCCCCCCCCNCCCCCCCCN=C(N)N RONFGUROBZGJKP-UHFFFAOYSA-N 0.000 claims description 5
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 229920000257 metiram Polymers 0.000 claims description 5
- 125000004434 sulfur atom Chemical group 0.000 claims description 5
- 125000004217 4-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C([H])([H])* 0.000 claims description 4
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 claims description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 4
- 241000223218 Fusarium Species 0.000 claims description 4
- 241000682645 Phakopsora pachyrhizi Species 0.000 claims description 4
- 239000005828 Pyrimethanil Substances 0.000 claims description 4
- 239000005829 Pyriofenone Substances 0.000 claims description 4
- 241000228452 Venturia inaequalis Species 0.000 claims description 4
- 235000014787 Vitis vinifera Nutrition 0.000 claims description 4
- 240000006365 Vitis vinifera Species 0.000 claims description 4
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 239000011630 iodine Substances 0.000 claims description 4
- 229910052740 iodine Inorganic materials 0.000 claims description 4
- ZLIBICFPKPWGIZ-UHFFFAOYSA-N pyrimethanil Chemical compound CC1=CC(C)=NC(NC=2C=CC=CC=2)=N1 ZLIBICFPKPWGIZ-UHFFFAOYSA-N 0.000 claims description 4
- NMVCBWZLCXANER-UHFFFAOYSA-N pyriofenone Chemical compound COC1=C(OC)C(OC)=CC(C)=C1C(=O)C1=C(C)C(Cl)=CN=C1OC NMVCBWZLCXANER-UHFFFAOYSA-N 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 239000011734 sodium Substances 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- 125000001174 sulfone group Chemical group 0.000 claims description 4
- 239000004094 surface-active agent Substances 0.000 claims description 4
- PPDBOQMNKNNODG-NTEUORMPSA-N (5E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1,2,4-triazol-1-ylmethyl)cyclopentanol Chemical compound C1=NC=NN1CC1(O)C(C)(C)CC\C1=C/C1=CC=C(Cl)C=C1 PPDBOQMNKNNODG-NTEUORMPSA-N 0.000 claims description 3
- QNBTYORWCCMPQP-JXAWBTAJSA-N (Z)-dimethomorph Chemical compound C1=C(OC)C(OC)=CC=C1C(\C=1C=CC(Cl)=CC=1)=C/C(=O)N1CCOCC1 QNBTYORWCCMPQP-JXAWBTAJSA-N 0.000 claims description 3
- JWUCHKBSVLQQCO-UHFFFAOYSA-N 1-(2-fluorophenyl)-1-(4-fluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanol Chemical compound C=1C=C(F)C=CC=1C(C=1C(=CC=CC=1)F)(O)CN1C=NC=N1 JWUCHKBSVLQQCO-UHFFFAOYSA-N 0.000 claims description 3
- VGPIBGGRCVEHQZ-UHFFFAOYSA-N 1-(biphenyl-4-yloxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butan-2-ol Chemical compound C1=NC=NN1C(C(O)C(C)(C)C)OC(C=C1)=CC=C1C1=CC=CC=C1 VGPIBGGRCVEHQZ-UHFFFAOYSA-N 0.000 claims description 3
- PZBPKYOVPCNPJY-UHFFFAOYSA-N 1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]imidazole Chemical compound ClC1=CC(Cl)=CC=C1C(OCC=C)CN1C=NC=C1 PZBPKYOVPCNPJY-UHFFFAOYSA-N 0.000 claims description 3
- MGNFYQILYYYUBS-UHFFFAOYSA-N 1-[3-(4-tert-butylphenyl)-2-methylpropyl]piperidine Chemical compound C=1C=C(C(C)(C)C)C=CC=1CC(C)CN1CCCCC1 MGNFYQILYYYUBS-UHFFFAOYSA-N 0.000 claims description 3
- YIKWKLYQRFRGPM-UHFFFAOYSA-N 1-dodecylguanidine acetate Chemical compound CC(O)=O.CCCCCCCCCCCCN=C(N)N YIKWKLYQRFRGPM-UHFFFAOYSA-N 0.000 claims description 3
- YTOPFCCWCSOHFV-UHFFFAOYSA-N 2,6-dimethyl-4-tridecylmorpholine Chemical compound CCCCCCCCCCCCCN1CC(C)OC(C)C1 YTOPFCCWCSOHFV-UHFFFAOYSA-N 0.000 claims description 3
- STMIIPIFODONDC-UHFFFAOYSA-N 2-(2,4-dichlorophenyl)-1-(1H-1,2,4-triazol-1-yl)hexan-2-ol Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(O)(CCCC)CN1C=NC=N1 STMIIPIFODONDC-UHFFFAOYSA-N 0.000 claims description 3
- UFNOUKDBUJZYDE-UHFFFAOYSA-N 2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol Chemical compound C1=NC=NN1CC(O)(C=1C=CC(Cl)=CC=1)C(C)C1CC1 UFNOUKDBUJZYDE-UHFFFAOYSA-N 0.000 claims description 3
- JERZEQUMJNCPRJ-UHFFFAOYSA-N 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol Chemical compound C=1C=C(OC=2C=CC(Cl)=CC=2)C=C(C(F)(F)F)C=1C(O)(C)CN1C=NC=N1 JERZEQUMJNCPRJ-UHFFFAOYSA-N 0.000 claims description 3
- SIIJJFOXEOHODQ-UHFFFAOYSA-N 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-3-methyl-1-(1,2,4-triazol-1-yl)butan-2-ol Chemical compound C=1C=C(OC=2C=CC(Cl)=CC=2)C=C(C(F)(F)F)C=1C(O)(C(C)C)CN1C=NC=N1 SIIJJFOXEOHODQ-UHFFFAOYSA-N 0.000 claims description 3
- RQDJADAKIFFEKQ-UHFFFAOYSA-N 4-(4-chlorophenyl)-2-phenyl-2-(1,2,4-triazol-1-ylmethyl)butanenitrile Chemical compound C1=CC(Cl)=CC=C1CCC(C=1C=CC=CC=1)(C#N)CN1N=CN=C1 RQDJADAKIFFEKQ-UHFFFAOYSA-N 0.000 claims description 3
- SBUKOHLFHYSZNG-UHFFFAOYSA-N 4-dodecyl-2,6-dimethylmorpholine Chemical compound CCCCCCCCCCCCN1CC(C)OC(C)C1 SBUKOHLFHYSZNG-UHFFFAOYSA-N 0.000 claims description 3
- GOFJDXZZHFNFLV-UHFFFAOYSA-N 5-fluoro-1,3-dimethyl-N-[2-(4-methylpentan-2-yl)phenyl]pyrazole-4-carboxamide Chemical compound CC(C)CC(C)C1=CC=CC=C1NC(=O)C1=C(F)N(C)N=C1C GOFJDXZZHFNFLV-UHFFFAOYSA-N 0.000 claims description 3
- 239000005727 Amisulbrom Substances 0.000 claims description 3
- 241000894006 Bacteria Species 0.000 claims description 3
- 239000005734 Benalaxyl Substances 0.000 claims description 3
- 239000005736 Benthiavalicarb Substances 0.000 claims description 3
- 239000005737 Benzovindiflupyr Substances 0.000 claims description 3
- 239000005741 Bromuconazole Substances 0.000 claims description 3
- 239000005747 Chlorothalonil Substances 0.000 claims description 3
- 239000005754 Cyazofamid Substances 0.000 claims description 3
- 239000005755 Cyflufenamid Substances 0.000 claims description 3
- 239000005757 Cyproconazole Substances 0.000 claims description 3
- 239000005760 Difenoconazole Substances 0.000 claims description 3
- 239000005761 Dimethomorph Substances 0.000 claims description 3
- 239000005765 Dodemorph Substances 0.000 claims description 3
- 239000005766 Dodine Substances 0.000 claims description 3
- 241000588694 Erwinia amylovora Species 0.000 claims description 3
- 239000005775 Fenbuconazole Substances 0.000 claims description 3
- 239000005776 Fenhexamid Substances 0.000 claims description 3
- 239000005777 Fenpropidin Substances 0.000 claims description 3
- 239000005785 Fluquinconazole Substances 0.000 claims description 3
- 239000005786 Flutolanil Substances 0.000 claims description 3
- 239000005787 Flutriafol Substances 0.000 claims description 3
- 239000005789 Folpet Substances 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- 239000005795 Imazalil Substances 0.000 claims description 3
- 239000005796 Ipconazole Substances 0.000 claims description 3
- 239000005797 Iprovalicarb Substances 0.000 claims description 3
- NWUWYYSKZYIQAE-ZBFHGGJFSA-N L-(R)-iprovalicarb Chemical compound CC(C)OC(=O)N[C@@H](C(C)C)C(=O)N[C@H](C)C1=CC=C(C)C=C1 NWUWYYSKZYIQAE-ZBFHGGJFSA-N 0.000 claims description 3
- 239000005807 Metalaxyl Substances 0.000 claims description 3
- 239000005808 Metalaxyl-M Substances 0.000 claims description 3
- 239000005868 Metconazole Substances 0.000 claims description 3
- CCCGEKHKTPTUHJ-UHFFFAOYSA-N N-[9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1-methylpyrazole-4-carboxamide Chemical compound FC(F)C1=NN(C)C=C1C(=O)NC1=CC=CC2=C1C1CCC2C1=C(Cl)Cl CCCGEKHKTPTUHJ-UHFFFAOYSA-N 0.000 claims description 3
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims description 3
- 244000061176 Nicotiana tabacum Species 0.000 claims description 3
- 239000005815 Penflufen Substances 0.000 claims description 3
- 241001281803 Plasmopara viticola Species 0.000 claims description 3
- 241000317981 Podosphaera fuliginea Species 0.000 claims description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 3
- 241000589516 Pseudomonas Species 0.000 claims description 3
- 241001123569 Puccinia recondita Species 0.000 claims description 3
- 241000520648 Pyrenophora teres Species 0.000 claims description 3
- 239000005858 Triflumizole Substances 0.000 claims description 3
- 239000005859 Triticonazole Substances 0.000 claims description 3
- 241000221577 Uromyces appendiculatus Species 0.000 claims description 3
- 241000700605 Viruses Species 0.000 claims description 3
- 241000589634 Xanthomonas Species 0.000 claims description 3
- CGIHPACLZJDCBQ-UHFFFAOYSA-N acibenzolar Chemical compound SC(=O)C1=CC=CC2=C1SN=N2 CGIHPACLZJDCBQ-UHFFFAOYSA-N 0.000 claims description 3
- 239000011717 all-trans-retinol Substances 0.000 claims description 3
- 235000019169 all-trans-retinol Nutrition 0.000 claims description 3
- BREATYVWRHIPIY-UHFFFAOYSA-N amisulbrom Chemical compound CN(C)S(=O)(=O)N1C=NC(S(=O)(=O)N2C3=CC(F)=CC=C3C(Br)=C2C)=N1 BREATYVWRHIPIY-UHFFFAOYSA-N 0.000 claims description 3
- AKNQMEBLVAMSNZ-UHFFFAOYSA-N azaconazole Chemical compound ClC1=CC(Cl)=CC=C1C1(CN2N=CN=C2)OCCO1 AKNQMEBLVAMSNZ-UHFFFAOYSA-N 0.000 claims description 3
- 229950000294 azaconazole Drugs 0.000 claims description 3
- RIOXQFHNBCKOKP-UHFFFAOYSA-N benomyl Chemical compound C1=CC=C2N(C(=O)NCCCC)C(NC(=O)OC)=NC2=C1 RIOXQFHNBCKOKP-UHFFFAOYSA-N 0.000 claims description 3
- VVSLYIKSEBPRSN-PELKAZGASA-N benthiavalicarb Chemical compound C1=C(F)C=C2SC([C@@H](C)NC(=O)[C@@H](NC(O)=O)C(C)C)=NC2=C1 VVSLYIKSEBPRSN-PELKAZGASA-N 0.000 claims description 3
- MITFXPHMIHQXPI-UHFFFAOYSA-N benzoxaprofen Natural products N=1C2=CC(C(C(O)=O)C)=CC=C2OC=1C1=CC=C(Cl)C=C1 MITFXPHMIHQXPI-UHFFFAOYSA-N 0.000 claims description 3
- HJJVPARKXDDIQD-UHFFFAOYSA-N bromuconazole Chemical compound ClC1=CC(Cl)=CC=C1C1(CN2N=CN=C2)OCC(Br)C1 HJJVPARKXDDIQD-UHFFFAOYSA-N 0.000 claims description 3
- JHRWWRDRBPCWTF-OLQVQODUSA-N captafol Chemical compound C1C=CC[C@H]2C(=O)N(SC(Cl)(Cl)C(Cl)Cl)C(=O)[C@H]21 JHRWWRDRBPCWTF-OLQVQODUSA-N 0.000 claims description 3
- CRQQGFGUEAVUIL-UHFFFAOYSA-N chlorothalonil Chemical compound ClC1=C(Cl)C(C#N)=C(Cl)C(C#N)=C1Cl CRQQGFGUEAVUIL-UHFFFAOYSA-N 0.000 claims description 3
- CWVRPJSBNHNJSI-XQNSMLJCSA-N coumoxystrobin Chemical compound C1=C2OC(=O)C(CCCC)=C(C)C2=CC=C1OCC1=CC=CC=C1\C(=C/OC)C(=O)OC CWVRPJSBNHNJSI-XQNSMLJCSA-N 0.000 claims description 3
- YXKMMRDKEKCERS-UHFFFAOYSA-N cyazofamid Chemical compound CN(C)S(=O)(=O)N1C(C#N)=NC(Cl)=C1C1=CC=C(C)C=C1 YXKMMRDKEKCERS-UHFFFAOYSA-N 0.000 claims description 3
- ACMXQHFNODYQAT-UHFFFAOYSA-N cyflufenamid Chemical compound FC1=CC=C(C(F)(F)F)C(C(NOCC2CC2)=NC(=O)CC=2C=CC=CC=2)=C1F ACMXQHFNODYQAT-UHFFFAOYSA-N 0.000 claims description 3
- BQYJATMQXGBDHF-UHFFFAOYSA-N difenoconazole Chemical compound O1C(C)COC1(C=1C(=CC(OC=2C=CC(Cl)=CC=2)=CC=1)Cl)CN1N=CN=C1 BQYJATMQXGBDHF-UHFFFAOYSA-N 0.000 claims description 3
- JMXKCYUTURMERF-UHFFFAOYSA-N dodemorph Chemical compound C1C(C)OC(C)CN1C1CCCCCCCCCCC1 JMXKCYUTURMERF-UHFFFAOYSA-N 0.000 claims description 3
- 229960002125 enilconazole Drugs 0.000 claims description 3
- VMNULHCTRPXWFJ-UJSVPXBISA-N enoxastrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1CO\N=C(/C)\C=C\C1=CC=C(Cl)C=C1 VMNULHCTRPXWFJ-UJSVPXBISA-N 0.000 claims description 3
- VDLGAVXLJYLFDH-UHFFFAOYSA-N fenhexamid Chemical compound C=1C=C(O)C(Cl)=C(Cl)C=1NC(=O)C1(C)CCCCC1 VDLGAVXLJYLFDH-UHFFFAOYSA-N 0.000 claims description 3
- IJJVMEJXYNJXOJ-UHFFFAOYSA-N fluquinconazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1N1C(=O)C2=CC(F)=CC=C2N=C1N1C=NC=N1 IJJVMEJXYNJXOJ-UHFFFAOYSA-N 0.000 claims description 3
- FQKUGOMFVDPBIZ-UHFFFAOYSA-N flusilazole Chemical compound C=1C=C(F)C=CC=1[Si](C=1C=CC(F)=CC=1)(C)CN1C=NC=N1 FQKUGOMFVDPBIZ-UHFFFAOYSA-N 0.000 claims description 3
- KGXUEPOHGFWQKF-ZCXUNETKSA-N flutianil Chemical compound COC1=CC=CC=C1N(CCS\1)C/1=C(C#N)/SC1=CC(C(F)(F)F)=CC=C1F KGXUEPOHGFWQKF-ZCXUNETKSA-N 0.000 claims description 3
- PTCGDEVVHUXTMP-UHFFFAOYSA-N flutolanil Chemical compound CC(C)OC1=CC=CC(NC(=O)C=2C(=CC=CC=2)C(F)(F)F)=C1 PTCGDEVVHUXTMP-UHFFFAOYSA-N 0.000 claims description 3
- HKIOYBQGHSTUDB-UHFFFAOYSA-N folpet Chemical compound C1=CC=C2C(=O)N(SC(Cl)(Cl)Cl)C(=O)C2=C1 HKIOYBQGHSTUDB-UHFFFAOYSA-N 0.000 claims description 3
- AGKSTYPVMZODRV-UHFFFAOYSA-N imibenconazole Chemical compound C1=CC(Cl)=CC=C1CSC(CN1N=CN=C1)=NC1=CC=C(Cl)C=C1Cl AGKSTYPVMZODRV-UHFFFAOYSA-N 0.000 claims description 3
- YTCIYOXHHQLDEI-SNVBAGLBSA-N inpyrfluxam Chemical compound C([C@H](C=12)C)C(C)(C)C2=CC=CC=1NC(=O)C1=CN(C)N=C1C(F)F YTCIYOXHHQLDEI-SNVBAGLBSA-N 0.000 claims description 3
- QTYCMDBMOLSEAM-UHFFFAOYSA-N ipconazole Chemical compound C1=NC=NN1CC1(O)C(C(C)C)CCC1CC1=CC=C(Cl)C=C1 QTYCMDBMOLSEAM-UHFFFAOYSA-N 0.000 claims description 3
- ZQEIXNIJLIKNTD-GFCCVEGCSA-N metalaxyl-M Chemical compound COCC(=O)N([C@H](C)C(=O)OC)C1=C(C)C=CC=C1C ZQEIXNIJLIKNTD-GFCCVEGCSA-N 0.000 claims description 3
- XWPZUHJBOLQNMN-UHFFFAOYSA-N metconazole Chemical compound C1=NC=NN1CC1(O)C(C)(C)CCC1CC1=CC=C(Cl)C=C1 XWPZUHJBOLQNMN-UHFFFAOYSA-N 0.000 claims description 3
- ZQEIXNIJLIKNTD-UHFFFAOYSA-N methyl N-(2,6-dimethylphenyl)-N-(methoxyacetyl)alaninate Chemical compound COCC(=O)N(C(C)C(=O)OC)C1=C(C)C=CC=C1C ZQEIXNIJLIKNTD-UHFFFAOYSA-N 0.000 claims description 3
- CJPQIRJHIZUAQP-UHFFFAOYSA-N methyl N-(2,6-dimethylphenyl)-N-(phenylacetyl)alaninate Chemical compound CC=1C=CC=C(C)C=1N(C(C)C(=O)OC)C(=O)CC1=CC=CC=C1 CJPQIRJHIZUAQP-UHFFFAOYSA-N 0.000 claims description 3
- HIIRDDUVRXCDBN-OBGWFSINSA-N metominostrobin Chemical compound CNC(=O)C(=N\OC)\C1=CC=CC=C1OC1=CC=CC=C1 HIIRDDUVRXCDBN-OBGWFSINSA-N 0.000 claims description 3
- JHIPUJPTQJYEQK-ZLHHXESBSA-N orysastrobin Chemical compound CNC(=O)C(=N\OC)\C1=CC=CC=C1CO\N=C(/C)\C(=N\OC)\C(\C)=N\OC JHIPUJPTQJYEQK-ZLHHXESBSA-N 0.000 claims description 3
- AMEKQAFGQBKLKX-UHFFFAOYSA-N oxycarboxin Chemical compound O=S1(=O)CCOC(C)=C1C(=O)NC1=CC=CC=C1 AMEKQAFGQBKLKX-UHFFFAOYSA-N 0.000 claims description 3
- 229910052700 potassium Inorganic materials 0.000 claims description 3
- 239000011591 potassium Substances 0.000 claims description 3
- DWTVBEZBWMDXIY-UHFFFAOYSA-N pyrametostrobin Chemical compound COC(=O)N(OC)C1=CC=CC=C1COC1=C(C)C(C=2C=CC=CC=2)=NN1C DWTVBEZBWMDXIY-UHFFFAOYSA-N 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- 239000002689 soil Substances 0.000 claims description 3
- 239000004308 thiabendazole Substances 0.000 claims description 3
- WJCNZQLZVWNLKY-UHFFFAOYSA-N thiabendazole Chemical compound S1C=NC(C=2NC3=CC=CC=C3N=2)=C1 WJCNZQLZVWNLKY-UHFFFAOYSA-N 0.000 claims description 3
- 235000010296 thiabendazole Nutrition 0.000 claims description 3
- 229960004546 thiabendazole Drugs 0.000 claims description 3
- HSMVPDGQOIQYSR-KGENOOAVSA-N triflumizole Chemical compound C1=CN=CN1C(/COCCC)=N/C1=CC=C(Cl)C=C1C(F)(F)F HSMVPDGQOIQYSR-KGENOOAVSA-N 0.000 claims description 3
- LDVVMCZRFWMZSG-OLQVQODUSA-N (3ar,7as)-2-(trichloromethylsulfanyl)-3a,4,7,7a-tetrahydroisoindole-1,3-dione Chemical compound C1C=CC[C@H]2C(=O)N(SC(Cl)(Cl)Cl)C(=O)[C@H]21 LDVVMCZRFWMZSG-OLQVQODUSA-N 0.000 claims description 2
- BKBSMMUEEAWFRX-NBVRZTHBSA-N (E)-flumorph Chemical compound C1=C(OC)C(OC)=CC=C1C(\C=1C=CC(F)=CC=1)=C\C(=O)N1CCOCC1 BKBSMMUEEAWFRX-NBVRZTHBSA-N 0.000 claims description 2
- WURBVZBTWMNKQT-UHFFFAOYSA-N 1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butan-2-one Chemical compound C1=NC=NN1C(C(=O)C(C)(C)C)OC1=CC=C(Cl)C=C1 WURBVZBTWMNKQT-UHFFFAOYSA-N 0.000 claims description 2
- HZJKXKUJVSEEFU-UHFFFAOYSA-N 2-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)hexanenitrile Chemical compound C=1C=C(Cl)C=CC=1C(CCCC)(C#N)CN1C=NC=N1 HZJKXKUJVSEEFU-UHFFFAOYSA-N 0.000 claims description 2
- YABFPHSQTSFWQB-UHFFFAOYSA-N 2-(4-fluorophenyl)-1-(1,2,4-triazol-1-yl)-3-(trimethylsilyl)propan-2-ol Chemical compound C=1C=C(F)C=CC=1C(O)(C[Si](C)(C)C)CN1C=NC=N1 YABFPHSQTSFWQB-UHFFFAOYSA-N 0.000 claims description 2
- NRTLIYOWLVMQBO-UHFFFAOYSA-N 5-chloro-1,3-dimethyl-N-(1,1,3-trimethyl-1,3-dihydro-2-benzofuran-4-yl)pyrazole-4-carboxamide Chemical compound C=12C(C)OC(C)(C)C2=CC=CC=1NC(=O)C=1C(C)=NN(C)C=1Cl NRTLIYOWLVMQBO-UHFFFAOYSA-N 0.000 claims description 2
- PCCSBWNGDMYFCW-UHFFFAOYSA-N 5-methyl-5-(4-phenoxyphenyl)-3-(phenylamino)-1,3-oxazolidine-2,4-dione Chemical compound O=C1C(C)(C=2C=CC(OC=3C=CC=CC=3)=CC=2)OC(=O)N1NC1=CC=CC=C1 PCCSBWNGDMYFCW-UHFFFAOYSA-N 0.000 claims description 2
- 239000005739 Bordeaux mixture Substances 0.000 claims description 2
- 239000005745 Captan Substances 0.000 claims description 2
- JJLJMEJHUUYSSY-UHFFFAOYSA-L Copper hydroxide Chemical compound [OH-].[OH-].[Cu+2] JJLJMEJHUUYSSY-UHFFFAOYSA-L 0.000 claims description 2
- 239000005750 Copper hydroxide Substances 0.000 claims description 2
- 239000005772 Famoxadone Substances 0.000 claims description 2
- 239000005774 Fenamidone Substances 0.000 claims description 2
- 239000005781 Fludioxonil Substances 0.000 claims description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 2
- 239000005802 Mancozeb Substances 0.000 claims description 2
- 239000005811 Myclobutanil Substances 0.000 claims description 2
- XFOXDUJCOHBXRC-UHFFFAOYSA-N N-Ethyl-N-methyl-4-(trifluoromethyl)-2-(3,4-dimethoxyphenyl)benzamide Chemical compound CCN(C)C(=O)C1=CC=C(C(F)(F)F)C=C1C1=CC=C(OC)C(OC)=C1 XFOXDUJCOHBXRC-UHFFFAOYSA-N 0.000 claims description 2
- NQRFDNJEBWAUBL-UHFFFAOYSA-N N-[cyano(2-thienyl)methyl]-4-ethyl-2-(ethylamino)-1,3-thiazole-5-carboxamide Chemical compound S1C(NCC)=NC(CC)=C1C(=O)NC(C#N)C1=CC=CS1 NQRFDNJEBWAUBL-UHFFFAOYSA-N 0.000 claims description 2
- 239000005819 Potassium phosphonate Substances 0.000 claims description 2
- 239000005822 Propiconazole Substances 0.000 claims description 2
- 239000005823 Propineb Substances 0.000 claims description 2
- 239000005831 Quinoxyfen Substances 0.000 claims description 2
- 239000005835 Silthiofam Substances 0.000 claims description 2
- 229930182692 Strobilurin Natural products 0.000 claims description 2
- 239000005846 Triadimenol Substances 0.000 claims description 2
- DGYIJVNZSDYBOE-UHFFFAOYSA-N [CH2]C1=CC=NC=C1 Chemical group [CH2]C1=CC=NC=C1 DGYIJVNZSDYBOE-UHFFFAOYSA-N 0.000 claims description 2
- 229910052783 alkali metal Inorganic materials 0.000 claims description 2
- 150000001340 alkali metals Chemical class 0.000 claims description 2
- 150000008059 anilinopyrimidines Chemical class 0.000 claims description 2
- 239000003242 anti bacterial agent Substances 0.000 claims description 2
- 229940088710 antibiotic agent Drugs 0.000 claims description 2
- 125000004429 atom Chemical group 0.000 claims description 2
- 150000001556 benzimidazoles Chemical class 0.000 claims description 2
- 229940117949 captan Drugs 0.000 claims description 2
- RXDMAYSSBPYBFW-UHFFFAOYSA-N carpropamid Chemical compound C=1C=C(Cl)C=CC=1C(C)NC(=O)C1(CC)C(C)C1(Cl)Cl RXDMAYSSBPYBFW-UHFFFAOYSA-N 0.000 claims description 2
- 229910001956 copper hydroxide Inorganic materials 0.000 claims description 2
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 claims description 2
- 150000008056 dicarboxyimides Chemical class 0.000 claims description 2
- YXXXKCDYKKSZHL-UHFFFAOYSA-M dipotassium;dioxido(oxo)phosphanium Chemical compound [K+].[K+].[O-][P+]([O-])=O YXXXKCDYKKSZHL-UHFFFAOYSA-M 0.000 claims description 2
- 239000012990 dithiocarbamate Substances 0.000 claims description 2
- 150000004659 dithiocarbamates Chemical class 0.000 claims description 2
- 230000008686 ergosterol biosynthesis Effects 0.000 claims description 2
- LMVPQMGRYSRMIW-KRWDZBQOSA-N fenamidone Chemical compound O=C([C@@](C)(N=C1SC)C=2C=CC=CC=2)N1NC1=CC=CC=C1 LMVPQMGRYSRMIW-KRWDZBQOSA-N 0.000 claims description 2
- 239000003337 fertilizer Substances 0.000 claims description 2
- MUJOIMFVNIBMKC-UHFFFAOYSA-N fludioxonil Chemical compound C=12OC(F)(F)OC2=CC=CC=1C1=CNC=C1C#N MUJOIMFVNIBMKC-UHFFFAOYSA-N 0.000 claims description 2
- 239000004009 herbicide Substances 0.000 claims description 2
- 239000000411 inducer Substances 0.000 claims description 2
- 239000003112 inhibitor Substances 0.000 claims description 2
- 230000002401 inhibitory effect Effects 0.000 claims description 2
- 239000002917 insecticide Substances 0.000 claims description 2
- 239000000543 intermediate Substances 0.000 claims description 2
- 229910052744 lithium Inorganic materials 0.000 claims description 2
- YKSNLCVSTHTHJA-UHFFFAOYSA-L maneb Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S YKSNLCVSTHTHJA-UHFFFAOYSA-L 0.000 claims description 2
- 229920000940 maneb Polymers 0.000 claims description 2
- CIEXPHRYOLIQQD-UHFFFAOYSA-N methyl N-(2,6-dimethylphenyl)-N-2-furoylalaninate Chemical compound CC=1C=CC=C(C)C=1N(C(C)C(=O)OC)C(=O)C1=CC=CO1 CIEXPHRYOLIQQD-UHFFFAOYSA-N 0.000 claims description 2
- 231100001184 nonphytotoxic Toxicity 0.000 claims description 2
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 150000008060 phenylpyrroles Chemical class 0.000 claims description 2
- 125000005543 phthalimide group Chemical class 0.000 claims description 2
- 239000005648 plant growth regulator Substances 0.000 claims description 2
- WHHIPMZEDGBUCC-UHFFFAOYSA-N probenazole Chemical compound C1=CC=C2C(OCC=C)=NS(=O)(=O)C2=C1 WHHIPMZEDGBUCC-UHFFFAOYSA-N 0.000 claims description 2
- STJLVHWMYQXCPB-UHFFFAOYSA-N propiconazole Chemical compound O1C(CCC)COC1(C=1C(=CC(Cl)=CC=1)Cl)CN1N=CN=C1 STJLVHWMYQXCPB-UHFFFAOYSA-N 0.000 claims description 2
- KKMLIVYBGSAJPM-UHFFFAOYSA-L propineb Chemical compound [Zn+2].[S-]C(=S)NC(C)CNC([S-])=S KKMLIVYBGSAJPM-UHFFFAOYSA-L 0.000 claims description 2
- WRPIRSINYZBGPK-UHFFFAOYSA-N quinoxyfen Chemical compound C1=CC(F)=CC=C1OC1=CC=NC2=CC(Cl)=CC(Cl)=C12 WRPIRSINYZBGPK-UHFFFAOYSA-N 0.000 claims description 2
- MXMXHPPIGKYTAR-UHFFFAOYSA-N silthiofam Chemical compound CC=1SC([Si](C)(C)C)=C(C(=O)NCC=C)C=1C MXMXHPPIGKYTAR-UHFFFAOYSA-N 0.000 claims description 2
- 230000009885 systemic effect Effects 0.000 claims description 2
- LWLJEQHTPVPKSJ-UHFFFAOYSA-N tebufloquin Chemical compound C1=C(C(C)(C)C)C=C2C(OC(=O)C)=C(C)C(C)=NC2=C1F LWLJEQHTPVPKSJ-UHFFFAOYSA-N 0.000 claims description 2
- ISIJQEHRDSCQIU-UHFFFAOYSA-N tert-butyl 2,7-diazaspiro[4.5]decane-7-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCCC11CNCC1 ISIJQEHRDSCQIU-UHFFFAOYSA-N 0.000 claims description 2
- BAZVSMNPJJMILC-UHFFFAOYSA-N triadimenol Chemical compound C1=NC=NN1C(C(O)C(C)(C)C)OC1=CC=C(Cl)C=C1 BAZVSMNPJJMILC-UHFFFAOYSA-N 0.000 claims description 2
- DQJCHOQLCLEDLL-UHFFFAOYSA-N tricyclazole Chemical compound CC1=CC=CC2=C1N1C=NN=C1S2 DQJCHOQLCLEDLL-UHFFFAOYSA-N 0.000 claims description 2
- 244000141359 Malus pumila Species 0.000 claims 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 75
- 239000000243 solution Substances 0.000 description 44
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 39
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 28
- 239000000047 product Substances 0.000 description 26
- 239000011541 reaction mixture Substances 0.000 description 26
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 25
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 24
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 21
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 21
- 238000006243 chemical reaction Methods 0.000 description 20
- 238000003756 stirring Methods 0.000 description 19
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 18
- 230000000694 effects Effects 0.000 description 17
- 238000004587 chromatography analysis Methods 0.000 description 16
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 16
- 239000012071 phase Substances 0.000 description 16
- 239000000741 silica gel Substances 0.000 description 16
- 229910002027 silica gel Inorganic materials 0.000 description 16
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 15
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 14
- 239000007832 Na2SO4 Substances 0.000 description 12
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 12
- 239000008346 aqueous phase Substances 0.000 description 12
- 239000012074 organic phase Substances 0.000 description 12
- 239000012047 saturated solution Substances 0.000 description 12
- 239000011780 sodium chloride Substances 0.000 description 12
- 229910052938 sodium sulfate Inorganic materials 0.000 description 12
- 235000011152 sodium sulphate Nutrition 0.000 description 12
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 11
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 10
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 10
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- 150000002431 hydrogen Chemical class 0.000 description 10
- 238000000746 purification Methods 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 8
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 8
- 239000003480 eluent Substances 0.000 description 8
- 239000000725 suspension Substances 0.000 description 8
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- 235000019253 formic acid Nutrition 0.000 description 7
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 239000002054 inoculum Substances 0.000 description 6
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 6
- 238000010992 reflux Methods 0.000 description 6
- 241000209140 Triticum Species 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 230000009466 transformation Effects 0.000 description 5
- 238000000844 transformation Methods 0.000 description 5
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 4
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 4
- FCOUHTHQYOMLJT-UHFFFAOYSA-N 6-methylheptan-2-ol Chemical compound CC(C)CCCC(C)O FCOUHTHQYOMLJT-UHFFFAOYSA-N 0.000 description 4
- 244000070406 Malus silvestris Species 0.000 description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
- 235000021307 Triticum Nutrition 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 125000005907 alkyl ester group Chemical group 0.000 description 4
- 235000021186 dishes Nutrition 0.000 description 4
- 230000002538 fungal effect Effects 0.000 description 4
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 125000006239 protecting group Chemical group 0.000 description 4
- 238000006722 reduction reaction Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 230000002195 synergetic effect Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- 229920000742 Cotton Polymers 0.000 description 3
- 239000005791 Fuberidazole Substances 0.000 description 3
- 241001330975 Magnaporthe oryzae Species 0.000 description 3
- 241000233622 Phytophthora infestans Species 0.000 description 3
- 231100000674 Phytotoxicity Toxicity 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- 235000002595 Solanum tuberosum Nutrition 0.000 description 3
- 244000061456 Solanum tuberosum Species 0.000 description 3
- 230000000843 anti-fungal effect Effects 0.000 description 3
- 229940121375 antifungal agent Drugs 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 238000006170 formylation reaction Methods 0.000 description 3
- UYJUZNLFJAWNEZ-UHFFFAOYSA-N fuberidazole Chemical compound C1=COC(C=2NC3=CC=CC=C3N=2)=C1 UYJUZNLFJAWNEZ-UHFFFAOYSA-N 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 229910000027 potassium carbonate Inorganic materials 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 230000003449 preventive effect Effects 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- 235000013311 vegetables Nutrition 0.000 description 3
- 239000011787 zinc oxide Substances 0.000 description 3
- VUXIWECKDVXDBG-ZCFIWIBFSA-N (2r)-2-[(2-methylpropan-2-yl)oxycarbonylamino]butanethioic s-acid Chemical compound CC[C@H](C(S)=O)NC(=O)OC(C)(C)C VUXIWECKDVXDBG-ZCFIWIBFSA-N 0.000 description 2
- UGJQNSILMBYITH-UHFFFAOYSA-N (4-hydroxyphenyl)iminourea Chemical compound NC(=O)N=Nc1ccc(O)cc1 UGJQNSILMBYITH-UHFFFAOYSA-N 0.000 description 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 2
- CKPCAYZTYMHQEX-NBVRZTHBSA-N (e)-1-(2,4-dichlorophenyl)-n-methoxy-2-pyridin-3-ylethanimine Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(=N/OC)/CC1=CC=CN=C1 CKPCAYZTYMHQEX-NBVRZTHBSA-N 0.000 description 2
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 2
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 2
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 2
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
- OGBSAJWRIPNIER-UHFFFAOYSA-N 2-chloro-6-(furan-2-ylmethoxy)-4-(trichloromethyl)pyridine Chemical compound ClC1=CC(C(Cl)(Cl)Cl)=CC(OCC=2OC=CC=2)=N1 OGBSAJWRIPNIER-UHFFFAOYSA-N 0.000 description 2
- YEDUAINPPJYDJZ-UHFFFAOYSA-N 2-hydroxybenzothiazole Chemical compound C1=CC=C2SC(O)=NC2=C1 YEDUAINPPJYDJZ-UHFFFAOYSA-N 0.000 description 2
- OVFHHJZHXHZIHT-UHFFFAOYSA-N 3-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-yl)quinazolin-4-one Chemical compound ClC1=CC(Cl)=CC=C1N1C(=O)C2=CC=CC=C2N=C1N1N=CN=C1 OVFHHJZHXHZIHT-UHFFFAOYSA-N 0.000 description 2
- OBHHCPRYWZKEIM-UHFFFAOYSA-N 3-hydroxy-4-methoxypyridine-2-carboxylic acid Chemical compound COC1=CC=NC(C(O)=O)=C1O OBHHCPRYWZKEIM-UHFFFAOYSA-N 0.000 description 2
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 244000291564 Allium cepa Species 0.000 description 2
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 2
- 244000144725 Amygdalus communis Species 0.000 description 2
- 235000011437 Amygdalus communis Nutrition 0.000 description 2
- 244000144730 Amygdalus persica Species 0.000 description 2
- 235000017060 Arachis glabrata Nutrition 0.000 description 2
- 244000105624 Arachis hypogaea Species 0.000 description 2
- 235000010777 Arachis hypogaea Nutrition 0.000 description 2
- 235000018262 Arachis monticola Nutrition 0.000 description 2
- 244000003416 Asparagus officinalis Species 0.000 description 2
- 235000005340 Asparagus officinalis Nutrition 0.000 description 2
- 235000007319 Avena orientalis Nutrition 0.000 description 2
- 244000075850 Avena orientalis Species 0.000 description 2
- 235000000832 Ayote Nutrition 0.000 description 2
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 2
- 241000167854 Bourreria succulenta Species 0.000 description 2
- 240000002791 Brassica napus Species 0.000 description 2
- 240000007124 Brassica oleracea Species 0.000 description 2
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 2
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 2
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 2
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 2
- YJVQZQLORSIHLL-UHFFFAOYSA-N CC(O)C(C1=CC=C(F)C=C1)C1=CC=C(F)C=C1 Chemical compound CC(O)C(C1=CC=C(F)C=C1)C1=CC=C(F)C=C1 YJVQZQLORSIHLL-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 235000002566 Capsicum Nutrition 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 241000530549 Cercospora beticola Species 0.000 description 2
- 244000241235 Citrullus lanatus Species 0.000 description 2
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 description 2
- 235000005979 Citrus limon Nutrition 0.000 description 2
- 244000131522 Citrus pyriformis Species 0.000 description 2
- 241001672694 Citrus reticulata Species 0.000 description 2
- 240000000560 Citrus x paradisi Species 0.000 description 2
- 235000013162 Cocos nucifera Nutrition 0.000 description 2
- 244000060011 Cocos nucifera Species 0.000 description 2
- 240000007154 Coffea arabica Species 0.000 description 2
- 241001120669 Colletotrichum lindemuthianum Species 0.000 description 2
- 241000219112 Cucumis Species 0.000 description 2
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 2
- 240000004244 Cucurbita moschata Species 0.000 description 2
- 235000009854 Cucurbita moschata Nutrition 0.000 description 2
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 2
- 235000002767 Daucus carota Nutrition 0.000 description 2
- 244000000626 Daucus carota Species 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 235000016623 Fragaria vesca Nutrition 0.000 description 2
- 240000009088 Fragaria x ananassa Species 0.000 description 2
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 241000219146 Gossypium Species 0.000 description 2
- 244000020551 Helianthus annuus Species 0.000 description 2
- 235000003222 Helianthus annuus Nutrition 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- FAIXYKHYOGVFKA-UHFFFAOYSA-N Kinetin Natural products N=1C=NC=2N=CNC=2C=1N(C)C1=CC=CO1 FAIXYKHYOGVFKA-UHFFFAOYSA-N 0.000 description 2
- 235000003228 Lactuca sativa Nutrition 0.000 description 2
- 240000008415 Lactuca sativa Species 0.000 description 2
- 235000014647 Lens culinaris subsp culinaris Nutrition 0.000 description 2
- 244000043158 Lens esculenta Species 0.000 description 2
- CPLXHLVBOLITMK-UHFFFAOYSA-N Magnesium oxide Chemical compound [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- 240000005561 Musa balbisiana Species 0.000 description 2
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 239000006002 Pepper Substances 0.000 description 2
- 235000016761 Piper aduncum Nutrition 0.000 description 2
- 240000003889 Piper guineense Species 0.000 description 2
- 235000017804 Piper guineense Nutrition 0.000 description 2
- 235000008184 Piper nigrum Nutrition 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 240000004713 Pisum sativum Species 0.000 description 2
- 235000010582 Pisum sativum Nutrition 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 235000014443 Pyrus communis Nutrition 0.000 description 2
- 241000918584 Pythium ultimum Species 0.000 description 2
- CDEWHBGYSWJUFP-UHFFFAOYSA-N Quinacetol sulfate Chemical compound OS(O)(=O)=O.C1=CC=C2C(C(=O)C)=CC=C(O)C2=N1.C1=CC=C2C(C(=O)C)=CC=C(O)C2=N1 CDEWHBGYSWJUFP-UHFFFAOYSA-N 0.000 description 2
- 235000004443 Ricinus communis Nutrition 0.000 description 2
- 241001092459 Rubus Species 0.000 description 2
- 235000017848 Rubus fruticosus Nutrition 0.000 description 2
- 240000007651 Rubus glaucus Species 0.000 description 2
- 235000011034 Rubus glaucus Nutrition 0.000 description 2
- 235000009122 Rubus idaeus Nutrition 0.000 description 2
- 240000000111 Saccharum officinarum Species 0.000 description 2
- 235000007201 Saccharum officinarum Nutrition 0.000 description 2
- 241000209056 Secale Species 0.000 description 2
- 235000007238 Secale cereale Nutrition 0.000 description 2
- 241001533598 Septoria Species 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 235000002597 Solanum melongena Nutrition 0.000 description 2
- 244000061458 Solanum melongena Species 0.000 description 2
- 240000003829 Sorghum propinquum Species 0.000 description 2
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 2
- 235000009337 Spinacia oleracea Nutrition 0.000 description 2
- 244000300264 Spinacia oleracea Species 0.000 description 2
- 241001466451 Stramenopiles Species 0.000 description 2
- 235000021536 Sugar beet Nutrition 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 235000009470 Theobroma cacao Nutrition 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- 241000723873 Tobacco mosaic virus Species 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 235000020224 almond Nutrition 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- LJOZMWRYMKECFF-UHFFFAOYSA-N benodanil Chemical compound IC1=CC=CC=C1C(=O)NC1=CC=CC=C1 LJOZMWRYMKECFF-UHFFFAOYSA-N 0.000 description 2
- CEJAMBAOKKMZRC-UHFFFAOYSA-N benzyl 2-nitrooxybenzoate Chemical compound [O-][N+](=O)OC1=CC=CC=C1C(=O)OCC1=CC=CC=C1 CEJAMBAOKKMZRC-UHFFFAOYSA-N 0.000 description 2
- 235000021029 blackberry Nutrition 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 235000019693 cherries Nutrition 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- 235000020971 citrus fruits Nutrition 0.000 description 2
- 239000003245 coal Substances 0.000 description 2
- 235000016213 coffee Nutrition 0.000 description 2
- 235000013353 coffee beverage Nutrition 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 230000001143 conditioned effect Effects 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- YPHMISFOHDHNIV-FSZOTQKASA-N cycloheximide Chemical compound C1[C@@H](C)C[C@H](C)C(=O)[C@@H]1[C@H](O)CC1CC(=O)NC(=O)C1 YPHMISFOHDHNIV-FSZOTQKASA-N 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000009036 growth inhibition Effects 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- HJOVHMDZYOCNQW-UHFFFAOYSA-N isophorone Chemical compound CC1=CC(=O)CC(C)(C)C1 HJOVHMDZYOCNQW-UHFFFAOYSA-N 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- QANMHLXAZMSUEX-UHFFFAOYSA-N kinetin Chemical compound N=1C=NC=2N=CNC=2C=1NCC1=CC=CO1 QANMHLXAZMSUEX-UHFFFAOYSA-N 0.000 description 2
- 229960001669 kinetin Drugs 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 235000021374 legumes Nutrition 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 229910052763 palladium Inorganic materials 0.000 description 2
- 235000020232 peanut Nutrition 0.000 description 2
- 239000000575 pesticide Substances 0.000 description 2
- 239000001965 potato dextrose agar Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 235000015136 pumpkin Nutrition 0.000 description 2
- DHTJFQWHCVTNRY-OEMAIJDKSA-N pyrisoxazole Chemical compound C1([C@@]2(C)CC(ON2C)C=2C=CC(Cl)=CC=2)=CC=CN=C1 DHTJFQWHCVTNRY-OEMAIJDKSA-N 0.000 description 2
- XRJLAOUDSILTFT-UHFFFAOYSA-N pyroquilon Chemical compound O=C1CCC2=CC=CC3=C2N1CC3 XRJLAOUDSILTFT-UHFFFAOYSA-N 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 238000009331 sowing Methods 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- HHVIBTZHLRERCL-UHFFFAOYSA-N sulfonyldimethane Chemical compound CS(C)(=O)=O HHVIBTZHLRERCL-UHFFFAOYSA-N 0.000 description 2
- 235000013616 tea Nutrition 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- QIJRTFXNRTXDIP-UHFFFAOYSA-N (1-carboxy-2-sulfanylethyl)azanium;chloride;hydrate Chemical compound O.Cl.SCC(N)C(O)=O QIJRTFXNRTXDIP-UHFFFAOYSA-N 0.000 description 1
- YNWVFADWVLCOPU-MDWZMJQESA-N (1E)-1-(4-chlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)pent-1-en-3-ol Chemical compound C1=NC=NN1/C(C(O)C(C)(C)C)=C/C1=CC=C(Cl)C=C1 YNWVFADWVLCOPU-MDWZMJQESA-N 0.000 description 1
- PTKVPQXEKZOPNA-UHFFFAOYSA-N (2,4-dinitro-6-octan-2-ylphenyl) methylsulfanylformate Chemical compound CCCCCCC(C)C1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1OC(=O)SC PTKVPQXEKZOPNA-UHFFFAOYSA-N 0.000 description 1
- QQHRSBLQLJPBPJ-UHFFFAOYSA-N (2,4-dinitro-6-pentan-2-ylphenyl) propan-2-yl carbonate Chemical compound CCCC(C)C1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1OC(=O)OC(C)C QQHRSBLQLJPBPJ-UHFFFAOYSA-N 0.000 description 1
- NHOWDZOIZKMVAI-UHFFFAOYSA-N (2-chlorophenyl)(4-chlorophenyl)pyrimidin-5-ylmethanol Chemical compound C=1N=CN=CC=1C(C=1C(=CC=CC=1)Cl)(O)C1=CC=C(Cl)C=C1 NHOWDZOIZKMVAI-UHFFFAOYSA-N 0.000 description 1
- IXNUTQCZWAHNPN-UHFFFAOYSA-N (2-tert-butyl-4,6-dinitrophenyl) ethyl carbonate Chemical compound CCOC(=O)OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1C(C)(C)C IXNUTQCZWAHNPN-UHFFFAOYSA-N 0.000 description 1
- YJVQZQLORSIHLL-JTQLQIEISA-N (2S)-1,1-bis(4-fluorophenyl)propan-2-ol Chemical compound C[C@H](O)C(C1=CC=C(F)C=C1)C1=CC=C(F)C=C1 YJVQZQLORSIHLL-JTQLQIEISA-N 0.000 description 1
- CXNPLSGKWMLZPZ-GIFSMMMISA-N (2r,3r,6s)-3-[[(3s)-3-amino-5-[carbamimidoyl(methyl)amino]pentanoyl]amino]-6-(4-amino-2-oxopyrimidin-1-yl)-3,6-dihydro-2h-pyran-2-carboxylic acid Chemical compound O1[C@@H](C(O)=O)[C@H](NC(=O)C[C@@H](N)CCN(C)C(N)=N)C=C[C@H]1N1C(=O)N=C(N)C=C1 CXNPLSGKWMLZPZ-GIFSMMMISA-N 0.000 description 1
- PWWPULQZEAPTTB-UHFFFAOYSA-N (4-phenoxyphenyl)methyl 2-amino-6-methylpyridine-3-carboxylate Chemical compound NC1=NC(C)=CC=C1C(=O)OCC(C=C1)=CC=C1OC1=CC=CC=C1 PWWPULQZEAPTTB-UHFFFAOYSA-N 0.000 description 1
- MBIZXFATKUQOOA-UHFFFAOYSA-N 1,3,4-thiadiazole Chemical compound C1=NN=CS1 MBIZXFATKUQOOA-UHFFFAOYSA-N 0.000 description 1
- IAQLCKZJGNTRDO-UHFFFAOYSA-N 1-(4-{4-[5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone Chemical compound CC1=CC(C(F)(F)F)=NN1CC(=O)N1CCC(C=2SC=C(N=2)C=2CC(ON=2)C=2C(=CC=CC=2F)F)CC1 IAQLCKZJGNTRDO-UHFFFAOYSA-N 0.000 description 1
- DELJNDWGTWHHFA-UHFFFAOYSA-N 1-azaniumylpropyl(hydroxy)phosphinate Chemical compound CCC(N)P(O)(O)=O DELJNDWGTWHHFA-UHFFFAOYSA-N 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- XEZNGIUYQVAUSS-UHFFFAOYSA-N 18-crown-6 Chemical compound C1COCCOCCOCCOCCOCCO1 XEZNGIUYQVAUSS-UHFFFAOYSA-N 0.000 description 1
- 125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 description 1
- NIOPZPCMRQGZCE-WEVVVXLNSA-N 2,4-dinitro-6-(octan-2-yl)phenyl (E)-but-2-enoate Chemical compound CCCCCCC(C)C1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1OC(=O)\C=C\C NIOPZPCMRQGZCE-WEVVVXLNSA-N 0.000 description 1
- OILIYWFQRJOPAI-UHFFFAOYSA-N 2-(2-chlorophenyl)-1h-benzimidazole Chemical compound ClC1=CC=CC=C1C1=NC2=CC=CC=C2N1 OILIYWFQRJOPAI-UHFFFAOYSA-N 0.000 description 1
- FYYCHCQKJPTKKJ-UHFFFAOYSA-N 2-(3-fluoro-4-methylphenyl)propan-2-ol Chemical compound CC1=CC=C(C(C)(C)O)C=C1F FYYCHCQKJPTKKJ-UHFFFAOYSA-N 0.000 description 1
- QURXIISLVHJNGB-UHFFFAOYSA-N 2-(4-fluorophenyl)propan-2-ol Chemical compound CC(C)(O)C1=CC=C(F)C=C1 QURXIISLVHJNGB-UHFFFAOYSA-N 0.000 description 1
- ZEXXEODAXHSRDJ-UHFFFAOYSA-N 2-[(ethanesulfonyl)amino]-5-fluoro-4-[4-methyl-5-oxo-3-(trifluoromethyl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]benzene-1-carbothioamide Chemical compound CS(=O)(=O)OC1=CC=CC(Cl)=C1C1ON=C(C=2N=C(SC=2)C2CCN(CC2)C(=O)CN2C(=CC(=N2)C(F)F)C(F)F)C1 ZEXXEODAXHSRDJ-UHFFFAOYSA-N 0.000 description 1
- OWDLFBLNMPCXSD-UHFFFAOYSA-N 2-chloro-N-(2,6-dimethylphenyl)-N-(2-oxotetrahydrofuran-3-yl)acetamide Chemical compound CC1=CC=CC(C)=C1N(C(=O)CCl)C1C(=O)OCC1 OWDLFBLNMPCXSD-UHFFFAOYSA-N 0.000 description 1
- WWWFHFGUOIQNJC-UHFFFAOYSA-N 2-hydroxy-3-nitrobenzoic acid Chemical compound OC(=O)C1=CC=CC([N+]([O-])=O)=C1O WWWFHFGUOIQNJC-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- ZRDUSMYWDRPZRM-UHFFFAOYSA-N 2-sec-butyl-4,6-dinitrophenyl 3-methylbut-2-enoate Chemical compound CCC(C)C1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1OC(=O)C=C(C)C ZRDUSMYWDRPZRM-UHFFFAOYSA-N 0.000 description 1
- BZGLBXYQOMFXAU-UHFFFAOYSA-N 3-(2-methylpiperidin-1-yl)propyl 3,4-dichlorobenzoate Chemical compound CC1CCCCN1CCCOC(=O)C1=CC=C(Cl)C(Cl)=C1 BZGLBXYQOMFXAU-UHFFFAOYSA-N 0.000 description 1
- FSCWZHGZWWDELK-UHFFFAOYSA-N 3-(3,5-dichlorophenyl)-5-ethenyl-5-methyl-2,4-oxazolidinedione Chemical compound O=C1C(C)(C=C)OC(=O)N1C1=CC(Cl)=CC(Cl)=C1 FSCWZHGZWWDELK-UHFFFAOYSA-N 0.000 description 1
- HBLSGPQATABNRY-UHFFFAOYSA-N 3-(4-chlorophenyl)-2-n-methyl-4-n,5-n-bis(trifluoromethyl)-1,3-thiazolidine-2,4,5-triimine Chemical compound CN=C1SC(=NC(F)(F)F)C(=NC(F)(F)F)N1C1=CC=C(Cl)C=C1 HBLSGPQATABNRY-UHFFFAOYSA-N 0.000 description 1
- DGOAXBPOVUPPEB-UHFFFAOYSA-N 3-(difluoromethyl)-N-methoxy-1-methyl-N-[1-(2,4,6-trichlorophenyl)propan-2-yl]pyrazole-4-carboxamide Chemical compound C=1N(C)N=C(C(F)F)C=1C(=O)N(OC)C(C)CC1=C(Cl)C=C(Cl)C=C1Cl DGOAXBPOVUPPEB-UHFFFAOYSA-N 0.000 description 1
- LCOWUMNPNWEMAZ-UHFFFAOYSA-N 3-[benzyl(methyl)amino]-2-cyanoprop-2-enoic acid Chemical compound N#CC(C(O)=O)=CN(C)CC1=CC=CC=C1 LCOWUMNPNWEMAZ-UHFFFAOYSA-N 0.000 description 1
- 125000004975 3-butenyl group Chemical group C(CC=C)* 0.000 description 1
- ZNBJSAAROMDHOX-UHFFFAOYSA-N 3-chloro-4-(2,6-difluorophenyl)-6-methyl-5-phenylpyridazine Chemical group C=1C=CC=CC=1C=1C(C)=NN=C(Cl)C=1C1=C(F)C=CC=C1F ZNBJSAAROMDHOX-UHFFFAOYSA-N 0.000 description 1
- RHLVCLIPMVJYKS-UHFFFAOYSA-N 3-octanone Chemical compound CCCCCC(=O)CC RHLVCLIPMVJYKS-UHFFFAOYSA-N 0.000 description 1
- NEKULYKCZPJMMJ-UHFFFAOYSA-N 5-chloro-N-{1-[4-(difluoromethoxy)phenyl]propyl}-6-methylpyrimidin-4-amine Chemical compound C=1C=C(OC(F)F)C=CC=1C(CC)NC1=NC=NC(C)=C1Cl NEKULYKCZPJMMJ-UHFFFAOYSA-N 0.000 description 1
- SJDGOKGRYGWNTC-UHFFFAOYSA-N 5-isothiocyanato-2-methoxy-n,n,3-trimethylbenzamide Chemical compound COC1=C(C)C=C(N=C=S)C=C1C(=O)N(C)C SJDGOKGRYGWNTC-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical class O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- ZYASLTYCYTYKFC-UHFFFAOYSA-N 9-methylidenefluorene Chemical compound C1=CC=C2C(=C)C3=CC=CC=C3C2=C1 ZYASLTYCYTYKFC-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 241000223600 Alternaria Species 0.000 description 1
- 241000223602 Alternaria alternata Species 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 241000235349 Ascomycota Species 0.000 description 1
- 241000221198 Basidiomycota Species 0.000 description 1
- MQIVNMHALJNFMG-ILYHAJGMSA-N Benquinox Chemical compound O/N=C(\C=C1)/C=C/C\1=N\NC(C1=CC=CC=C1)=O MQIVNMHALJNFMG-ILYHAJGMSA-N 0.000 description 1
- 241000190150 Bipolaris sorokiniana Species 0.000 description 1
- 241001480061 Blumeria graminis Species 0.000 description 1
- 241001465180 Botrytis Species 0.000 description 1
- 241000233685 Bremia lactucae Species 0.000 description 1
- 239000005742 Bupirimate Substances 0.000 description 1
- ZZVVDIVWGXTDRQ-BSYVCWPDSA-N Buthiobate Chemical compound C=1C=CN=CC=1\N=C(/SCCCC)SCC1=CC=C(C(C)(C)C)C=C1 ZZVVDIVWGXTDRQ-BSYVCWPDSA-N 0.000 description 1
- MXJKXXLTZHNLKB-SSDOTTSWSA-N CCC[C@H](C(O)=S)NC(OC(C)(C)C)=O Chemical compound CCC[C@H](C(O)=S)NC(OC(C)(C)C)=O MXJKXXLTZHNLKB-SSDOTTSWSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241001157813 Cercospora Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 241000222199 Colletotrichum Species 0.000 description 1
- 241000371644 Curvularia ravenelii Species 0.000 description 1
- MKZGVGOBXZJKGV-UHFFFAOYSA-N Cypendazole Chemical compound C1=CC=C2N(C(=O)NCCCCCC#N)C(NC(=O)OC)=NC2=C1 MKZGVGOBXZJKGV-UHFFFAOYSA-N 0.000 description 1
- 239000005759 Diethofencarb Substances 0.000 description 1
- HDWLUGYOLUHEMN-UHFFFAOYSA-N Dinobuton Chemical compound CCC(C)C1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1OC(=O)OC(C)C HDWLUGYOLUHEMN-UHFFFAOYSA-N 0.000 description 1
- ODOSVAWLEGXOPB-UHFFFAOYSA-N Dinocton 6 Chemical compound COC(=O)OC1=C(CCCCCC(C)C)C=C([N+]([O-])=O)C=C1[N+]([O-])=O ODOSVAWLEGXOPB-UHFFFAOYSA-N 0.000 description 1
- MTBZIGHNGSTDJV-UHFFFAOYSA-N Ditalimfos Chemical compound C1=CC=C2C(=O)N(P(=S)(OCC)OCC)C(=O)C2=C1 MTBZIGHNGSTDJV-UHFFFAOYSA-N 0.000 description 1
- 239000005764 Dithianon Substances 0.000 description 1
- 239000005767 Epoxiconazole Substances 0.000 description 1
- IWDQPCIQCXRBQP-UHFFFAOYSA-M Fenaminosulf Chemical compound [Na+].CN(C)C1=CC=C(N=NS([O-])(=O)=O)C=C1 IWDQPCIQCXRBQP-UHFFFAOYSA-M 0.000 description 1
- OQOULEWDDRNBSG-UHFFFAOYSA-N Fenapanil Chemical compound C=1C=CC=CC=1C(CCCC)(C#N)CN1C=CN=C1 OQOULEWDDRNBSG-UHFFFAOYSA-N 0.000 description 1
- LXMQMMSGERCRSU-UHFFFAOYSA-N Fluotrimazole Chemical compound FC(F)(F)C1=CC=CC(C(C=2C=CC=CC=2)(C=2C=CC=CC=2)N2N=CN=C2)=C1 LXMQMMSGERCRSU-UHFFFAOYSA-N 0.000 description 1
- 241000223195 Fusarium graminearum Species 0.000 description 1
- 101100134922 Gallus gallus COR5 gene Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 239000005794 Hymexazol Substances 0.000 description 1
- 239000005798 Isofetamid Substances 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- ZCAHBOURBFRXOT-UHFFFAOYSA-N Mecarbinzid Chemical compound C1=CC=C2N(C(=O)NCCSC)C(NC(=O)OC)=NC2=C1 ZCAHBOURBFRXOT-UHFFFAOYSA-N 0.000 description 1
- 239000005806 Meptyldinocap Substances 0.000 description 1
- 239000002169 Metam Substances 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical group CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- UDSJPFPDKCMYBD-UHFFFAOYSA-N Metsulfovax Chemical compound S1C(C)=NC(C)=C1C(=O)NC1=CC=CC=C1 UDSJPFPDKCMYBD-UHFFFAOYSA-N 0.000 description 1
- 241001518729 Monilinia Species 0.000 description 1
- 241001518836 Monilinia fructigena Species 0.000 description 1
- 241000131448 Mycosphaerella Species 0.000 description 1
- IUOKJNROJISWRO-UHFFFAOYSA-N N-(2-cyano-3-methylbutan-2-yl)-2-(2,4-dichlorophenoxy)propanamide Chemical compound CC(C)C(C)(C#N)NC(=O)C(C)OC1=CC=C(Cl)C=C1Cl IUOKJNROJISWRO-UHFFFAOYSA-N 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- FHFBSBQYPLFMHC-TURZUDJPSA-N N-[(2Z)-2-[2-chloro-4-(2-cyclopropylethynyl)phenyl]-2-propan-2-yloxyiminoethyl]-3-(difluoromethyl)-1-methylpyrazole-4-carboxamide Chemical compound CC(C)O\N=C(/CNC(=O)c1cn(C)nc1C(F)F)c1ccc(cc1Cl)C#CC1CC1 FHFBSBQYPLFMHC-TURZUDJPSA-N 0.000 description 1
- NGDNVOAEIVQRFH-VIFPVBQESA-N Nonan-2S-ol Chemical compound CCCCCCC[C@H](C)O NGDNVOAEIVQRFH-VIFPVBQESA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical class CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 241001668536 Oculimacula yallundae Species 0.000 description 1
- 241000233654 Oomycetes Species 0.000 description 1
- 239000005812 Oxathiapiprolin Substances 0.000 description 1
- YYVFXSYQSOZCOQ-UHFFFAOYSA-N Oxyquinoline sulfate Chemical compound [O-]S([O-])(=O)=O.C1=C[NH+]=C2C(O)=CC=CC2=C1.C1=C[NH+]=C2C(O)=CC=CC2=C1 YYVFXSYQSOZCOQ-UHFFFAOYSA-N 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 239000005814 Pencycuron Substances 0.000 description 1
- 241001223281 Peronospora Species 0.000 description 1
- 241000440444 Phakopsora Species 0.000 description 1
- 241000896242 Podosphaera Species 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 241001281805 Pseudoperonospora cubensis Species 0.000 description 1
- 241000221300 Puccinia Species 0.000 description 1
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 1
- 241000228453 Pyrenophora Species 0.000 description 1
- 241000228454 Pyrenophora graminea Species 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 241001361634 Rhizoctonia Species 0.000 description 1
- 241000813090 Rhizoctonia solani Species 0.000 description 1
- 241001515786 Rhynchosporium Species 0.000 description 1
- IDIDJDIHTAOVLG-UHFFFAOYSA-N S-methyl-L-cysteine Natural products CSCC(N)C(O)=O IDIDJDIHTAOVLG-UHFFFAOYSA-N 0.000 description 1
- IDIDJDIHTAOVLG-VKHMYHEASA-N S-methylcysteine Chemical compound CSC[C@H](N)C(O)=O IDIDJDIHTAOVLG-VKHMYHEASA-N 0.000 description 1
- 241000221662 Sclerotinia Species 0.000 description 1
- 241000221696 Sclerotinia sclerotiorum Species 0.000 description 1
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-NQAPHZHOSA-N Sorbitol Polymers OCC(O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-NQAPHZHOSA-N 0.000 description 1
- 241000579741 Sphaerotheca <fungi> Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical class OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- GNOOAFGERMHQJE-UHFFFAOYSA-N Thicyofen Chemical compound CCS(=O)C=1SC(C#N)=C(Cl)C=1C#N GNOOAFGERMHQJE-UHFFFAOYSA-N 0.000 description 1
- 239000005843 Thiram Substances 0.000 description 1
- 241000722133 Tilletia Species 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical class OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 241000510929 Uncinula Species 0.000 description 1
- 241000221576 Uromyces Species 0.000 description 1
- 241000221566 Ustilago Species 0.000 description 1
- 235000015919 Ustilago maydis Nutrition 0.000 description 1
- 244000301083 Ustilago maydis Species 0.000 description 1
- 239000005860 Valifenalate Substances 0.000 description 1
- 241000317942 Venturia <ichneumonid wasp> Species 0.000 description 1
- 239000005870 Ziram Substances 0.000 description 1
- 241001507534 Zora Species 0.000 description 1
- OGQICQVSFDPSEI-UHFFFAOYSA-N Zorac Chemical compound N1=CC(C(=O)OCC)=CC=C1C#CC1=CC=C(SCCC2(C)C)C2=C1 OGQICQVSFDPSEI-UHFFFAOYSA-N 0.000 description 1
- ZJOCMGQZWCTWNX-UHFFFAOYSA-N [ethoxy(ethylsulfanyl)phosphoryl]oxycyclohexane Chemical compound CCOP(=O)(SCC)OC1CCCCC1 ZJOCMGQZWCTWNX-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 125000005910 alkyl carbonate group Chemical group 0.000 description 1
- 229940045714 alkyl sulfonate alkylating agent Drugs 0.000 description 1
- 150000008052 alkyl sulfonates Chemical class 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- IMHBYKMAHXWHRP-UHFFFAOYSA-N anilazine Chemical compound ClC1=CC=CC=C1NC1=NC(Cl)=NC(Cl)=N1 IMHBYKMAHXWHRP-UHFFFAOYSA-N 0.000 description 1
- 230000002528 anti-freeze Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 239000002635 aromatic organic solvent Substances 0.000 description 1
- 125000005228 aryl sulfonate group Chemical group 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 229960000892 attapulgite Drugs 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 238000005574 benzylation reaction Methods 0.000 description 1
- CXNPLSGKWMLZPZ-UHFFFAOYSA-N blasticidin-S Natural products O1C(C(O)=O)C(NC(=O)CC(N)CCN(C)C(N)=N)C=CC1N1C(=O)N=C(N)C=C1 CXNPLSGKWMLZPZ-UHFFFAOYSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- DSKJPMWIHSOYEA-UHFFFAOYSA-N bupirimate Chemical compound CCCCC1=C(C)N=C(NCC)N=C1OS(=O)(=O)N(C)C DSKJPMWIHSOYEA-UHFFFAOYSA-N 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229910000420 cerium oxide Inorganic materials 0.000 description 1
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 1
- PFIADAMVCJPXSF-UHFFFAOYSA-N chloroneb Chemical compound COC1=CC(Cl)=C(OC)C=C1Cl PFIADAMVCJPXSF-UHFFFAOYSA-N 0.000 description 1
- NHTGQOXRZFUGJX-UHFFFAOYSA-N chlorquinox Chemical compound N1=CC=NC2=C(Cl)C(Cl)=C(Cl)C(Cl)=C21 NHTGQOXRZFUGJX-UHFFFAOYSA-N 0.000 description 1
- 239000002361 compost Substances 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 238000012272 crop production Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000298 cyclopropenyl group Chemical group [H]C1=C([H])C1([H])* 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000000131 cyclopropyloxy group Chemical group C1(CC1)O* 0.000 description 1
- 229960001305 cysteine hydrochloride Drugs 0.000 description 1
- 125000004772 dichloromethyl group Chemical group [H]C(Cl)(Cl)* 0.000 description 1
- LNJNFVJKDJYTEU-UHFFFAOYSA-N diethofencarb Chemical compound CCOC1=CC=C(NC(=O)OC(C)C)C=C1OCC LNJNFVJKDJYTEU-UHFFFAOYSA-N 0.000 description 1
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- CJHXCRMKMMBYJQ-UHFFFAOYSA-N dimethirimol Chemical compound CCCCC1=C(C)NC(N(C)C)=NC1=O CJHXCRMKMMBYJQ-UHFFFAOYSA-N 0.000 description 1
- ZHIKKPYAYGUYPV-UHFFFAOYSA-N dimethylaminocarbamothioylsulfanyl n-(dimethylamino)carbamodithioate Chemical compound CN(C)NC(=S)SSC(=S)NN(C)C ZHIKKPYAYGUYPV-UHFFFAOYSA-N 0.000 description 1
- FBOUIAKEJMZPQG-BLXFFLACSA-N diniconazole-M Chemical compound C1=NC=NN1/C([C@H](O)C(C)(C)C)=C/C1=CC=C(Cl)C=C1Cl FBOUIAKEJMZPQG-BLXFFLACSA-N 0.000 description 1
- ZHDBTKPXEJDTTQ-UHFFFAOYSA-N dipyrithione Chemical compound [O-][N+]1=CC=CC=C1SSC1=CC=CC=[N+]1[O-] ZHDBTKPXEJDTTQ-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- PYZSVQVRHDXQSL-UHFFFAOYSA-N dithianon Chemical compound S1C(C#N)=C(C#N)SC2=C1C(=O)C1=CC=CC=C1C2=O PYZSVQVRHDXQSL-UHFFFAOYSA-N 0.000 description 1
- 239000010459 dolomite Substances 0.000 description 1
- 229910000514 dolomite Inorganic materials 0.000 description 1
- AWZOLILCOUMRDG-UHFFFAOYSA-N edifenphos Chemical compound C=1C=CC=CC=1SP(=O)(OCC)SC1=CC=CC=C1 AWZOLILCOUMRDG-UHFFFAOYSA-N 0.000 description 1
- 239000004495 emulsifiable concentrate Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- DWRKFAJEBUWTQM-UHFFFAOYSA-N etaconazole Chemical compound O1C(CC)COC1(C=1C(=CC(Cl)=CC=1)Cl)CN1N=CN=C1 DWRKFAJEBUWTQM-UHFFFAOYSA-N 0.000 description 1
- IGUYEXXAGBDLLX-UHFFFAOYSA-N ethyl 3-(3,5-dichlorophenyl)-5-methyl-2,4-dioxo-1,3-oxazolidine-5-carboxylate Chemical compound O=C1C(C(=O)OCC)(C)OC(=O)N1C1=CC(Cl)=CC(Cl)=C1 IGUYEXXAGBDLLX-UHFFFAOYSA-N 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- RBWGTZRSEOIHFD-UHUFKFKFSA-N fenaminstrobin Chemical compound CNC(=O)C(=N\OC)\C1=CC=CC=C1CO\N=C(/C)\C=C\C1=C(Cl)C=CC=C1Cl RBWGTZRSEOIHFD-UHUFKFKFSA-N 0.000 description 1
- JFSPBVWPKOEZCB-UHFFFAOYSA-N fenfuram Chemical compound O1C=CC(C(=O)NC=2C=CC=CC=2)=C1C JFSPBVWPKOEZCB-UHFFFAOYSA-N 0.000 description 1
- FKLFBQCQQYDUAM-UHFFFAOYSA-N fenpiclonil Chemical compound ClC1=CC=CC(C=2C(=CNC=2)C#N)=C1Cl FKLFBQCQQYDUAM-UHFFFAOYSA-N 0.000 description 1
- QGTOTYJSCYHYFK-RBODFLQRSA-N fenpicoxamid Chemical compound COC1=CC=NC(C(=O)N[C@@H]2C(O[C@@H](C)[C@H](OC(=O)C(C)C)[C@@H](CC=3C=CC=CC=3)C(=O)OC2)=O)=C1OCOC(=O)C(C)C QGTOTYJSCYHYFK-RBODFLQRSA-N 0.000 description 1
- BFWMWWXRWVJXSE-UHFFFAOYSA-M fentin hydroxide Chemical compound C=1C=CC=CC=1[Sn](C=1C=CC=CC=1)(O)C1=CC=CC=C1 BFWMWWXRWVJXSE-UHFFFAOYSA-M 0.000 description 1
- WHDGWKAJBYRJJL-UHFFFAOYSA-K ferbam Chemical compound [Fe+3].CN(C)C([S-])=S.CN(C)C([S-])=S.CN(C)C([S-])=S WHDGWKAJBYRJJL-UHFFFAOYSA-K 0.000 description 1
- GOWLARCWZRESHU-AQTBWJFISA-N ferimzone Chemical compound C=1C=CC=C(C)C=1C(/C)=N\NC1=NC(C)=CC(C)=N1 GOWLARCWZRESHU-AQTBWJFISA-N 0.000 description 1
- DNJKFZQFTZJKDK-UHFFFAOYSA-N fluopimomide Chemical compound FC1=C(F)C(OC)=C(F)C(F)=C1C(=O)NCC1=NC=C(C(F)(F)F)C=C1Cl DNJKFZQFTZJKDK-UHFFFAOYSA-N 0.000 description 1
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 description 1
- GNVDAZSPJWCIQZ-UHFFFAOYSA-N flusulfamide Chemical compound ClC1=CC([N+](=O)[O-])=CC=C1NS(=O)(=O)C1=CC=C(Cl)C(C(F)(F)F)=C1 GNVDAZSPJWCIQZ-UHFFFAOYSA-N 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000010440 gypsum Substances 0.000 description 1
- 229910052602 gypsum Inorganic materials 0.000 description 1
- 125000000262 haloalkenyl group Chemical group 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 125000006343 heptafluoro propyl group Chemical group 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- KGVPNLBXJKTABS-UHFFFAOYSA-N hymexazol Chemical compound CC1=CC(O)=NO1 KGVPNLBXJKTABS-UHFFFAOYSA-N 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- KWIBRJGXWFDQNU-UHFFFAOYSA-N iodomethyl 2-methylpropanoate Chemical compound CC(C)C(=O)OCI KWIBRJGXWFDQNU-UHFFFAOYSA-N 0.000 description 1
- DHEPIQOGGUAJGR-UHFFFAOYSA-N iodomethyl propan-2-yl carbonate Chemical compound CC(C)OC(=O)OCI DHEPIQOGGUAJGR-UHFFFAOYSA-N 0.000 description 1
- DSXOWZNZGWXWMX-UHFFFAOYSA-N ipflufenoquin Chemical compound CC1=NC2=C(F)C(F)=CC=C2C=C1OC1=CC=CC(F)=C1C(C)(C)O DSXOWZNZGWXWMX-UHFFFAOYSA-N 0.000 description 1
- FCOAHACKGGIURQ-UHFFFAOYSA-N iprobenfos Chemical compound CC(C)OP(=O)(OC(C)C)SCC1=CC=CC=C1 FCOAHACKGGIURQ-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- GJRQTCIYDGXPES-UHFFFAOYSA-N iso-butyl acetate Natural products CC(C)COC(C)=O GJRQTCIYDGXPES-UHFFFAOYSA-N 0.000 description 1
- FGKJLKRYENPLQH-UHFFFAOYSA-M isocaproate Chemical compound CC(C)CCC([O-])=O FGKJLKRYENPLQH-UHFFFAOYSA-M 0.000 description 1
- WMKZDPFZIZQROT-UHFFFAOYSA-N isofetamid Chemical compound CC1=CC(OC(C)C)=CC=C1C(=O)C(C)(C)NC(=O)C1=C(C)C=CS1 WMKZDPFZIZQROT-UHFFFAOYSA-N 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- UFHLMYOGRXOCSL-UHFFFAOYSA-N isoprothiolane Chemical compound CC(C)OC(=O)C(C(=O)OC(C)C)=C1SCCS1 UFHLMYOGRXOCSL-UHFFFAOYSA-N 0.000 description 1
- WLPCAERCXQSYLQ-UHFFFAOYSA-N isotianil Chemical compound ClC1=NSC(C(=O)NC=2C(=CC=CC=2)C#N)=C1Cl WLPCAERCXQSYLQ-UHFFFAOYSA-N 0.000 description 1
- OQAGVSWESNCJJT-UHFFFAOYSA-N isovaleric acid methyl ester Natural products COC(=O)CC(C)C OQAGVSWESNCJJT-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- CFHGBZLNZZVTAY-UHFFFAOYSA-N lawesson's reagent Chemical compound C1=CC(OC)=CC=C1P1(=S)SP(=S)(C=2C=CC(OC)=CC=2)S1 CFHGBZLNZZVTAY-UHFFFAOYSA-N 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- BCTQJXQXJVLSIG-UHFFFAOYSA-N mepronil Chemical compound CC(C)OC1=CC=CC(NC(=O)C=2C(=CC=CC=2)C)=C1 BCTQJXQXJVLSIG-UHFFFAOYSA-N 0.000 description 1
- HYVVJDQGXFXBRZ-UHFFFAOYSA-N metam Chemical compound CNC(S)=S HYVVJDQGXFXBRZ-UHFFFAOYSA-N 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- IXJOSTZEBSTPAG-UHFFFAOYSA-N methasulfocarb Chemical compound CNC(=O)SC1=CC=C(OS(C)(=O)=O)C=C1 IXJOSTZEBSTPAG-UHFFFAOYSA-N 0.000 description 1
- ZWJNEYVWPYIKMB-UHFFFAOYSA-N methfuroxam Chemical compound CC1=C(C)OC(C)=C1C(=O)NC1=CC=CC=C1 ZWJNEYVWPYIKMB-UHFFFAOYSA-N 0.000 description 1
- 229960004452 methionine Drugs 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- JEFUQUGZXLEHLD-UHFFFAOYSA-N n-[(5-chloro-2-propan-2-ylphenyl)methyl]-n-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methylpyrazole-4-carboxamide Chemical compound CC(C)C1=CC=C(Cl)C=C1CN(C(=O)C=1C(=NN(C)C=1F)C(F)F)C1CC1 JEFUQUGZXLEHLD-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000006199 nebulizer Substances 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
- NGDNVOAEIVQRFH-UHFFFAOYSA-N nonan-2-ol Natural products CCCCCCCC(C)O NGDNVOAEIVQRFH-UHFFFAOYSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- UWVQIROCRJWDKL-UHFFFAOYSA-N oxadixyl Chemical compound CC=1C=CC=C(C)C=1N(C(=O)COC)N1CCOC1=O UWVQIROCRJWDKL-UHFFFAOYSA-N 0.000 description 1
- BMMGVYCKOGBVEV-UHFFFAOYSA-N oxo(oxoceriooxy)cerium Chemical compound [Ce]=O.O=[Ce]=O BMMGVYCKOGBVEV-UHFFFAOYSA-N 0.000 description 1
- 229910052625 palygorskite Inorganic materials 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- OGYFATSSENRIKG-UHFFFAOYSA-N pencycuron Chemical compound C1=CC(Cl)=CC=C1CN(C(=O)NC=1C=CC=CC=1)C1CCCC1 OGYFATSSENRIKG-UHFFFAOYSA-N 0.000 description 1
- WBTYBAGIHOISOQ-UHFFFAOYSA-N pent-4-en-1-yl 2-[(2-furylmethyl)(imidazol-1-ylcarbonyl)amino]butanoate Chemical compound C1=CN=CN1C(=O)N(C(CC)C(=O)OCCCC=C)CC1=CC=CO1 WBTYBAGIHOISOQ-UHFFFAOYSA-N 0.000 description 1
- 125000006340 pentafluoro ethyl group Chemical group FC(F)(F)C(F)(F)* 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 125000000286 phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- URHWNXDZOULUHC-ULJHMMPZSA-N picarbutrazox Chemical compound CN1N=NN=C1\C(C=1C=CC=CC=1)=N/OCC1=CC=CC(NC(=O)OC(C)(C)C)=N1 URHWNXDZOULUHC-ULJHMMPZSA-N 0.000 description 1
- 229920005646 polycarboxylate Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- JPFWJDMDPLEUBD-ITJAGOAWSA-N polyoxorim Polymers O[C@@H]1[C@H](O)[C@@H]([C@H](NC(=O)[C@H]([C@H](O)[C@@H](O)COC(N)=O)N)C(O)=O)O[C@H]1N1C(=O)NC(=O)C(C(O)=O)=C1 JPFWJDMDPLEUBD-ITJAGOAWSA-N 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- URXNNPCNKVAQRA-XMHGGMMESA-N pyraoxystrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1COC1=CC(C=2C=CC(Cl)=CC=2)=NN1C URXNNPCNKVAQRA-XMHGGMMESA-N 0.000 description 1
- KKEJMLAPZVXPOF-UHFFFAOYSA-N pyraziflumid Chemical compound C1=C(F)C(F)=CC=C1C1=CC=CC=C1NC(=O)C1=NC=CN=C1C(F)(F)F KKEJMLAPZVXPOF-UHFFFAOYSA-N 0.000 description 1
- JOOMJVFZQRQWKR-UHFFFAOYSA-N pyrazophos Chemical compound N1=C(C)C(C(=O)OCC)=CN2N=C(OP(=S)(OCC)OCC)C=C21 JOOMJVFZQRQWKR-UHFFFAOYSA-N 0.000 description 1
- CRFYLQMIDWBKRT-LPYMAVHISA-N pyribencarb Chemical compound C1=C(Cl)C(CNC(=O)OC)=CC(C(\C)=N\OCC=2N=C(C)C=CC=2)=C1 CRFYLQMIDWBKRT-LPYMAVHISA-N 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 229960003811 pyrithione disulfide Drugs 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000028070 sporulation Effects 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000006277 sulfonation reaction Methods 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- WOSNCVAPUOFXEH-UHFFFAOYSA-N thifluzamide Chemical compound S1C(C)=NC(C(F)(F)F)=C1C(=O)NC1=C(Br)C=C(OC(F)(F)F)C=C1Br WOSNCVAPUOFXEH-UHFFFAOYSA-N 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
- YFNCATAIYKQPOO-UHFFFAOYSA-N thiophanate Chemical compound CCOC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OCC YFNCATAIYKQPOO-UHFFFAOYSA-N 0.000 description 1
- ILERPRJWJPJZDN-UHFFFAOYSA-N thioquinox Chemical compound C1=CC=C2N=C(SC(=S)S3)C3=NC2=C1 ILERPRJWJPJZDN-UHFFFAOYSA-N 0.000 description 1
- 229960002447 thiram Drugs 0.000 description 1
- KUAZQDVKQLNFPE-UHFFFAOYSA-N thiram Chemical compound CN(C)C(=S)SSC(=S)N(C)C KUAZQDVKQLNFPE-UHFFFAOYSA-N 0.000 description 1
- VJQYLJSMBWXGDV-UHFFFAOYSA-N tiadinil Chemical compound N1=NSC(C(=O)NC=2C=C(Cl)C(C)=CC=2)=C1C VJQYLJSMBWXGDV-UHFFFAOYSA-N 0.000 description 1
- HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 description 1
- RSOBJVBYZCMJOS-CYBMUJFWSA-N tolprocarb Chemical compound FC(F)(F)COC(=O)N[C@@H](C(C)C)CNC(=O)C1=CC=C(C)C=C1 RSOBJVBYZCMJOS-CYBMUJFWSA-N 0.000 description 1
- 125000002827 triflate group Chemical group FC(S(=O)(=O)O*)(F)F 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- RROQIUMZODEXOR-UHFFFAOYSA-N triforine Chemical compound O=CNC(C(Cl)(Cl)Cl)N1CCN(C(NC=O)C(Cl)(Cl)Cl)CC1 RROQIUMZODEXOR-UHFFFAOYSA-N 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- YNWVFADWVLCOPU-MAUPQMMJSA-N uniconazole P Chemical compound C1=NC=NN1/C([C@@H](O)C(C)(C)C)=C/C1=CC=C(Cl)C=C1 YNWVFADWVLCOPU-MAUPQMMJSA-N 0.000 description 1
- DBXFMOWZRXXBRN-LWKPJOBUSA-N valifenalate Chemical compound CC(C)OC(=O)N[C@@H](C(C)C)C(=O)NC(CC(=O)OC)C1=CC=C(Cl)C=C1 DBXFMOWZRXXBRN-LWKPJOBUSA-N 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000004562 water dispersible granule Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- DUBNHZYBDBBJHD-UHFFFAOYSA-L ziram Chemical compound [Zn+2].CN(C)C([S-])=S.CN(C)C([S-])=S DUBNHZYBDBBJHD-UHFFFAOYSA-L 0.000 description 1
- FJBGIXKIXPUXBY-UHFFFAOYSA-N {2-[3-(4-chlorophenyl)propyl]-2,4,4-trimethyl-1,3-oxazolidin-3-yl}(imidazol-1-yl)methanone Chemical compound C1=CN=CN1C(=O)N1C(C)(C)COC1(C)CCCC1=CC=C(Cl)C=C1 FJBGIXKIXPUXBY-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/44—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids
- A01N37/46—N-acyl derivatives
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
- A01N43/40—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C321/00—Thiols, sulfides, hydropolysulfides or polysulfides
- C07C321/12—Sulfides, hydropolysulfides, or polysulfides having thio groups bound to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C321/00—Thiols, sulfides, hydropolysulfides or polysulfides
- C07C321/12—Sulfides, hydropolysulfides, or polysulfides having thio groups bound to acyclic carbon atoms
- C07C321/16—Sulfides, hydropolysulfides, or polysulfides having thio groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Dentistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Plant Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Pest Control & Pesticides (AREA)
- Agronomy & Crop Science (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Description
?Composti ad attivit? fungicida, relative composizioni agronomiche e uso per il controllo di funghi fitopatogeni? ? Activity compounds? fungicide, related agronomic compositions and use for the control of phytopathogenic fungi?
La presente invenzione riguarda amminoesteri ad elevata attivit? fungicida; in particolare riguarda composti opportunamente sostituiti dotati di elevata attivit? fungicida e il loro uso per il controllo di funghi fitopatogeni di importanti colture agricole. The present invention relates to high activity aminoesters? fungicide; in particular it concerns suitably substituted compounds endowed with high activity? fungicide and their use for the control of phytopathogenic fungi of important agricultural crops.
Amminoesteri ad attivit? fungicida sono stati descritti in letteratura e in particolare sono descritti nelle domande di brevetto WO99/27783, WO01/14339, WO01/12587 e WO01/05769. Activity aminoesters fungicides have been described in the literature and are described in particular in patent applications WO99 / 27783, WO01 / 14339, WO01 / 12587 and WO01 / 05769.
I prodotti descritti in questi documenti risultano per? spesso insoddisfacenti sotto il profilo dell?efficacia nei confronti di diversi funghi fitopatogeni di interesse in importanti colture agricole. The products described in these documents result in? often unsatisfactory in terms of efficacy against various phytopathogenic fungi of interest in important agricultural crops.
La Richiedente ha ora sorprendentemente scoperto che la combinazione di sostituenti specifici in tali composti consente di ampliare lo spettro di azione gi? noto in precedenza su composti analoghi, senza dimostrare sintomi di fitotossicit? nelle colture agricole di interesse. The Applicant has now surprisingly discovered that the combination of specific substituents in such compounds allows to broaden the spectrum of action already? previously known on similar compounds, without demonstrating symptoms of phytotoxicity? in agricultural crops of interest.
Costituiscono pertanto oggetto della presente invenzione nuovi composti di formula generale (I): Therefore, new compounds of general formula (I) are the object of the present invention:
in cui: in which:
- X rappresenta un atomo di idrogeno oppure un gruppo C(O)R<5>; - X represents a hydrogen atom or a C (O) R <5> group;
- Y rappresenta un atomo di idrogeno oppure un gruppo C(O)R<5 >oppure un gruppo Q: - Y represents a hydrogen atom or a C (O) R <5> group or a Q group:
- Z<1 >e Z<2 >, uguali o diversi tra loro, possono rappresentare un atomo di azoto, un gruppo N?O, oppure un gruppo CRc; - Z <1> and Z <2>, equal or different from each other, can represent a nitrogen atom, a N? O group, or a CRc group;
- Rc rappresenta un atomo di idrogeno, un atomo di alogeno scelto tra fluoro, cloro, bromo o iodio, un gruppo C1-C12 alcossile, un gruppo C1-C12 tioalcossile, un gruppo nitro, un gruppo amminico, un gruppo formilamminico; - M rappresenta un atomo di alogeno scelto tra fluoro, cloro, bromo o iodio o un gruppo W<2>-R<6>; - Rc represents a hydrogen atom, a halogen atom selected from fluorine, chlorine, bromine or iodine, a C1-C12 alkoxy group, a C1-C12 thioalkoxyl group, a nitro group, an amino group, a formylamine group; - M represents a halogen atom selected from fluorine, chlorine, bromine or iodine or a W <2> -R <6> group;
- W<1 >e W<2>, uguali o diversi tra loro, rappresentano un atomo di ossigeno oppure un atomo di zolfo; - W <1> and W <2>, equal or different from each other, represent an oxygen atom or a sulfur atom;
- R<6 >rappresenta un atomo di idrogeno, un gruppo benzilico anche opzionalmente sostituito sull?anello fenilico, un gruppo COR<7>, un gruppo CH2OCOR<7>, un gruppo CH(CH3)OCOR<7>, un gruppo (CH2)pOR<7>, un gruppo (CH2)pSR<7>, un gruppo CH2COOR<7>; un gruppo CH(CH3)COOR<7>; - R <6> represents a hydrogen atom, a benzyl group also optionally substituted on the phenyl ring, a COR <7> group, a CH2OCOR <7> group, a CH (CH3) OCOR <7> group, a ( CH2) pOR <7>, a group (CH2) pSR <7>, a group CH2COOR <7>; a CH (CH3) COOR <7> group;
- R<7 >rappresenta un gruppo C1-C12 alchilico, un gruppo C3-C12 cicloalchilico, un gruppo C1-C12 aloalchilico, un gruppo C1-C12 alcossilico, detti gruppi essendo opzionalmente sostituiti con uno o pi? gruppi Rd uguali o diversi tra loro; - R <7> represents a C1-C12 alkyl group, a C3-C12 cycloalkyl group, a C1-C12 haloalkyl group, a C1-C12 alkoxy group, said groups being optionally substituted with one or more? Rd groups equal or different from each other;
- Rd rappresenta un gruppo nitro, un gruppo ciano, un gruppo C1-C12 alchilico, un gruppo C3-C12 cicloalchilico, un gruppo C3-C12cicloalchil-C1-C12-alchilico, gruppo C1-C12 aloalchilico, un gruppo C2-C12 alchenilico, un gruppo C2-C12 aloalchenilico, un gruppo C3-C12 cicloalchenilico, un gruppo C1-C12 alcossilico, un gruppo C1-C12 tioalcossilico, un gruppo C3-C12 cicloalcossilico, un gruppo arilico, un gruppo fenossilico, un gruppo benzilossi, un gruppo aril-C1-C12-alchilico, oppure un gruppo eterociclil-C1-C12-alchilico in cui il gruppo eterociclico ? come sopra definito; un gruppo C(=W<1>)R<8>, un gruppo C(=O)OR<8>, un gruppo C(=O)NR<8>R<9>, un gruppo S(=O)nR<8>, un gruppo S(=O)2NR<8>R<9>; - Rd represents a nitro group, a cyano group, a C1-C12 alkyl group, a C3-C12 cycloalkyl group, a C3-C12cycloalkyl-C1-C12-alkyl group, a C1-C12 haloalkyl group, a C2-C12 alkenyl group, a C2-C12 haloalkenyl group, a C3-C12 cycloalkenyl group, a C1-C12 alkoxy group, a C1-C12 thioalkoxy group, a C3-C12 cycloalkoxyl group, an aryl group, a phenoxy group, a benzyloxy group, an aryl group -C1-C12-alkyl, or a heterocyclyl-C1-C12-alkyl group wherein the heterocyclic group? as defined above; a group C (= W <1>) R <8>, a group C (= O) OR <8>, a group C (= O) NR <8> R <9>, a group S (= O) nR <8>, a group S (= O) 2NR <8> R <9>;
- n rappresenta un numero compreso tra 0 e 2; - n represents a number between 0 and 2;
- m rappresenta un numero compreso tra 1 e 2; - m represents a number between 1 and 2;
- p rappresenta un numero compreso tra 1 e 4; - p represents a number between 1 and 4;
- R<5 >rappresenta un gruppo C1-C12 alcossilico, un gruppo benzilossi oppure un gruppo fluorenilmetossi; - R <5> represents a C1-C12 alkoxy group, a benzyloxy group or a fluorenylmethoxy group;
- R<8 >e R<9>, uguali o diversi tra loro, rappresentano un atomo di idrogeno, un gruppo C1-C12 alchilico, un gruppo C1-C12 aloalchilico, un gruppo C2-C12 alchenilico, un gruppo C2-C12 aloalchenilico, un gruppo C3-C12 cicloalchilico, un gruppo C3-C12 alocicloalchilico, un gruppo arilico, un gruppo aril-C1-C12-alchilico, detti gruppi essendo opzionalmente sostituiti con uno o pi? gruppi Rd uguali o diversi tra loro; - R <8> and R <9>, the same or different from each other, represent a hydrogen atom, a C1-C12 alkyl group, a C1-C12 haloalkyl group, a C2-C12 alkenyl group, a C2-C12 haloalkenyl group , a C3-C12 cycloalkyl group, a C3-C12 haloalkyl group, an aryl group, an aryl-C1-C12-alkyl group, said groups being optionally substituted with one or more? Rd groups equal or different from each other;
- Ra e Rb uguali o diversi tra loro, rappresentano un atomo di idrogeno, un gruppo C1-C12 alchilico; - Ra and Rb equal or different from each other, represent a hydrogen atom, a C1-C12 alkyl group;
- oppure Ra e Rb insieme all?atomo di carbonio a cui sono legati formano un anello C3-C12 cicloalchilico; - or Ra and Rb together with the carbon atom to which they are bonded form a C3-C12 cycloalkyl ring;
- R<1>, R<2 >ed R<3>, uguali o diversi tra loro, rappresentano un atomo di idrogeno, un gruppo C1-C12 alchilico, un gruppo C1-C6 aloalchilico, un gruppo C2-C12 alchenilico, un gruppo C2-C12 aloalchenilico, un gruppo C3-C12 cicloalchilico, un gruppo C3-C12 cicloalchenilico, un gruppo C3-C12cicloalchil-C1-C12-alchilico, un gruppo arilico, un gruppo aril-C1-C12-alchilico, un gruppo eterociclico, pentaoppure esa-atomico, aromatico o non aromatico, anche benzocondensato od eterobiciclico, contenente almeno un eteroatomo scelto tra ossigeno, zolfo, eventualmente ossidato a solfossido o a solfone, azoto, eventualmente ossidato a N-ossido oppure un gruppo eterociclil-C1-C12-alchilico in cui il gruppo eterociclico ? come sopra definito; detti gruppi essendo opzionalmente sostituiti con uno o pi? gruppi Rd; - R <1>, R <2> and R <3>, the same or different from each other, represent a hydrogen atom, a C1-C12 alkyl group, a C1-C6 haloalkyl group, a C2-C12 alkenyl group, a C2-C12 haloalkenyl group, a C3-C12 cycloalkyl group, a C3-C12 cycloalkenyl group, a C3-C12 cycloalkyl-C1-C12-alkyl group, an aryl group, an aryl-C1-C12-alkyl group, a heterocyclic group, penta or hexa-atomic, aromatic or non-aromatic, also benzocondensed or heterobicyclic, containing at least one heteroatom selected from oxygen, sulfur, optionally oxidized to sulfoxide or sulphone, nitrogen, optionally oxidized to N-oxide or a heterocyclyl-C1-C12-alkyl group in which the heterocyclic group? as defined above; said groups being optionally replaced with one or more? Rd groups;
- oppure R<2 >e R<3 >insieme all?atomo di carbonio a cui sono legati formano un gruppo C3-C12 cicloalchilico oppure un gruppo C3-C12 cicloalchenilico, oppure un gruppo eterociclico, penta- oppure esa-atomico, contenente almeno un eteroatomo scelto tra ossigeno, zolfo, eventualmente ossidato a solfossido o a solfone, azoto, eventualmente ossidato a N-ossido, detti gruppi essendo opzionalmente sostituiti con uno o pi? gruppi Rd; - or R <2> and R <3> together with the carbon atom to which they are bound form a C3-C12 cycloalkyl group or a C3-C12 cycloalkenyl group, or a heterocyclic, penta- or hexa-atomic group, containing at least a heteroatom selected from oxygen, sulfur, optionally oxidized to sulfoxide or sulfone, nitrogen, optionally oxidized to N-oxide, said groups being optionally replaced with one or more? Rd groups;
- R<4 >rappresenta un atomo di idrogeno, un gruppo C1-C12 alchilico, un gruppo C1-C12 aloalchilico, un gruppo C2-C12 alchenilico, un gruppo C2-C12 aloalchenilico, un gruppo C3-C12 cicloalchilico, un gruppo C3-C12 cicloalchenilico, un gruppo C3-C12 cicloalchil-C1-C12-alchilico, un gruppo arilico, un gruppo aril-C1-C12-alchilico, un gruppo eterociclico penta-oppure esa-atomico, aromatico o non aromatico, anche benzocondensato od eterobiciclico, contenente almeno un eteroatomo scelto tra ossigeno, zolfo, eventualmente ossidato a solfossido o a solfone, azoto, eventualmente ossidato a N-ossido oppure un gruppo eterociclil-C1-C12-alchilico in cui il gruppo eterociclico ? come sopra definito, detti gruppi essendo opzionalmente sostituiti con uno o pi? gruppi Rd, oppure R<4 >rappresenta un gruppo T: - R <4> represents a hydrogen atom, a C1-C12 alkyl group, a C1-C12 haloalkyl group, a C2-C12 alkenyl group, a C2-C12 haloalkenyl group, a C3-C12 cycloalkyl group, a C3- C12 cycloalkenyl, a C3-C12 cycloalkyl-C1-C12-alkyl group, an aryl group, an aryl-C1-C12-alkyl group, a penta-or hexa-atomic, aromatic or non-aromatic heterocyclic group, whether or not benzocondensed or heterobicyclic, containing at least one heteroatom selected from oxygen, sulfur, optionally oxidized to sulfoxide or sulfone, nitrogen, optionally oxidized to N-oxide or a heterocyclyl-C1-C12-alkyl group in which the heterocyclic group? as defined above, said groups being optionally replaced with one or more? Rd groups, or R <4> represents a T group:
T = T =
in cui: in which:
- Re , Rf, uguali o diversi tra loro, rappresentano un gruppo C1-C12 alchilico, un gruppo C1-C12 aloalchilico, un gruppo C2-C12 alchenilico, un gruppo C2-C12 aloalchenilico, un gruppo C3-C12 cicloalchilico, un gruppo arilico, un gruppo aril-C1-C12-alchilico, un gruppo eterociclico penta- oppure esa-atomico, aromatico o non aromatico, anche benzocondensato od eterobiciclico, contenente almeno un eteroatomo scelto tra ossigeno, zolfo, eventualmente ossidato a solfossido o a solfone, azoto, eventualmente ossidato a N-ossido oppure un gruppo eterociclil-C1-C12-alchilico, detti gruppi essendo opzionalmente sostituiti uno o pi? gruppi Rd; - Re, Rf, the same or different, represent a C1-C12 alkyl group, a C1-C12 haloalkyl group, a C2-C12 alkenyl group, a C2-C12 haloalkenyl group, a C3-C12 cycloalkyl group, an aryl group , an aryl-C1-C12-alkyl group, a penta- or hexa-atomic, aromatic or non-aromatic heterocyclic group, also benzocondensed or heterobicyclic, containing at least one heteroatom selected from oxygen, sulfur, optionally oxidized to sulfoxide or sulfone, nitrogen, optionally oxidized to N-oxide or a heterocyclyl-C1-C12-alkyl group, said groups being optionally substituted by one or more? Rd groups;
- Rg rappresenta un atomo di idrogeno, un ossidrile, un atomo di alogeno scelto tra fluoro, cloro, bromo o iodio, un gruppo C1-C12 alchilico, un gruppo C1C12 aloalchilico, un gruppo C2-C12 alchenilico, un gruppo C2-C12 aloalchenilico, un gruppo C3-C12 cicloalchilico, un gruppo C1-C12 alcossilico; - Rg represents a hydrogen atom, a hydroxyl, a halogen atom chosen from fluorine, chlorine, bromine or iodine, a C1-C12 alkyl group, a C1C12 haloalkyl group, a C2-C12 alkenyl group, a C2-C12 haloalkenyl group , a C3-C12 cycloalkyl group, a C1-C12 alkoxy group;
a condizione che: provided that:
- quando Z<1 >assume il valore di CH, Z<2 >rappresenta un gruppo CRc dove Rc assume il significato di un gruppo formilammino oppure di un gruppo nitro, W<1 >e W<2 >sono entrambi ossigeno, R<6 >? un atomo di idrogeno, n assume il valore 0, m assume il valore 1 oppure 2 e Ra e Rb rappresentano entrambi un atomo di idrogeno e, se R<1 >assume il significato di metile, 4-metossibenzile oppure di 4-metossifenilcarbonile e R<4 >assume il significato di idrogeno, R<2 >e R<3>, diversi tra loro, non possono assumere i significati di idrogeno, etile, eptile ed isobutile; - when Z <1> assumes the value of CH, Z <2> represents a CRc group where Rc takes on the meaning of a formylamino group or a nitro group, W <1> and W <2> are both oxygen, R < 6>? a hydrogen atom, n takes the value 0, m takes the value 1 or 2 and Ra and Rb both represent a hydrogen atom and, if R <1> takes the meaning of methyl, 4-methoxybenzyl or 4-methoxyphenyl carbonyl and R <4> takes on the meaning of hydrogen, R <2> and R <3>, different from each other, cannot take on the meanings of hydrogen, ethyl, heptyl and isobutyl;
- quando Z<1 >assume il valore di N, Z<2 >rappresenta un gruppo CRc dove Rc assume il significato di idrogeno, W<1 >e W<2 >sono entrambi ossigeno, R<6 >? un atomo di idrogeno, n assume il valore 0, m assume il valore 1 e Ra e Rb rappresentano entrambi un atomo di idrogeno, se R<1 >assume il significato di metile, 2-naftilmetile, 4-piridilmetile oppure 2-piridilmetile, R<2>, R<3>, R<4 >non possono assumere il significato di idrogeno e, se R<1 >assume il significato di 2-piridilmetile, R<2 >e R<3 >assumono il significato di idrogeno, R<4 >non pu? assumere il significato di ottile. - when Z <1> takes the value of N, Z <2> represents a CRc group where Rc takes on the meaning of hydrogen, W <1> and W <2> are both oxygen, R <6>? a hydrogen atom, n takes the value 0, m takes the value 1 and Ra and Rb both represent a hydrogen atom, if R <1> takes the meaning of methyl, 2-naphthylmethyl, 4-pyridylmethyl or 2-pyridylmethyl, R <2>, R <3>, R <4> cannot assume the meaning of hydrogen and, if R <1> takes the meaning of 2-pyridylmethyl, R <2> and R <3> take the meaning of hydrogen , R <4> can not? take on the meaning of octyl.
Costituiscono ulteriore oggetto della presente invenzione, per X che assume il significato di idrogeno e Y che assume il significato di Q, nuovi composti di formula generale (I?) New compounds of general formula (I?) Constitute a further object of the present invention, for X which takes on the meaning of hydrogen and Y which takes on the meaning of Q
in cui in which
- G rappresenta un atomo di idrogeno oppure un atomo di un metallo alcalino quale per esempio litio, sodio, potassio oppure un gruppo NR<8>R<9>, - R<8>, R<9>, Q, n, m, R<1>, Ra e Rb assumono i significati descritti precedentemente; - G represents a hydrogen atom or an atom of an alkali metal such as for example lithium, sodium, potassium or a group NR <8> R <9>, - R <8>, R <9>, Q, n, m , R <1>, Ra and Rb take on the meanings described above;
a condizione che: provided that:
- quando Z<1 >assume il valore di N, Z<2 >rappresenta un gruppo CRc, Rc assume il significato di idrogeno, W<1 >e W<2 >sono entrambi ossigeno, R<6 >assume il significato di idrogeno, n assume il valore 0, m assume il valore di 1 oppure 2, Ra e Rb assumono il significato di idrogeno - when Z <1> takes the value of N, Z <2> represents a CRc group, Rc takes on the meaning of hydrogen, W <1> and W <2> are both oxygen, R <6> takes the meaning of hydrogen , n takes on the value 0, m takes on the value of 1 or 2, Ra and Rb take on the meaning of hydrogen
- quando R<1 >assume il significato di idrogeno, metile, 4-piridilimetile, 2-piridilmetile, G non assume il significato di idrogeno. - when R <1> takes on the meaning of hydrogen, methyl, 4-pyridylimethyl, 2-pyridylmethyl, G does not take on the meaning of hydrogen.
Preferibilmente i composti di formula generale (I) sono i composti in cui: Preferably the compounds of general formula (I) are the compounds in which:
- X rappresenta un atomo di idrogeno e Y rappresenta un gruppo Q; - X represents a hydrogen atom and Y represents a Q group;
- Z<1 >e Z<2 >, uguali o diversi tra loro, rappresentano un atomo di azoto oppure un gruppo CRc; - Z <1> and Z <2>, equal or different from each other, represent a nitrogen atom or a CRc group;
- Rc rappresenta un atomo di idrogeno, un atomo di alogeno, un gruppo C1-C12 alcossile, un gruppo C1-C12 tioalcossile, un gruppo formilamminico; - Rc represents a hydrogen atom, a halogen atom, a C1-C12 alkoxy group, a C1-C12 thioalkoxyl group, a formylamine group;
- M rappresenta un gruppo W<2>-R<6>; - M represents a group W <2> -R <6>;
- W<1 >e W<2>, uguali o diversi tra loro, rappresentano un atomo di ossigeno; - Rd rappresenta un atomo di idrogeno, un atomo di alogeno scelto tra fluoro, cloro, bromo o iodio, un gruppo nitro, un gruppo ciano, un gruppo C1-C12 alchilico, un gruppo C3-C12 cicloalchilico, un gruppo C3-C12cicloalchil-C1-C12-alchilico, gruppo C1-C12 aloalchilico, un gruppo C2-C12 alchenilico, un gruppo C2-C12 aloalchenilico, un gruppo C3-C12 cicloalchenilico, un gruppo C1-C12 alcossilico, un gruppo C1-C12 tioalcossilico, un gruppo C3-C12 cicloalcossilico, un gruppo arilico, un gruppo fenossilico, un gruppo benzilossi, un gruppo aril-C1-C12-alchilico, un gruppo eterociclico penta- oppure esa-atomico, aromatico o non aromatico, anche benzocondensato od eterobiciclico, contenente almeno un eteroatomo scelto tra ossigeno, zolfo, eventualmente ossidato a solfossido o a solfone, azoto, eventualmente ossidato a N-ossido oppure un gruppo eterociclil-C1-C12-alchilico in cui il gruppo eterociclico ? come sopra definito; un gruppo C(=W<1>)R<8>, un gruppo C(=O)OR<8>, un gruppo C(=O)NR<8>R<9>, un gruppo S(=O)nR<8>, un gruppo S(=O)2NR<8>R<9>; - W <1> and W <2>, equal or different from each other, represent an oxygen atom; - Rd represents a hydrogen atom, a halogen atom chosen from fluorine, chlorine, bromine or iodine, a nitro group, a cyano group, a C1-C12 alkyl group, a C3-C12 cycloalkyl group, a C3-C12 cycloalkyl group C1-C12-alkyl, C1-C12 haloalkyl group, a C2-C12 alkenyl group, a C2-C12 haloalkenyl group, a C3-C12 cycloalkenyl group, a C1-C12 alkoxy group, a C1-C12 thioalkoxyl group, a C3 group -C12 cycloalkoxy, an aryl group, a phenoxy group, a benzyloxy group, an aryl-C1-C12-alkyl group, a penta- or hexaatomic, aromatic or non-aromatic heterocyclic group, also benzocondensed or heterobicyclic, containing at least one heteroatom selected from oxygen, sulfur, optionally oxidized to sulfoxide or sulfone, nitrogen, optionally oxidized to N-oxide or a heterocyclyl-C1-C12-alkyl group in which the heterocyclic group? as defined above; a group C (= W <1>) R <8>, a group C (= O) OR <8>, a group C (= O) NR <8> R <9>, a group S (= O) nR <8>, a group S (= O) 2NR <8> R <9>;
- n rappresenta un numero compreso tra 0 e 2; - n represents a number between 0 and 2;
- m rappresenta un numero compreso tra 1 e 2; - m represents a number between 1 and 2;
- p rappresenta un numero compreso tra 1 e 2; - p represents a number between 1 and 2;
- R<6 >rappresenta un atomo di idrogeno, un gruppo benzilico anche opzionalmente sostituito sull?anello fenilico, un gruppo COR<7>, un gruppo CH2OCOR<7>, un gruppo CH(CH3)OCOR<7>, un gruppo (CH2)pOR<7>, un gruppo (CH2)pSR<7>, un gruppo CH2COOR<7>, un gruppo CH(CH3)COOR<7>; - R <6> represents a hydrogen atom, a benzyl group also optionally substituted on the phenyl ring, a COR <7> group, a CH2OCOR <7> group, a CH (CH3) OCOR <7> group, a ( CH2) pOR <7>, a group (CH2) pSR <7>, a group CH2COOR <7>, a group CH (CH3) COOR <7>;
- R<7 >rappresenta un gruppo C1-C12 alchilico, un gruppo C3-C12 cicloalchilico, un gruppo C1-C12 aloalchilico, un gruppo C1-C12 alcossilico, detti gruppi essendo opzionalmente sostituiti con uno o pi? gruppi Rd uguali o diversi tra loro; - R <7> represents a C1-C12 alkyl group, a C3-C12 cycloalkyl group, a C1-C12 haloalkyl group, a C1-C12 alkoxy group, said groups being optionally substituted with one or more? Rd groups equal or different from each other;
- R<8 >e R<9>, uguali o diversi tra loro, rappresentano un atomo di idrogeno, un gruppo C1-C12 alchilico, un gruppo C1-C12 aloalchilico, un gruppo C3-C12 cicloalchilico, un gruppo C3-C12 alocicloalchilico, un gruppo arilico, un gruppo aril-C1-C12-alchilico, detti gruppi essendo opzionalmente sostituiti con uno o pi? gruppi Rd uguali o diversi tra loro; - R <8> and R <9>, the same or different from each other, represent a hydrogen atom, a C1-C12 alkyl group, a C1-C12 haloalkyl group, a C3-C12 cycloalkyl group, a C3-C12 haloalkyl group , an aryl group, an aryl-C1-C12-alkyl group, said groups being optionally substituted with one or more? Rd groups equal or different from each other;
- Ra e Rb uguali o diversi tra loro, rappresentano un atomo di idrogeno, un gruppo C1-C12 alchilico; - Ra and Rb equal or different from each other, represent a hydrogen atom, a C1-C12 alkyl group;
- oppure Ra e Rb insieme all?atomo di carbonio a cui sono legati formano un anello C3-C12 cicloalchilico; - or Ra and Rb together with the carbon atom to which they are bonded form a C3-C12 cycloalkyl ring;
- R<1>, R<2 >ed R<3>, uguali o diversi tra loro, rappresentano un atomo di idrogeno, un gruppo C1-C12 alchilico, un gruppo C1-C6 aloalchilico, un gruppo C3-C12 cicloalchilico, un gruppo C3-C12 cicloalchil-C1-C12-alchilico, un gruppo arilico, un gruppo aril-C1-C12-alchilico, un gruppo eterociclico, penta- oppure esa-atomico, aromatico o non aromatico, anche benzocondensato od eterobiciclico, contenente almeno un eteroatomo scelto tra ossigeno, zolfo, eventualmente ossidato a solfossido o a solfone, azoto, eventualmente ossidato a N-ossido oppure un gruppo eterociclil-C1-C12-alchilico in cui il gruppo eterociclico ? come sopra definito; detti gruppi essendo opzionalmente sostituiti con uno o pi? gruppi Rd; - R<4 >rappresenta un atomo di idrogeno, un gruppo C1-C12 alchilico, un gruppo C1-C12 aloalchilico, un gruppo C2-C12 alchenilico, un gruppo C2-C12 aloalchenilico, un gruppo C3-C12 cicloalchilico, un gruppo C3-C12 cicloalchenilico, un gruppo C3-C12 cicloalchil-C1-C12-alchilico, un gruppo arilico, un gruppo aril-C1-C12-alchilico, detti gruppi essendo opzionalmente sostituiti con uno o pi? gruppi Rd, oppure R<4 >rappresenta un gruppo T: - R <1>, R <2> and R <3>, the same or different from each other, represent a hydrogen atom, a C1-C12 alkyl group, a C1-C6 haloalkyl group, a C3-C12 cycloalkyl group, a C3-C12 cycloalkyl-C1-C12-alkyl group, an aryl group, an aryl-C1-C12-alkyl group, a heterocyclic, penta- or hexa-atomic, aromatic or non-aromatic group, also benzocondensed or heterobicyclic, containing at least one heteroatom selected from oxygen, sulfur, optionally oxidized to sulfoxide or sulfone, nitrogen, optionally oxidized to N-oxide or a heterocyclyl-C1-C12-alkyl group in which the heterocyclic group? as defined above; said groups being optionally replaced with one or more? Rd groups; - R <4> represents a hydrogen atom, a C1-C12 alkyl group, a C1-C12 haloalkyl group, a C2-C12 alkenyl group, a C2-C12 haloalkenyl group, a C3-C12 cycloalkyl group, a C3- C12 cycloalkenyl, a C3-C12 cycloalkyl-C1-C12-alkyl group, an aryl group, an aryl-C1-C12-alkyl group, said groups being optionally substituted with one or more? Rd groups, or R <4> represents a T group:
T = T =
in cui: in which:
- Re, Rf, uguali o diversi tra loro, rappresentano un gruppo C1-C12 alchilico, un gruppo C1-C12 aloalchilico, un gruppo C2-C12 alchenilico, un gruppo C2-C12 aloalchenilico, un gruppo C3-C12 cicloalchilico, un gruppo arilico, un gruppo aril-C1-C12-alchilico, un gruppo eterociclico penta- oppure esa-atomico, aromatico o non aromatico, anche benzocondensato od eterobiciclico, contenente almeno un eteroatomo scelto tra ossigeno, zolfo, eventualmente ossidato a solfossido o a solfone, azoto, eventualmente ossidato a N-ossido oppure un gruppo eterociclil-C1-C12-alchilico, detti gruppi essendo opzionalmente sostituiti uno o pi? gruppi Rd; - Re, Rf, the same or different, represent a C1-C12 alkyl group, a C1-C12 haloalkyl group, a C2-C12 alkenyl group, a C2-C12 haloalkenyl group, a C3-C12 cycloalkyl group, an aryl group , an aryl-C1-C12-alkyl group, a penta- or hexa-atomic, aromatic or non-aromatic heterocyclic group, also benzocondensed or heterobicyclic, containing at least one heteroatom selected from oxygen, sulfur, optionally oxidized to sulfoxide or sulfone, nitrogen, optionally oxidized to N-oxide or a heterocyclyl-C1-C12-alkyl group, said groups being optionally substituted by one or more? Rd groups;
- Rg rappresenta un atomo di idrogeno, un gruppo C1-C12 alchilico, un gruppo C3-C12 cicloalchilico, un gruppo C1-C12 alcossilico; - Rg represents a hydrogen atom, a C1-C12 alkyl group, a C3-C12 cycloalkyl group, a C1-C12 alkoxy group;
- oppure R<2 >e R<3 >insieme all?atomo di carbonio a cui sono legati formano un gruppo C3-C12 cicloalchilico oppure un gruppo C3-C12 cicloalchenilico, oppure un gruppo eterociclico, penta- oppure esa-atomico, contenente almeno un eteroatomo scelto tra ossigeno, zolfo, eventualmente ossidato a solfossido o a solfone, azoto, eventualmente ossidato a N-ossido, detti gruppi essendo opzionalmente sostituiti con uno o pi? gruppi Rd. - or R <2> and R <3> together with the carbon atom to which they are bound form a C3-C12 cycloalkyl group or a C3-C12 cycloalkenyl group, or a heterocyclic, penta- or hexa-atomic group, containing at least a heteroatom selected from oxygen, sulfur, optionally oxidized to sulfoxide or sulfone, nitrogen, optionally oxidized to N-oxide, said groups being optionally replaced with one or more? Rd groups.
Nella presente descrizione, quando si indica un intervallo numerico, si intendono essere compresi nello stesso anche gli estremi. In the present description, when a numerical interval is indicated, the extremes are also intended to be included therein.
Esempi di alchili C1-C12 che possono essere lineari o ramificati, sono metile, etile, n-propile, isopropile, n-butile, isobutile, sec-butile, tert-butile, n-pentile, 3-metilbutile, n-esile, 3,3-dimetilbutile. Examples of C1-C12 alkyls which may be linear or branched are methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, 3-methylbutyl, n-hexyl, 3,3-dimethylbutyl.
Esempi di aloalchili C1-C12 sono fluorometile, difluorometile, trifluorometile, clorometile, diclorometile, 2,2,2-trifluoroetile, 1,1,2,2-tetrafluoroetile, pentafluoroetile, eptafluoropropile, 4,4,4-tricloro-butile, 4,4-difluoropentile, 5,5-difluoroesile. Examples of C1-C12 haloalkyls are fluoromethyl, difluoromethyl, trifluoromethyl, chloromethyl, dichloromethyl, 2,2,2-trifluoroethyl, 1,1,2,2-tetrafluoroethyl, pentafluoroethyl, heptafluoropropyl, 4,4,4-trichloro-butyl, 4 , 4-difluoropentyl, 5,5-difluorohexyl.
Esempi di alchenili C2-C12, che possono essere lineari o ramificati, sono vinile, allile, 3-butenile, 4-pentile. Examples of C2-C12 alkenyls, which can be linear or branched, are vinyl, allyl, 3-butenyl, 4-pentyl.
Esempi di aloalchenili sono C2-C12 sono 1-(1,1,2-trifluoro)-butenile, 1-(2,2-difluoro)-butenile. Examples of haloalkenyls are C2-C12 are 1- (1,1,2-trifluoro) -butenyl, 1- (2,2-difluoro) -butenyl.
Esempi di cicloalchili C3-C12 sono ciclopropile, ciclobutile, ciclopentile, cicloesile. Examples of C3-C12 cycloalkyls are cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl.
Esempi di cicloalchenili C3-C12 sono ciclopropenile, ciclopentenile, cicloesenile. Esempi di alocicloalchili C3-C12 sono 2,2-dicloro-ciclopropile, 2,2-difluorociclopropile, 2,2,3,3-tetrafluorociclobutile, 3,3-difluorociclopentile, 2-fluorocicloesile. Examples of C3-C12 cycloalkenyls are cyclopropenyl, cyclopentenyl, cyclohexenyl. Examples of C3-C12 haloalkyls are 2,2-dichloro-cyclopropyl, 2,2-difluorocyclopropyl, 2,2,3,3-tetrafluorocyclobutyl, 3,3-difluorocyclopentyl, 2-fluorocyclohexyl.
Esempi di C3-C12cicloalchil-C1-C12-achilici sono ciclopropilmetile, 2-ciclopentiletile, 2- cicloesilpropile. Examples of C3-C12cycloalkyl-C1-C12-alkyl are cyclopropylmethyl, 2-cyclopentylethyl, 2-cyclohexylpropyl.
Esempi di alcossili C1-C12 sono metossile, etossile, iso-propossile, tert-butossile. Esempi di tioalcossili C1-C12 sono tiometossile, tioetossile, iso-tiopropossile. Esempi di cicloalcossilici C3-C12 sono ciclopropossile, ciclopentossile. Examples of C1-C12 alkoxy are methoxy, ethoxy, iso-propoxy, tert-butoxy. Examples of C1-C12 thioalkoxyls are thiomethoxy, thioethoxy, iso-thiopropoxy. Examples of C3-C12 cycloalkoxyls are cyclopropoxy, cyclopentoxyl.
Esempi di gruppi fenossilici sono 4-cloro-fenossile, 2,4-difluoro-fenossile, 3-metil-fenossile. Examples of phenoxy groups are 4-chloro-phenoxy, 2,4-difluoro-phenoxy, 3-methyl-phenoxy.
Esempi di arili, per i quali si intendono sistemi aromatici formati da soli atomi di carbonio, sono fenile, naftile. Examples of aryls, for which aromatic systems formed by carbon atoms only, are phenyl, naphthyl.
Esempi di anelli eterociclici, per i quali si intendono sistemi ciclici a 5 o 6 termini, aromatici o non aromatici, eventualmente benzocondensati contenenti da 1 a 3 eteroatomi scelti tra O, N, S, sono: tiazolo, 1,3,4 tiadiazolo, pirrolidina, piperidina, morfolina, pirazolo ecc. Examples of heterocyclic rings, for which we mean cyclic systems with 5 or 6 terms, aromatic or non-aromatic, possibly benzocondensed containing from 1 to 3 heteroatoms selected from O, N, S, are: thiazole, 1,3,4 thiadiazole, pyrrolidine, piperidine, morpholine, pyrazole etc.
Esempi di aril-C1-C12-alchilico sono benzile, feniletile, 2-fenil-propile, 3-(2-fluoro)-fenil-butile. Examples of aryl-C1-C12-alkyl are benzyl, phenylethyl, 2-phenyl-propyl, 3- (2-fluoro) -phenyl-butyl.
Esempi di eterociclil-C1-C12-alchilico sono 2-(1,3,4-tiadiazolil)-metile, 4-pirazolil-metile, 2-[3-(N-metil)-pirrolidinil]-propile. Examples of heterocyclyl-C1-C12-alkyl are 2- (1,3,4-thiadiazolyl) -methyl, 4-pyrazolyl-methyl, 2- [3- (N-methyl) -pyrrolidinyl] -propyl.
Si intendono rientrare nello spirito della presente invenzione anche: It is also intended to fall within the spirit of the present invention:
a) tutti gli eventuali isomeri geometrici dei composti di formula generale (I) e (I?) e tutti gli stereoisomeri determinati dai centri chirali presenti nelle molecole di formula generale (I) e (I?); a) all the possible geometric isomers of the compounds of general formula (I) and (I?) and all the stereoisomers determined by the chiral centers present in the molecules of general formula (I) and (I?);
b) i sali dei composti di formula (I) e (I?) ottenuti per addizione di acidi inorganici od organici; b) the salts of the compounds of formula (I) and (I?) obtained by addition of inorganic or organic acids;
c) eventuali forme idrate dei composti di formula (I) e (I?); c) any hydrated forms of the compounds of formula (I) and (I?);
d) eventuali forme ossidate sugli atomi di zolfo e azoto dei composti di formula generale (I) e (I?). d) any oxidized forms on the sulfur and nitrogen atoms of the compounds of general formula (I) and (I?).
Esempi di composti di formula generale (I) con X che assume il significato di idrogeno e Y che rappresenta un gruppo C(O)R<5 >(composti di formula generale (Ia)), sono i composti in cui m, n, Ra, Rb, R<1>, R<2>, R<3>, R<4 >ed R<5 >assumono i significati riportati in Tabella 1: Examples of compounds of general formula (I) with X assuming the meaning of hydrogen and Y representing a group C (O) R <5> (compounds of general formula (Ia)), are the compounds in which m, n, Ra, Rb, R <1>, R <2>, R <3>, R <4> and R <5> take on the meanings shown in Table 1:
Tabella 1 Table 1
Esempi di composti di formula generale (I) con X e Y che rappresentano un atomo di idrogeno (composti di formula generale (Ib)), sono i composti in cui, Ra, Rb, n, m, R<1>, R<2>, R<3 >ed R<4 >assumono i significati riportati in Tabella 2: Examples of compounds of general formula (I) with X and Y representing a hydrogen atom (compounds of general formula (Ib)), are the compounds in which, Ra, Rb, n, m, R <1>, R < 2>, R <3> and R <4> take on the meanings shown in Table 2:
Tabella 2 Table 2
Per i composti di formula generale (I) in cui Y assume il significato di Q come descritto sopra, detto gruppo pu? assumere i seguenti significati Q1-Q4, come riportato nelle tabelle 3-6. For compounds of general formula (I) in which Y takes on the meaning of Q as described above, said group can? assume the following meanings Q1-Q4, as reported in tables 3-6.
Q1: Z<1 >= CH, Z<2 >= CRcQ1: Z <1> = CH, Z <2> = CRc
Tabella 3 Table 3
Q2: Z<1 >= N, Z<2 >= CRc Q2: Z <1> = N, Z <2> = CRc
Tabella 4 Table 4
Q3: Z<1 >= CRc, Z<2 >= N Q3: Z <1> = CRc, Z <2> = N
Tabella 5 Table 5
Q4: Z<1 >= Z<2 >= N Q4: Z <1> = Z <2> = N
Tabella 6 Table 6
Esempi di composti di formula generale (I) in cui X rappresenta un atomo di idrogeno e Y assume il significato di Q scelto tra i gruppi da Q1 a Q4 (composti di formula generale (Ic)) sono riportati in Tabella 7. Examples of compounds of general formula (I) in which X represents a hydrogen atom and Y takes on the meaning of Q selected from the groups from Q1 to Q4 (compounds of general formula (Ic)) are reported in Table 7.
Tabella 7 Table 7
Particolarmente preferiti sono i composti di formula generale (Ic) in cui X rappresenta un atomo di idrogeno e Q, Ra, Rb, n, m, R<1>, R<2>, R<3 >ed R<4 >assumono i significati riportati in Tabella 8. Particularly preferred are the compounds of general formula (Ic) in which X represents a hydrogen atom and Q, Ra, Rb, n, m, R <1>, R <2>, R <3> and R <4> assume the meanings reported in Table 8.
Tabella 8 Table 8
Ancor pi? preferiti sono i composti di formula generale (Ic) in cui X rappresenta un atomo di idrogeno e Q, Ra, Rb, n, m, R<1>, R<2>, R<3 >ed R<4 >assumono i significati riportati in Tabella 9. Even more? preferred are the compounds of general formula (Ic) in which X represents a hydrogen atom and Q, Ra, Rb, n, m, R <1>, R <2>, R <3> and R <4> assume the meanings reported in Table 9.
Tabella 9 Table 9
Esempi di composti di formula generale (I?) con X che rappresenta un atomo idrogeno e Y che assume il significato di Q, scelto tra i gruppi da Q1 a Q4, sono i composti in cui Q m, n, Ra, Rb, R<1>, e G assumono i significati riportati in Tabella 10: Examples of compounds of general formula (I?) With X representing a hydrogen atom and Y assuming the meaning of Q, chosen from the groups Q1 to Q4, are the compounds in which Q m, n, Ra, Rb, R <1>, and G take on the meanings shown in Table 10:
Tabella 10 Table 10
723 Q1.48 H H 0 1 CH3 Li 723 Q1.48 H H 0 1 CH3 Li
724 Q1.48 H H 0 1 CH3 Na 724 Q1.48 H H 0 1 CH3 Na
725 Q1.48 H H 0 1 CH3 K 725 Q1.48 H H 0 1 CH3 K
726 Q1.48 H H 0 1 CH3 NH4726 Q1.48 H H 0 1 CH3 NH4
727 Q1.48 H H 0 1 CH3 N(Et)3727 Q1.48 H H 0 1 CH3 N (Et) 3
Un ulteriore oggetto della presente invenzione ? l?uso dei suddetti composti di formula (I?) come intermedi nella preparazione dei composti di formula generale (Ic). A further object of the present invention? the use of the above compounds of formula (I?) as intermediates in the preparation of compounds of general formula (Ic).
I composti di formula generale (I) dove X assume il valore di idrogeno e Y rappresenta un gruppo Q, (composti di formula generale (Ic)) possono essere ottenuti utilizzando varie metodologie sintetiche; ad esempio, a scopo esemplificativo ma non esaustivo, possono essere preparati dai composti di formula generale (II) per reazione con un?opportuna ammina di formula generale (Ib) secondo lo schema di reazione 1. Compounds of general formula (I) where X assumes the value of hydrogen and Y represents a group Q, (compounds of general formula (Ic)) can be obtained using various synthetic methods; for example, by way of example but not exhaustive, they can be prepared from the compounds of general formula (II) by reaction with a suitable amine of general formula (Ib) according to reaction scheme 1.
Schema 1 Scheme 1
(II) (Ib) (Ic) (II) (Ib) (Ic)
La reazione viene condotta attivando l?acido mediante formazione del corrispondente cloruro, ad esempio con cloruro di tionile in diclorometano o cloroformio a una temperatura compresa tra -10?C e la temperatura di riflusso del solvente usato, oppure utilizzando un agente condensante quale N,N?-dicicloesilcarbodimmide oppure N-(3-dimetilamminopropil)-N?-etilcarbodimmide in tetraidrofurano o acetato di etile, oppure utilizzando 1,1-carbonildimidazolo in tetraidrofurano o cloruro di metilene oppure PyBOP [(1-Benzotriazolilossi)tripirrolidinofosfonio esafluorofosfato], HATU (1-[Bis(dimetilammino)metilene]-1H-1,2,3-triazolo[4,5-b]piridinio-3-ossido The reaction is carried out by activating the acid by forming the corresponding chloride, for example with thionyl chloride in dichloromethane or chloroform at a temperature between -10 ° C and the reflux temperature of the solvent used, or by using a condensing agent such as N, N? -Dicyclohexylcarbodimide or N- (3-dimethylaminopropyl) -N? -Ethylcarbodimide in tetrahydrofuran or ethyl acetate, or using 1,1-carbonyldimidazole in tetrahydrofuran or methylene chloride or PyBOP [(1-Benzotriazolaphylloxy) triphoniophonate (1- [Bis (dimethylamino) methylene] -1H-1,2,3-triazole [4,5-b] pyridinium-3-oxide
esafluorofosfato) a temperatura compresa tra 0?C e la temperatura di riflusso del solvente usato, come ampiamente descritto in R. C. Larock ?Comprehensive Organic Transformations?. hexafluorophosphate) at a temperature between 0 ° C and the reflux temperature of the solvent used, as widely described in R. C. Larock? Comprehensive Organic Transformations ?.
La forma attivata dell?acido, in presenza dell?ammina di formula (Ib) reagisce in un opportuno solvente quale cloruro di metilene, oppure dicloroetano, oppure cloroformio a una temperatura compresa tra 0?C e la temperatura di riflusso del solvente in presenza o in assenza di una base quale ad esempio trietilammina o 4-dimetilamminopiridina o diisopropiletilammina a dare i composti di formula generale (I), secondo quanto noto in letteratura in R. C. Larock ?Comprehensive Organic Transformations?. The activated form of the acid, in the presence of the amine of formula (Ib), reacts in a suitable solvent such as methylene chloride, or dichloroethane, or chloroform at a temperature between 0 ° C and the reflux temperature of the solvent in the presence or in the absence of a base such as triethylamine or 4-dimethylaminopyridine or diisopropylethylamine to give the compounds of general formula (I), according to what is known in the literature in R. C. Larock? Comprehensive Organic Transformations ?.
Alternativamente i composti di formula generale (I) dove X assume il valore di idrogeno e Y il valore di Q (composti di formula generale (Ic)) possono essere ottenuti secondo lo schema di reazione 2. Alternatively the compounds of general formula (I) where X takes on the value of hydrogen and Y the value of Q (compounds of general formula (Ic)) can be obtained according to reaction scheme 2.
Schema 2 Scheme 2
La forma attivata dell?acido acido di formula generale (II) ottenuta secondo quanto detto precedentemente nello schema di reazione 1, reagisce in presenza dell?ammina di formula generale (Ib), a dare il composto di formula generale (Ic) dove R?, in entrambi i casi, assume il significato di C1-C4 alchile. Quest?ultimo viene sottoposto a idrolisi acida o basica a dare il composto (I?) che viene fatto condensare con un opportuno alcool di formula generale (III) in un solvente conveniente quale cloruro di metilene, oppure dicloroetano, oppure cloroformio, in presenza di un agente condensante quale N,N?-dicicloesilcarbodimmide oppure N-(3-dimetilamminopropil)-N?-etilcarbodimmide in tetraidrofurano o acetato di etile, oppure utilizzando 1,1-carbonildimidazolo in tetraidrofurano o cloruro di metilene ad una temperatura compresa tra 0?C e la temperatura di riflusso del solvente in presenza o in assenza di una base quale ad esempio trietilammina o 4-dimetilamminopiridina o diisopropiletilammina secondo quanto noto in letteratura in R. C. Larock ?Comprehensive Organic Transformations?. The activated form of the acidic acid of general formula (II) obtained according to what previously said in the reaction scheme 1, reacts in the presence of the amine of general formula (Ib), to give the compound of general formula (Ic) where R? , in both cases, it assumes the meaning of C1-C4 alkyl. The latter is subjected to acid or basic hydrolysis to give compound (I?) Which is condensed with a suitable alcohol of general formula (III) in a suitable solvent such as methylene chloride, or dichloroethane, or chloroform, in the presence of a condensing agent such as N, N? -dicyclohexylcarbodimide or N- (3-dimethylaminopropyl) -N? -ethylcarbodimide in tetrahydrofuran or ethyl acetate, or using 1,1-carbonyldimidazole in tetrahydrofuran or methylene chloride at a temperature between 0? C is the reflux temperature of the solvent in the presence or absence of a base such as triethylamine or 4-dimethylaminopyridine or diisopropylethylamine according to what is known in the literature in R. C. Larock? Comprehensive Organic Transformations ?.
Alternativamente i composti di formula generale (Ic) quando Z<1 >assume il significato di gruppo CH e Z<2 >di gruppo CRc, con Rc che rappresenta il gruppo NHCHO, possono essere ottenuti mediante condensazione dell?opportuno acido 3-nitrosalicilico di formula (IIa) con l?amminoestere di formula generale (Ib) a dare il composto di formula (Ic?). Per successiva reazione di riduzione del nitro gruppo si ottiene il composto di formula (Ic??) che pu? essere sottoposto a reazione di formilazione a dare il composto di formula generale (Ic), secondo lo schema di reazione 4: Alternatively, the compounds of general formula (Ic) when Z <1> assumes the meaning of group CH and Z <2> of group CRc, with Rc representing the NHCHO group, can be obtained by condensation of the appropriate 3-nitrosalicylic acid of formula (IIa) with the aminoester of general formula (Ib) to give the compound of formula (Ic?). By subsequent reaction of reduction of the nitro group, the compound of formula (Ic ??) is obtained which can? be subjected to a formylation reaction to give the compound of general formula (Ic), according to reaction scheme 4:
Schema 4 Scheme 4
La stessa sequenza di reazioni pu? essere applicata anche negli schemi di reazione 2 e 3 quando Z<1 >assume il significato di gruppo CH e Z<2 >rappresenta il gruppo CRc, con Rc che rappresenta il gruppo NHCHO. The same sequence of reactions can? be applied also in reaction schemes 2 and 3 when Z <1> assumes the meaning of CH group and Z <2> represents the CRc group, with Rc representing the NHCHO group.
Le modalit? per condurre la reazione di condensazione tra i composti di formula generale (IIa) e (Ib) sono le medesime descritte nei paragrafi precedenti. The modalities? to carry out the condensation reaction between the compounds of general formula (IIa) and (Ib) are the same as described in the previous paragraphs.
La reazione di riduzione del gruppo nitro presente nei composti di formula generale (Ic?) pu? essere condotta secondo le usuali metodiche ben note nell?arte e descritte ampiamente in R. C. Larock ?Comprehensive Organic Transformations?, quali per esempio l?idrogenazione catalitica in presenza di catalizzatori quali ad esempio Pd su carbone al 5% o Pd su carbone al 10% in un solvente quale metanolo, etanolo o tetraidrofurano, a pressione atmosferica o sotto pressione e ad una temperatura compresa tra i valori ambientali e 80?C, oppure utilizzando formiato d?ammonio in metanolo a pressione atmosferica e temperatura ambiente oppure ferro metallico e acido acetico in una miscela idroalcoolica a temperature comprese tra valori ambientali e quelle di riflusso della miscela di reazione, oppure cloruro di stagno in acetato di etile alla temperatura di riflusso del solvente. The reduction reaction of the nitro group present in the compounds of general formula (Ic?) Pu? be carried out according to the usual methods well known in the art and described extensively in R. C. Larock? Comprehensive Organic Transformations?, such as for example the catalytic hydrogenation in the presence of catalysts such as for example Pd on coal at 5% or Pd on coal at 10% in a solvent such as methanol, ethanol or tetrahydrofuran, at atmospheric pressure or under pressure and at a temperature between ambient values and 80 ° C, or using ammonium formate in methanol at atmospheric pressure and ambient temperature or metallic iron and acetic acid in a hydroalcoholic mixture at temperatures between ambient and reflux values of the reaction mixture, or tin chloride in ethyl acetate at the reflux temperature of the solvent.
La reazione di formilazione del gruppo ammino cos? ottenuto, pu? essere condotta secondo le usuali metodiche ben note nell?arte quali, per esempio, utilizzando un?anidride mista tra acido formico e anidride acetica in un solvente quale tetraidrofurano o diossano come descritto in Krishnamurthy S. ?Tetrahedron Letters?, 1982, vol. 23, pag. 3315-3318, oppure in formammide a 150?C come descritto in John Janetzko, Robert A. Batey, ?Journal of Organic Chemistry?, 2014, vol. 79, pag 7415-7424 oppure con zinco ossido e acido formico come descritto in Hosseini-Sarvari Mona, Sharghi Hashem, ?Journal of Organic Chemistry?, 2006, vol. 71 (17), pag. 6652-6654 o cerio ossido e acido formico in presenza di ultrasuoni come descritto in Sajadi S. Mohammad et al., ?Letters in Organic Chemistry?, 2014, vol.11, pag 49-54. The formylation reaction of the amino group cos? obtained, can? be carried out according to the usual methods well known in the art such as, for example, using a mixed anhydride between formic acid and acetic anhydride in a solvent such as tetrahydrofuran or dioxane as described in Krishnamurthy S.? Tetrahedron Letters ?, 1982, vol. 23, p. 3315-3318, or in formamide at 150? C as described in John Janetzko, Robert A. Batey,? Journal of Organic Chemistry ?, 2014, vol. 79, pages 7415-7424 or with zinc oxide and formic acid as described in Hosseini-Sarvari Mona, Sharghi Hashem,? Journal of Organic Chemistry ?, 2006, vol. 71 (17), p. 6652-6654 or cerium oxide and formic acid in the presence of ultrasound as described in Sajadi S. Mohammad et al.,? Letters in Organic Chemistry ?, 2014, vol. 11, pages 49-54.
Alternativamente i composti di formula generale (Ic) quando Z<1 >assume il significato di gruppo CH e Z<2 >di gruppo CRc, con Rc che rappresenta un gruppo NHCHO, possono essere ottenuti secondo la procedure descritta nello schema 2, ovvero mediante condensazione dell?opportuno composto di formula generale (IIb), dove PG rappresenta un gruppo protettivo, quale ad esempio un raggruppamento benzilico oppure un gruppo p-metossibenzilico o pclorobenzilico con un?ammina di formula generale (Ib) a dare il composto di formula (Ic<???>), dove R? assume, in entrambi i casi, il significato di C1-C4 alchile. Quest?ultimo viene sottoposto a idrolisi acida o basica a dare il composto (I?a) che viene fatto condensare con un opportuno alcool di formula generale (III) a dare il composto di formula generale (Ic<????>). Alternatively, the compounds of general formula (Ic) when Z <1> assumes the meaning of group CH and Z <2> of group CRc, with Rc representing an NHCHO group, can be obtained according to the procedure described in scheme 2, i.e. by condensation of the appropriate compound of general formula (IIb), where PG represents a protective group, such as for example a benzyl group or a p-methoxybenzyl or pchlorobenzyl group with an amine of general formula (Ib) to give the compound of formula ( Ic <???>), where R? in both cases it assumes the meaning of C1-C4 alkyl. The latter is subjected to acid or basic hydrolysis to give compound (I? A) which is condensed with a suitable alcohol of general formula (III) to give the compound of general formula (Ic <????>).
La successiva reazione di riduzione del nitro gruppo comporta anche la rimozione del gruppo protettivo PG a dare il composto di formula (Ic??) che pu? essere sottoposto a reazione di formilazione a dare il composto di formula generale (Ic) utilizzando le procedure descritte precedentemente e secondo lo schema di reazione 5: The subsequent reaction of reduction of the nitro group also involves the removal of the protective group PG to give the compound of formula (Ic ??) which can? be subjected to a formylation reaction to give the compound of general formula (Ic) using the procedures described above and according to reaction scheme 5:
Schema 5 Scheme 5
I composti di formula generale (Ic) per W<1 >che assume il significato di atomo di zolfo, possono essere facilmente ottenuti dai corrispondenti composti con W<1 >che rappresenta un atomo di ossigeno, per solfonazione delle ammidi mediante reazione con P4S10 o con il reattivo di Lawesson, secondo quanto noto in letteratura e descritto, ad esempio, in R. Larock ?Comprehensive Organic Transformations? e secondo lo schema di reazione 6: The compounds of general formula (Ic) for W <1> which assumes the meaning of sulfur atom, can be easily obtained from the corresponding compounds with W <1> which represents an oxygen atom, by sulfonation of amides by reaction with P4S10 or with Lawesson's reagent, according to what is known in the literature and described, for example, in R. Larock? Comprehensive Organic Transformations? and according to reaction scheme 6:
Schema 6 Scheme 6
I composti di formula generale (Ic) in cui R<6 >assume il significato di gruppo benzilico o di gruppo COR<7>, oppure di gruppo CH2OCOR<7>, oppure di gruppo CH2OR<7>, oppure di gruppo CH2SR<7 >possono essere ottenuti mediante reazione di benzilazione o acilazione o alchilazione dei corrispondenti composti di formula generale (Ic), in cui M rappresenta un gruppo W<2>H, utilizzando un composto di formula generale L-R<6>, con R<6 >diverso da atomo di idrogeno e con L che rappresenta un gruppo uscente quale un atomo di alogeno, scelto tra cloro, bromo o iodio, oppure un gruppo mesilato oppure un gruppo triflato, in un opportuno solvente quale acetato di etile o N,N-dimetilformammide o acetone ad una temperatura compresa tra i -15?C e i 70?C, in presenza di una base organica o inorganica quale carbonato di potassio, o carbonato di sodio, o trietilammina o piridina o sodio idruro e in presenza o assenza di un catalizzatore quale ioduro di sodio, ioduro di potassio e di un etere corona quale 15-crown-5 oppure 18-crown-6, secondo metodi ben noti in letteratura e descritti, ad esempio, in WO2016/109257 e rappresentati nello schema di reazione 7. Compounds with general formula (Ic) in which R <6> takes on the meaning of benzyl group or COR group <7>, or of CH2OCOR group <7>, or of CH2OR group <7>, or of CH2SR group <7 > can be obtained by benzylation or acylation or alkylation reaction of the corresponding compounds of general formula (Ic), in which M represents a group W <2> H, using a compound of general formula L-R <6>, with R <6> other than a hydrogen atom and with L representing a leaving group such as a halogen atom, selected from chlorine, bromine or iodine, or a mesylate group or a triflate group, in a suitable solvent such as ethyl acetate or N, N-dimethylformamide o acetone at a temperature between -15 ° C and 70 ° C, in the presence of an organic or inorganic base such as potassium carbonate, or sodium carbonate, or triethylamine or pyridine or sodium hydride and in the presence or absence of a catalyst such as sodium iodide, potassium iodide and a corona ether such as 1 5-crown-5 or 18-crown-6, according to methods well known in literature and described, for example, in WO2016 / 109257 and represented in reaction scheme 7.
Schema 7 Scheme 7
I composti di formula (Ib), quando non sono commerciali e per X e Y che assumono il significato idrogeno, possono essere preparati come descritto, ad esempio, in EP652229. The compounds of formula (Ib), when they are not commercial and for X and Y which take the meaning of hydrogen, can be prepared as described, for example, in EP652229.
Gli alcoli di formula generale (III), quando non sono commerciali, possono essere facilmente ottenuti mediante reazione di riduzione dei corrispondenti chetoni mediante idruri quali sodio boroidruro, litio alluminio idruro in opportuni solventi quali tetraidrofurano o diossano a una temperatura compresa tra 0?C e la temperatura di ebollizione del solvente secondo metodi noti in letteratura come descritto in E. Tadashi, U. Norichika, Y. Masataka, et al. ? Tetrahedron?, 2009, vol. 65, pag. 9583 ? 9591, oppure in WO2016/109257. The alcohols of general formula (III), when they are not commercial, can be easily obtained by reducing the corresponding ketones by means of hydrides such as sodium borohydride, lithium aluminum hydride in suitable solvents such as tetrahydrofuran or dioxane at a temperature between 0 ° C and the boiling temperature of the solvent according to methods known in literature as described in E. Tadashi, U. Norichika, Y. Masataka, et al. ? Tetrahedron ?, 2009, vol. 65, p. 9583? 9591, or in WO2016 / 109257.
I gruppi Q1-Q4, quando non sono commerciali, possono essere ottenuti utilizzando le procedure riportate in R. E. Buntrock ?Review of Heterocyclic Chemistry?, 5?Edizione, 2012 Copyright ? 2012 The American Chemical Society and Division of Chemical Education, Inc. Q1-Q4 groups, when non-commercial, can be obtained using the procedures outlined in R. E. Buntrock? Review of Heterocyclic Chemistry ?, 5? Edition, 2012 Copyright? 2012 The American Chemical Society and Division of Chemical Education, Inc.
I composti di formula generale (Ic), per n che assume il valore di 1 o 2, possono essere ottenuti mediante reazioni di ossidazione dei composti di formula (Id), in cui PG? rappresenta un gruppo protettivo COR5, quale per esempio un gruppo tbutossicarbonile (BOC) oppure fluorenilmetossicarbonile (FMOC), a dare il composto di formula (Ie), secondo metodi noti in letteratura come descritto per esempio in Loginova, Rubtsova, Kuchin ?Chemistry of Natural Compounds, 2008, vol 44, pag. 752-754 oppure in WO2014/9759, WO2015/8019 oppure in M. Matteucci, G. Bhalay, M. Bradley ?Org. Lett. 2003, 5, 3, pag. 235-237?. I composti di formula generale (Ie), cos? ottenuti, possono essere sottoposti a reazione di estereficazione con un opportuno alcool di formula (III) e poi a successiva reazione di rimozione del gruppo protettivo PG? ottenendo i composti di formula (Ib). L?ammino estere cos? ottenuto viene fatto reagire con gli acidi di formula (II) a dare il composto di formula generale (Ic), secondo lo schema di reazione 8. The compounds of general formula (Ic), for n which takes the value of 1 or 2, can be obtained by oxidation reactions of the compounds of formula (Id), in which PG? represents a COR5 protective group, such as for example a tbutoxycarbonyl (BOC) or fluorenylmethoxycarbonyl (FMOC) group, to give the compound of formula (Ie), according to methods known in the literature as described for example in Loginova, Rubtsova, Kuchin? Chemistry of Natural Compounds, 2008, vol 44, p. 752-754 or in WO2014 / 9759, WO2015 / 8019 or in M. Matteucci, G. Bhalay, M. Bradley? Org. Lett. 2003, 5, 3, p. 235-237 ?. The compounds of general formula (Ie), cos? obtained, can they be subjected to an esterfication reaction with a suitable alcohol of formula (III) and then to a subsequent reaction to remove the protective group PG? obtaining the compounds of formula (Ib). The amino ester cos? obtained is reacted with the acids of formula (II) to give the compound of general formula (Ic), according to the reaction scheme 8.
Schema 8 Scheme 8
Alternativamente i composti di formula generale (Ic), per n che assume il valore di 1 o 2, possono essere ottenuti mediante reazione di ossidazione dei corrispondenti tioeteri di formula generale (Ic), in cui n assume il valore 0, secondo metodi noti in letteratura e descritti appena sopra, secondo lo schema di reazione 9: Alternatively the compounds of general formula (Ic), for n which takes the value of 1 or 2, can be obtained by oxidation reaction of the corresponding thioethers of general formula (Ic), in which n takes the value 0, according to methods known in literature and described above, according to reaction scheme 9:
Schema 9 Scheme 9
E? ulteriore oggetto della presente invenzione l?uso di composti di formula generale (I): AND? a further object of the present invention is the use of compounds of general formula (I):
in cui: in which:
- X rappresenta un atomo di idrogeno oppure un gruppo C(O)R<5>; - X represents a hydrogen atom or a C (O) R <5> group;
- Y rappresenta un atomo di idrogeno oppure un gruppo C(O)R<5 >oppure un gruppo Q: - Y represents a hydrogen atom or a C (O) R <5> group or a Q group:
- Z<1 >e Z<2 >, uguali o diversi tra loro, possono rappresentare un atomo di azoto, un gruppo N?O, oppure un gruppo CRc; - Z <1> and Z <2>, equal or different from each other, can represent a nitrogen atom, a N? O group, or a CRc group;
- Rc rappresenta un atomo di idrogeno, un atomo di alogeno scelto tra fluoro, cloro, bromo o iodio, un gruppo C1-C12 alcossile, un gruppo C1-C12 tioalcossile, un gruppo nitro, un gruppo amminico, un gruppo formilamminico; - M rappresenta un atomo di alogeno scelto tra fluoro, cloro, bromo o iodio o un gruppo W<2>-R<6>; - Rc represents a hydrogen atom, a halogen atom selected from fluorine, chlorine, bromine or iodine, a C1-C12 alkoxy group, a C1-C12 thioalkoxyl group, a nitro group, an amino group, a formylamine group; - M represents a halogen atom selected from fluorine, chlorine, bromine or iodine or a W <2> -R <6> group;
- W<1 >e W<2>, uguali o diversi tra loro, rappresentano un atomo di ossigeno oppure un atomo di zolfo; - W <1> and W <2>, equal or different from each other, represent an oxygen atom or a sulfur atom;
- R<6 >rappresenta un atomo di idrogeno, un gruppo benzilico anche opzionalmente sostituito sull?anello fenilico, un gruppo COR<7>, un gruppo CH2OCOR<7>, un gruppo CH(CH3)OCOR<7>, un gruppo (CH2)pOR<7>, un gruppo (CH2)pSR<7>, un gruppo CH2COOR<7>; un gruppo CH(CH3)COOR<7>; - R <6> represents a hydrogen atom, a benzyl group also optionally substituted on the phenyl ring, a COR <7> group, a CH2OCOR <7> group, a CH (CH3) OCOR <7> group, a ( CH2) pOR <7>, a group (CH2) pSR <7>, a group CH2COOR <7>; a CH (CH3) COOR <7> group;
- R<7 >rappresenta un gruppo C1-C12 alchilico, un gruppo C3-C12 cicloalchilico, un gruppo C1-C12 aloalchilico, un gruppo C1-C12 alcossilico, detti gruppi essendo opzionalmente sostituiti con uno o pi? gruppi Rd uguali o diversi tra loro; - R <7> represents a C1-C12 alkyl group, a C3-C12 cycloalkyl group, a C1-C12 haloalkyl group, a C1-C12 alkoxy group, said groups being optionally substituted with one or more? Rd groups equal or different from each other;
- Rd rappresenta un gruppo nitro, un gruppo ciano, un gruppo C1-C12 alchilico, un gruppo C3-C12 cicloalchilico, un gruppo C3-C12cicloalchil-C1-C12-alchilico, gruppo C1-C12 aloalchilico, un gruppo C2-C12 alchenilico, un gruppo C2-C12 aloalchenilico, un gruppo C3-C12 cicloalchenilico, un gruppo C1-C12 alcossilico, un gruppo C1-C12 tioalcossilico, un gruppo C3-C12 cicloalcossilico, un gruppo arilico, un gruppo fenossilico, un gruppo benzilossi, un gruppo aril-C1-C12-alchilico, oppure un gruppo eterociclil-C1-C12-alchilico in cui il gruppo eterociclico ? come sopra definito; un gruppo C(=W<1>)R<8>, un gruppo C(=O)OR<8>, un gruppo C(=O)NR<8>R<9>, un gruppo S(=O)nR<8>, un gruppo S(=O)2NR<8>R<9>; - Rd represents a nitro group, a cyano group, a C1-C12 alkyl group, a C3-C12 cycloalkyl group, a C3-C12cycloalkyl-C1-C12-alkyl group, a C1-C12 haloalkyl group, a C2-C12 alkenyl group, a C2-C12 haloalkenyl group, a C3-C12 cycloalkenyl group, a C1-C12 alkoxy group, a C1-C12 thioalkoxy group, a C3-C12 cycloalkoxyl group, an aryl group, a phenoxy group, a benzyloxy group, an aryl group -C1-C12-alkyl, or a heterocyclyl-C1-C12-alkyl group wherein the heterocyclic group? as defined above; a group C (= W <1>) R <8>, a group C (= O) OR <8>, a group C (= O) NR <8> R <9>, a group S (= O) nR <8>, a group S (= O) 2NR <8> R <9>;
- n rappresenta un numero compreso tra 0 e 2; - n represents a number between 0 and 2;
- m rappresenta un numero compreso tra 1 e 2; - m represents a number between 1 and 2;
- p rappresenta un numero compreso tra 1 e 4; - p represents a number between 1 and 4;
- R<5 >rappresenta un gruppo C1-C12 alcossilico, un gruppo benzilossi oppure un gruppo fluorenilmetossi; - R <5> represents a C1-C12 alkoxy group, a benzyloxy group or a fluorenylmethoxy group;
- R<8 >e R<9>, uguali o diversi tra loro, rappresentano un atomo di idrogeno, un gruppo C1-C12 alchilico, un gruppo C1-C12 aloalchilico, un gruppo C2-C12 alchenilico, un gruppo C2-C12 aloalchenilico, un gruppo C3-C12 cicloalchilico, un gruppo C3-C12 alocicloalchilico, un gruppo arilico, un gruppo aril-C1-C12-alchilico, detti gruppi essendo opzionalmente sostituiti con uno o pi? gruppi Rd uguali o diversi tra loro; - R <8> and R <9>, the same or different from each other, represent a hydrogen atom, a C1-C12 alkyl group, a C1-C12 haloalkyl group, a C2-C12 alkenyl group, a C2-C12 haloalkenyl group , a C3-C12 cycloalkyl group, a C3-C12 haloalkyl group, an aryl group, an aryl-C1-C12-alkyl group, said groups being optionally substituted with one or more? Rd groups equal or different from each other;
- Ra e Rb uguali o diversi tra loro, rappresentano un atomo di idrogeno, un gruppo C1-C12 alchilico; - Ra and Rb equal or different from each other, represent a hydrogen atom, a C1-C12 alkyl group;
- oppure Ra e Rb insieme all?atomo di carbonio a cui sono legati formano un anello C3-C12 cicloalchilico; - or Ra and Rb together with the carbon atom to which they are bonded form a C3-C12 cycloalkyl ring;
- R<1>, R<2 >ed R<3>, uguali o diversi tra loro, rappresentano un atomo di idrogeno, un gruppo C1-C12 alchilico, un gruppo C1-C6 aloalchilico, un gruppo C2-C12 alchenilico, un gruppo C2-C12 aloalchenilico, un gruppo C3-C12 cicloalchilico, un gruppo C3-C12 cicloalchenilico, un gruppo C3-C12cicloalchil-C1-C12-alchilico, un gruppo arilico, un gruppo aril-C1-C12-alchilico, un gruppo eterociclico, pentaoppure esa-atomico, aromatico o non aromatico, anche benzocondensato od eterobiciclico, contenente almeno un eteroatomo scelto tra ossigeno, zolfo, eventualmente ossidato a solfossido o a solfone, azoto, eventualmente ossidato a N-ossido oppure un gruppo eterociclil-C1-C12-alchilico in cui il gruppo eterociclico ? come sopra definito; detti gruppi essendo opzionalmente sostituiti con uno o pi? gruppi Rd; - R <1>, R <2> and R <3>, the same or different from each other, represent a hydrogen atom, a C1-C12 alkyl group, a C1-C6 haloalkyl group, a C2-C12 alkenyl group, a C2-C12 haloalkenyl group, a C3-C12 cycloalkyl group, a C3-C12 cycloalkenyl group, a C3-C12 cycloalkyl-C1-C12-alkyl group, an aryl group, an aryl-C1-C12-alkyl group, a heterocyclic group, penta or hexa-atomic, aromatic or non-aromatic, also benzocondensed or heterobicyclic, containing at least one heteroatom selected from oxygen, sulfur, optionally oxidized to sulfoxide or sulphone, nitrogen, optionally oxidized to N-oxide or a heterocyclyl-C1-C12-alkyl group in which the heterocyclic group? as defined above; said groups being optionally replaced with one or more? Rd groups;
- oppure R<2 >e R<3 >insieme all?atomo di carbonio a cui sono legati formano un gruppo C3-C12 cicloalchilico oppure un gruppo C3-C12 cicloalchenilico, oppure un gruppo eterociclico, penta- oppure esa-atomico, contenente almeno un eteroatomo scelto tra ossigeno, zolfo, eventualmente ossidato a solfossido o a solfone, azoto, eventualmente ossidato a N-ossido, detti gruppi essendo opzionalmente sostituiti con uno o pi? gruppi Rd; - or R <2> and R <3> together with the carbon atom to which they are bound form a C3-C12 cycloalkyl group or a C3-C12 cycloalkenyl group, or a heterocyclic, penta- or hexa-atomic group, containing at least a heteroatom selected from oxygen, sulfur, optionally oxidized to sulfoxide or sulfone, nitrogen, optionally oxidized to N-oxide, said groups being optionally replaced with one or more? Rd groups;
- R<4 >rappresenta un atomo di idrogeno, un gruppo C1-C12 alchilico, un gruppo C1-C12 aloalchilico, un gruppo C2-C12 alchenilico, un gruppo C2-C12 aloalchenilico, un gruppo C3-C12 cicloalchilico, un gruppo C3-C12 cicloalchenilico, un gruppo C3-C12 cicloalchil-C1-C12-alchilico, un gruppo arilico, un gruppo aril-C1-C12-alchilico, un gruppo eterociclico penta- oppure esa-atomico, aromatico o non aromatico, anche benzocondensato od eterobiciclico, contenente almeno un eteroatomo scelto tra ossigeno, zolfo, eventualmente ossidato a solfossido o a solfone, azoto, eventualmente ossidato a N-ossido oppure un gruppo eterociclil-C1-C12-alchilico in cui il gruppo eterociclico ? come sopra definito, detti gruppi essendo opzionalmente sostituiti con uno o pi? gruppi Rd, oppure R<4 >rappresenta un gruppo T: - R <4> represents a hydrogen atom, a C1-C12 alkyl group, a C1-C12 haloalkyl group, a C2-C12 alkenyl group, a C2-C12 haloalkenyl group, a C3-C12 cycloalkyl group, a C3- C12 cycloalkenyl, a C3-C12 cycloalkyl-C1-C12-alkyl group, an aryl group, an aryl-C1-C12-alkyl group, a penta- or hexa-atomic, aromatic or non-aromatic heterocyclic group, whether or not benzocondensed or heterobicyclic, containing at least one heteroatom selected from oxygen, sulfur, optionally oxidized to sulfoxide or sulfone, nitrogen, optionally oxidized to N-oxide or a heterocyclyl-C1-C12-alkyl group in which the heterocyclic group? as defined above, said groups being optionally replaced with one or more? Rd groups, or R <4> represents a T group:
T = T =
in cui: in which:
- Re , Rf, uguali o diversi tra loro, rappresentano un gruppo C1-C12 alchilico, un gruppo C1-C12 aloalchilico, un gruppo C2-C12 alchenilico, un gruppo C2-C12 aloalchenilico, un gruppo C3-C12 cicloalchilico, un gruppo arilico, un gruppo aril-C1-C12-alchilico, un gruppo eterociclico penta- oppure esa-atomico, aromatico o non aromatico, anche benzocondensato od eterobiciclico, contenente almeno un eteroatomo scelto tra ossigeno, zolfo, eventualmente ossidato a solfossido o a solfone, azoto, eventualmente ossidato a N-ossido oppure un gruppo eterociclil-C1-C12-alchilico, detti gruppi essendo opzionalmente sostituiti uno o pi? gruppi Rd; - Re, Rf, the same or different, represent a C1-C12 alkyl group, a C1-C12 haloalkyl group, a C2-C12 alkenyl group, a C2-C12 haloalkenyl group, a C3-C12 cycloalkyl group, an aryl group , an aryl-C1-C12-alkyl group, a penta- or hexa-atomic, aromatic or non-aromatic heterocyclic group, also benzocondensed or heterobicyclic, containing at least one heteroatom selected from oxygen, sulfur, optionally oxidized to sulfoxide or sulfone, nitrogen, optionally oxidized to N-oxide or a heterocyclyl-C1-C12-alkyl group, said groups being optionally substituted by one or more? Rd groups;
- Rg rappresenta un atomo di idrogeno, un ossidrile, un atomo di alogeno scelto tra fluoro, cloro, bromo o iodio, un gruppo C1-C12 alchilico, un gruppo C1C12 aloalchilico, un gruppo C2-C12 alchenilico, un gruppo C2-C12 aloalchenilico, un gruppo C3-C12 cicloalchilico, un gruppo C1-C12 alcossilico; - Rg represents a hydrogen atom, a hydroxyl, a halogen atom chosen from fluorine, chlorine, bromine or iodine, a C1-C12 alkyl group, a C1C12 haloalkyl group, a C2-C12 alkenyl group, a C2-C12 haloalkenyl group , a C3-C12 cycloalkyl group, a C1-C12 alkoxy group;
a condizione che: provided that:
- quando Z<1 >assume il valore di CH, Z<2 >rappresenta un gruppo CRc dove Rc assume il significato di un gruppo formilammino oppure di un gruppo nitro, W<1 >e W<2 >sono entrambi ossigeno, R<6 >? un atomo di idrogeno, n assume il valore 0, m assume il valore 1 oppure 2 e Ra e Rb rappresentano entrambi un atomo di idrogeno e, se R<1 >assume il significato di metile, 4-metossibenzile oppure di 4-metossifenilcarbonile e R<4 >assume il significato di idrogeno, R<2 >e R<3>, diversi tra loro, non possono assumere i significati di idrogeno, etile, eptile ed isobutile; - when Z <1> assumes the value of CH, Z <2> represents a CRc group where Rc takes on the meaning of a formylamino group or a nitro group, W <1> and W <2> are both oxygen, R < 6>? a hydrogen atom, n takes the value 0, m takes the value 1 or 2 and Ra and Rb both represent a hydrogen atom and, if R <1> takes the meaning of methyl, 4-methoxybenzyl or 4-methoxyphenyl carbonyl and R <4> takes on the meaning of hydrogen, R <2> and R <3>, different from each other, cannot take on the meanings of hydrogen, ethyl, heptyl and isobutyl;
per il controllo di funghi fitopatogeni di colture agricole. for the control of phytopathogenic fungi of agricultural crops.
I composti di formula generale (I) sono dotati infatti di un?attivit? fungicida molto elevata che si esplica nei confronti di numerosi funghi fitopatogeni che attaccano importanti colture agricole. The compounds of general formula (I) are in fact endowed with an activity? very high fungicide that is expressed against numerous phytopathogenic fungi that attack important agricultural crops.
Esempi di funghi fitopatogeni che possono essere efficacemente trattati e combattuti con i composti di formula generale (I) sono quelli appartenenti alle classi dei Basidiomiceti, Ascomiceti, Deuteromiceti o funghi imperfetti, Oomiceti: Puccinia spp., Ustilago spp., Tilletia spp., Uromyces spp., Phakopsora spp., Rhizoctonia spp., Eryiphe spp., Sphaerotheca spp., Podosphaera spp., Uncinula spp., Helminthosporium spp., Rhynchosporium spp., Pyrenophora spp., Monilinia spp., Sclerotinia spp., Septoria spp. (Mycosphaerella spp.), Venturia spp., Botrytis spp., Alternaria spp., Fusarium spp., Cercospora spp., Cercosporella herpotrichoides, Colletotrichum spp., Pyricularia oryzae, Sclerotium spp., Phytophtora spp., Pythium spp., Plasmopara viticola, Peronospora spp., Pseudoperonospora cubensis, Bremia lactucae. Examples of phytopathogenic fungi that can be effectively treated and combated with the compounds of general formula (I) are those belonging to the classes of Basidiomycetes, Ascomycetes, Deuteromycetes or imperfect fungi, Oomycetes: Puccinia spp., Ustilago spp., Tilletia spp., Uromyces spp., Phakopsora spp., Rhizoctonia spp., Eryiphe spp., Sphaerotheca spp., Podosphaera spp., Uncinula spp., Helminthosporium spp., Rhynchosporium spp., Pyrenophora spp., Monilinia spp., Sclerotoria spp., (Mycosphaerella spp.), Venturia spp., Botrytis spp., Alternaria spp., Fusarium spp., Cercospora spp., Cercosporella herpotrichoides, Colletotrichum spp., Pyricularia oryzae, Sclerotium spp., Phytophtora spp., Plythopasmium sppicola. , Peronospora spp., Pseudoperonospora cubensis, Bremia lactucae.
Le principali colture che possono essere protette con i composti secondo la presente invenzione comprendono cereali (grano, orzo, segale, avena, riso, mais, sorgo, ecc.), fruttiferi (melo, pero, susino, pesco, mandorlo, ciliegio, banano, vite, fragola, lampone, mora, ecc.), agrumi (arancio, limone, mandarino, pompelmo, ecc.), leguminose (fagiolo, pisello, lenticchia, soia, ecc.), orticole (spinacio, lattuga, asparago, cavolo, carota, cipolla, pomodoro, patata, melanzana, peperone, ecc.), cucurbitacee (zucca, zucchina, cetriolo, melone, anguria, ecc.), piante oleoginose (girasole, colza, arachide, ricino, cocco, ecc.), tabacco, caff?, t?, cacao, barbabietola da zucchero, canna da zucchero, cotone. The main crops that can be protected with the compounds according to the present invention include cereals (wheat, barley, rye, oats, rice, corn, sorghum, etc.), fruit trees (apple, pear, plum, peach, almond, cherry, banana , grapevine, strawberry, raspberry, blackberry, etc.), citrus fruits (orange, lemon, mandarin, grapefruit, etc.), legumes (bean, pea, lentil, soy, etc.), vegetables (spinach, lettuce, asparagus, cabbage , carrot, onion, tomato, potato, eggplant, pepper, etc.), cucurbits (pumpkin, courgette, cucumber, melon, watermelon, etc.), oil plants (sunflower, rapeseed, peanut, castor, coconut, etc.), tobacco, coffee, tea, cocoa, sugar beet, sugar cane, cotton.
In particolare, i composti di formula (I) si sono dimostrati notevolmente efficaci nel controllo di Plasmopara viticola su vite, Phytophtora infestans e Botrytis cinerea su pomodoro, Puccinia recondita, Erisiphae graminis, Helminthosporium teres, Septoria nodorum, Septoria tritici e Fusarium spp. su cereali, nel controllo di Phakopsora pachyrhizi su soia, nel controllo di Uromyces appendiculatus su fagiolo, nel controllo di Venturia inaequalis su melo, nel controllo di Sphaerotheca fuliginea su cetriolo. In particular, the compounds of formula (I) have proved remarkably effective in the control of Plasmopara viticola on grapevine, Phytophtora infestans and Botrytis cinerea on tomato, Puccinia recondita, Erisiphae graminis, Helminthosporium teres, Septoria nodorum, Septoria tritici and Fusarium spp. on cereals, in the control of Phakopsora pachyrhizi on soybeans, in the control of Uromyces appendiculatus on beans, in the control of Venturia inaequalis on apple trees, in the control of Sphaerotheca fuliginea on cucumber.
Inoltre, i composti di formula generale (I) sono efficaci anche nel controllo di batteri e virus fitopatogeni, quali ad esempio Xanthomonas spp., Pseudomonas spp., Erwinia amylovora, il virus del mosaico del tabacco. Furthermore, the compounds of general formula (I) are also effective in the control of phytopathogenic bacteria and viruses, such as for example Xanthomonas spp., Pseudomonas spp., Erwinia amylovora, the tobacco mosaic virus.
I composti di formula (I) sono in grado di esplicare un?azione fungicida a carattere sia curativo sia preventivo ed esibiscono una fitotossicit? molto bassa o nulla sulle colture trattate. The compounds of formula (I) are capable of carrying out a fungicidal action of both curative and preventive character and exhibit phytotoxicity. very little or no on treated crops.
Per gli impieghi pratici in agricoltura ? spesso preferibile utilizzare composizioni fungicide contenenti i composti secondo la presente invenzione opportunamente formulati. For practical uses in agriculture? it is often preferable to use fungicidal compositions containing suitably formulated compounds according to the present invention.
Sono un ulteriore oggetto della presente invenzione composizioni fungicide comprendenti uno o pi? composti di formula (I), un solvente e/o diluente solido o liquido, eventualmente un tensioattivo. A further object of the present invention are fungicidal compositions comprising one or more? compounds of formula (I), a solid or liquid solvent and / or diluent, optionally a surfactant.
Le suddette composizioni fungicide possono presentarsi sotto forma di polveri secche, polveri bagnabili, concentrati emulsionabili, emulsioni, microemulsioni, paste, granuli, granuli disperdibili in acqua, soluzioni, sospensioni, ecc.: la scelta del tipo di composizione dipender? dall?impiego specifico. The aforementioned fungicidal compositions can be in the form of dry powders, wettable powders, emulsifiable concentrates, emulsions, microemulsions, pastes, granules, water-dispersible granules, solutions, suspensions, etc .: the choice of the type of composition will depend on the product. from specific use.
Le composizioni fungicide vengono preparate in maniera nota, per esempio diluendo o sciogliendo la sostanza attiva con un mezzo solvente e/o un diluente solido o liquido, eventualmente in presenza di tensioattivi. The fungicidal compositions are prepared in a known manner, for example by diluting or dissolving the active substance with a solvent medium and / or a solid or liquid diluent, optionally in the presence of surfactants.
Come diluenti solidi, o supporti, possono essere ad esempio utilizzati: silice, caolino, bentonite, talco, farina fossile, dolomite, carbonato di calcio, magnesia, gesso, argille, silicati sintetici, attapulgite, seppiolite. As solid diluents or supports, for example, silica, kaolin, bentonite, talc, diatomaceous earth, dolomite, calcium carbonate, magnesia, gypsum, clays, synthetic silicates, attapulgite, seppiolite can be used.
Come solventi o diluenti liquidi possono essere ad esempio utilizzati, oltre all?acqua, solventi organici aromatici (xiloli o miscele di alchilbenzoli, clorobenzene, ecc.), paraffine (frazioni di petrolio), alcooli (metanolo, propanolo, butanolo, ottanolo, glicerina, ecc.), esteri (acetato di etile, di isobutile, alchil carbonati, esteri alchilici dell?acido adipico, esteri alchilici dell?acido glutarico, esteri alchilici dell?acido succinico, esteri alchilici dell?acido lattico, ecc.), olii vegetali (olio di colza, olio di girasole, olio di soia, olio di ricino, olio di mais, olio di arachidi, e loro esteri alchilici), chetoni (cicloesanone, acetone, acetofenone, isoforone, etilamilchetone, ecc.), ammidi (N,N-dimetilformammide, N-metilpirrolidone, ecc.), solfossidi e solfoni (dimetilsolfossido, dimetilsolfone, ecc.), e loro miscele. As liquid solvents or diluents, in addition to water, for example, aromatic organic solvents (xylols or mixtures of alkylbenzols, chlorobenzene, etc.), paraffins (petroleum fractions), alcohols (methanol, propanol, butanol, octanol, glycerin) can be used. , etc.), esters (ethyl acetate, isobutyl acetate, alkyl carbonates, alkyl esters of adipic acid, alkyl esters of glutaric acid, alkyl esters of succinic acid, alkyl esters of lactic acid, etc.), oils vegetables (rapeseed oil, sunflower oil, soybean oil, castor oil, corn oil, peanut oil, and their alkyl esters), ketones (cyclohexanone, acetone, acetophenone, isophorone, ethylamylketone, etc.), amides ( N, N-dimethylformamide, N-methylpyrrolidone, etc.), sulfoxides and sulfones (dimethylsulfoxide, dimethylsulfone, etc.), and their mixtures.
Quali diluenti liquefatti o sostanze liquefatte che gassificano a temperatura e pressione ambiente possono essere impiegati gas propellenti quali butano, propano, idrocarburi alogenati, azoto o biossido di carbonio. Propellant gases such as butane, propane, halogenated hydrocarbons, nitrogen or carbon dioxide can be used as liquefied diluents or liquefied substances that gasify at ambient temperature and pressure.
Come tensioattivi possono essere utilizzati sali di sodio, di calcio, di potassio, di trietilammina o trietanolammina di alchilnaftalensolfonati, poli-naftalensolfonati, alchilsolfonati, arilsolfonati, alchilarilsolfonati, policarbossilati, solfosuccinati, alchilsolfosuccinati, ligninsolfonati, alchilsolfati; ed ancora possono essere utilizzati alcoli grassi polietossilati, alchilfenoli polietossilati, arilfenoli polietossilati o polipropossi-polietossilati o esteri del sorbitolo polietossilati, polipropossi- polietossilati (block polymers). As surfactants, sodium, calcium, potassium, triethylamine or triethanolamine salts of alkylnaphthalenesulphonates, poly-naphthalenesulphonates, alkylsulfonates, arylsulfonates, alkylaryl sulphonates, polycarboxylates, sulphosuccinates, alkylsulfosulfonates, lymphosulfonates can be used; and polyethoxylated fatty alcohols, polyethoxylated alkylphenols, polyethoxylated arylphenols or polypropoxy-polyethoxylates or polyethoxylated, polypropoxy-polyethoxylated sorbitol esters (block polymers) can also be used.
Le composizioni fungicide possono anche contenere additivi speciali per particolari scopi, ad esempio anticongelanti quali glicole propilenico, oppure agenti adesivanti quali gomma arabica, alcool polivinilico, polivinilpirrolidone, disperdenti, ad esempio lignina e suoi sali, derivati di cellulosa o alginati, o stabilizzanti, ad esempio antiossidanti o assorbenti raggi ultravioletti. The fungicidal compositions can also contain special additives for particular purposes, for example antifreeze such as propylene glycol, or adhesive agents such as gum arabic, polyvinyl alcohol, polyvinylpyrrolidone, dispersants, for example lignin and its salts, cellulose or alginate derivatives, or stabilizers, for example for example antioxidants or ultraviolet absorbers.
La concentrazione di composto attivo di formula (I) nelle suddette composizioni pu? variare entro un ampio intervallo e dipende da diversi fattori. Essa varia in funzione del composto attivo di formula (I), delle applicazioni cui sono destinate dette composizioni, delle condizioni ambientali e del tipo di formulazione adottato. In generale, la concentrazione di composto attivo di formula (I) varia dallo 0,1 al 90% in peso rispetto al peso totale della composizione, preferibilmente dallo 0,5 al 90% in peso. The concentration of active compound of formula (I) in the above compositions can? vary over a wide range and depends on several factors. It varies according to the active compound of formula (I), the applications to which said compositions are intended, the environmental conditions and the type of formulation adopted. In general, the concentration of active compound of formula (I) ranges from 0.1 to 90% by weight with respect to the total weight of the composition, preferably from 0.5 to 90% by weight.
Qualora lo si desideri, ? possibile aggiungere alle composizioni fungicide contenenti i composti di formula generale (I), altri principi attivi con essi compatibili, quali ad esempio fungicidi diversi da quelli di formula generale (I), fitoregolatori, antibiotici, erbicidi, insetticidi, fertilizzanti, biostimolanti e/o loro miscele. If desired,? It is possible to add to the fungicidal compositions containing the compounds of general formula (I), other active ingredients compatible with them, such as for example fungicides other than those of general formula (I), plant growth regulators, antibiotics, herbicides, insecticides, fertilizers, biostimulants and / or their blends.
Esempi di fungicidi diversi da quelli di formula generale (I) che possono essere inclusi nelle composizioni fungicide oggetto della presente invenzione sono: acibenzolar, aldimorph, ametoctradin, aminopyrifen, amisulbrom, ampropylfos, anilazine, azaconazole, azithiram, azoxystrobin, benalaxyl, benalaxyl-M, benodanil, benomyl, benodanil, benquinox, benthiavalicarb, benzamacril, benzamorf, benzovindiflupyr, binapacryl, bitertanol, bixafen, blasticidin-S, boscalid, bromuconazole, bupirimate, buthiobate, captafol, captan, carbamorph, carbendazim, carboxin, carpropamid, chinomethionat, chlobenthiazone, chlorfenazole, chloroneb, chlorothalonil, chlorquinox, chlozolinate, cufraneb, coumoxystrobin, cyazofamid, cycloheximide, cyflufenamid, cymoxanil, cypendazole, cyproconazole, cyprodinil, dazomet, debacarb, decafentin, dichlobentiazox, dichlofluanid, dichlone, dichlorophen, dichlozoline, diclobutrazol, diclomezine, diclocymet, diethofencarb, difenoconazole, diflumetorim, dimethirimol, dimethomorph, dimoxystrobin, diniconazole, dinobuton, dinocap, dipymetitrone, dinocton, dinopenton, dinosulfon, dinoterbon, dipyrithione, ditalimfos, dithianon, dodemorph, dodine, edifenphos, enoxastrobin, epoxiconazole, etaconazole, ethaboxam, ethirimol, ethoxyquin, etridiazole, famoxadone, fenamidone, fenaminstrobin, fenaminosulf, fenapanil, fenarimol, fenbuconazole, fenfuram, fenhexamid, fenoxanil, fenpiclonil, fenpicoxamid, fenpropidin, fenpropimorph, fenpyrazamine, fentin, ferbam, ferimzone, florylpicoxamid, fluazinam, flubeneteram, fludioxonil, fluindapyr, flufenoxystrobin, flumetover, flumorph, fluopicolide, fluopyram, fluopimomide, fluotrimazole, fluoxapiprolin, fluoxastrobin, fluquinconazole, flusilazole, flusulfamide, flutianil, flutolanil, flutriafol, fluxapyroxad, folpet, fosetylaluminium, fuberidazole, furalaxyl, furametpyr, furcarbanil, furconazole, furconazole-cis, furophanate, guazatine, griseofulvin, halacrinate, hexaconazole, hexylthiofos, hymexazol, idrossichinolina solfato, imazalil, imibenconazole, iminoctadine, inpyrfluxam, ipconazole, ipfentrifluconazole, ipflufenoquin, iprobenfos, iprodione, isoprothiolane, iprovalicarb, isofetamid, isoflucypram, isopyrazam, isotianil, isovaledione, kasugamycin, kresoxim-methyl, mancopper, mancozeb, mandestrobin, mandipropamid, maneb, mebenil, mecarbinzid, mefentrifluconazole, mepanipyrim, mepronil, meptyldinocap, metalaxyl, metalaxyl-M, metam metconazole, methasulfocarb, methfuroxam, metiram, metominostrobin, metrafenone, metsulfovax, metyltetraprole, myclobutanil, myclozonil, nabam, natamycin, nicobifen, nitrothal-isopropyl, nuarimol, octhilinone, ofurace, orysastrobin, oxadixyl, oxathiapiprolin, oxpoconazole, oxycarboxin, pefurazoate, penconazole, pencycuron, penflufen, penthiopyrad, picarbutrazox, picoxystrobin, piperalin, polyoxorim, prochloraz, procymidone, propamocarb, propiconazole, propineb, proquinazid, prothiocarb, prothioconazole, pyracarbolid, pyraclostrobin, pyrametostrobin, pyraoxystrobin, pyrapropoyne, pyraziflumid, pyrazophos, pyribencarb, pyridachlometyl, pydiflumetofen, pyrifenox, pyrimethanil, pyriofenone, pyrisoxazole, pyroquilon, pyroxyfur, quinacetol, quinazamid, quinconazole, quinofumelin, quinoxyfen, quintozene, rabenzazole, sedaxane, silthiofam, simeconazole, spiroxamine, streptomycin, tebuconazole, tebufloquin, tetraconazole, thiabendazole, thiadifluor, thicyofen, thifluzamide, thiochlorfenphim, thiophanate, thiophanate-methyl, thioquinox, thiram, tiadinil, tioxymid, tolclofos-methyl, tolprocarb, tolylfluanid, triadimefon, triadimenol, triamiphos, triarimol, triazbutil, triazoxide, triclopyricarb, tricyclazole, tridemorf, trifloxystrobin, triflumizole, triforine, triticonazole, uniconazole, uniconazole-P, valifenalate, vinclozolin, zineb, ziram, zoxamide. Examples of fungicides other than those of general formula (I) that can be included in the fungicidal compositions object of the present invention are: acibenzolar, aldimorph, ametoctradin, aminopyrifen, amisulbrom, ampropylfos, anilazine, azaconazole, azithiram, azoxystrobin, benalaxyl, benalax , benodanil, benomyl, benodanil, benquinox, benthiavalicarb, benzamacril, benzamorf, benzovindiflupyr, binapacryl, bitertanol, bixafen, blasticidin-S, boscalid, bromuconazole, bupirimate, buthiobate, captafol, captanimamidia, carenthamorazole, carenthamorazole, captan-phorph , chlorfenazole, chloroneb, chlorothalonil, chlorquinox, chlozolinate, cufraneb, coumoxystrobin, cyazofamid, cycloheximide, cyflufenamid, cymoxanil, cypendazole, cyproconazole, cyprodinil, dazometoline, debloracarbent, dicafluxone, dichutlocol , diethofencarb, difenoconazole, diflumetorim, dimethirimol, dimethom orph, dimoxystrobin, diniconazole, dinobuton, dinocap, dipymethitrone, dinocton, dinopenton, dinosulfon, dinoterbon, dipyrithione, ditalimfos, dithianon, dodemorph, dodine, edifenphos, enoxastrobin, epoxiconazole, etaconazole, ethoxquinamamidy, ethboximidone, ethboxirone, fam fenaminstrobin, fenaminosulf, fenapanil, fenarimol, fenbuconazole, fenfuram, fenhexamid, fenoxanil, fenpiclonil, fenpicoxamid, fenpropidin, fenpropimorph, fenpyrazamine, fentin, ferbam, ferimzone, florylpicoufxamid, flicolapenam, flicolap fluopyram, fluopimomide, fluotrimazole, fluoxapiprolin, fluoxastrobin, fluquinconazole, flusilazole, flusulfamide, flutianil, flutolanil, flutriafol, fluxapyroxad, folpet, fosetylaluminium, fuberidazole, furalpacratine, furvinhanate, fuberidazole, furalpacratine, furvinconate, fuberidazole, furisacratine, fur hexaconazole, hexylthiofos, hymexazol, hydroxyquinoline sulfate, Imazalil, imibenconazole, iminoctadine, inpyrfluxam, ipconazole, ipfentrifluconazole, ipflufenoquin, iprobenfos, iprodione, isoprothiolane, iprovalicarb, isofetamid, isoflucypram, isopyrazam, isotianil, khugas-methyl, manbyl-methyl, manbyl-methyl, manbylamamid, kamilco-zestrus, mandilco-zestro mecarbinzid, mefentrifluconazole, mepanipyrim, mepronil, meptyldinocap, metalaxyl, metalaxyl-M, metam metconazole, methasulfocarb, methfuroxam, metiram, metominostrobin, metrafenone, metsulfovax, metyltetrautprole, myzylclobin, myzylclobin, myzylcloban, myzylcloban, myzyl-metil, nitrile, myzylcloban, myzil , ofurace, orysastrobin, oxadixyl, oxathiapiprolin, oxpoconazole, oxycarboxin, pefurazoate, penconazole, pencycuron, penflufen, penthiopyrad, picarbutrazox, picoxystrobin, piperalin, polyoxorim, prochloraz, propamarbole, prochloraz, propamarbidone, , pyrametostrobin, pyraoxystrobin, pyrapropoyne , pyraziflumid, pyrazophos, pyribencarb, pyridachlometyl, pydiflumetofen, pyrifenox, pyrimethanil, pyriofenone, pyrisoxazole, pyroquilon, pyroxyfur, quinacetol, quinazamid, quinconazole, quinoflumetofen, pyrifenox, pyrimethanil, pyriofenone, pyrisoxazole, pyroquilon, pyroxyfur, quinacetol, quinazamid, quinconazole, quinoflumetofen, quinofenamamine, silicofumelin, quinthoin , tetraconazole, thiabendazole, thiadifluor, thicyofen, thifluzamide, thiochlorfenphim, thiophanate, thiophanate-methyl, thioquinox, thiram, tiadinil, tioxymid, tolclofos-methyl, tolprocarb, tolzoxide-methyl , tridemorf, trifloxystrobin, triflumizole, triforine, triticonazole, uniconazole, uniconazole-P, valifenalate, vinclozolin, zineb, ziram, zoxamide.
Costituiscono pertanto un ulteriore oggetto della presente invenzione composizioni fungicide comprendenti almeno un composto di formula generale (I) e almeno un altro fungicida diverso dai composti di formula (I). Therefore, a further object of the present invention are fungicidal compositions comprising at least one compound of general formula (I) and at least one other fungicide different from the compounds of formula (I).
Composizioni fungicide contenenti almeno un composto di formula (I) e uno o pi? fungicidi noti, particolarmente preferite per lo spettro d?azione particolarmente ampio e uno spiccato effetto sinergico, sono quelle in cui uno o pi? composti di formula generale (I) sono combinati con uno o pi? fungicidi noti appartenenti alle seguenti classi: Fungicidal compositions containing at least one compound of formula (I) and one or more? known fungicides, particularly preferred for their particularly broad spectrum of action and a marked synergistic effect, are those in which one or more? compounds of general formula (I) are combined with one or more? known fungicides belonging to the following classes:
a) azoli scelti tra azaconazole, bitertanol, bromuconazole, cyproconazole, difenoconazole, epoxyconazole, fenbuconazole, fluquinconazole, flusilazole, flutriafol, hexaconazole, imazalil, imibenconazole, ipconazole, ipfentrifluconazole, mefentrifluconazole, metconazole, myclobutanil, penconazole, propiconazole, prochloraz, prothioconazole, simeconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, tricyclazole, triflumizole, triticonazole; a) azoli scelti tra azaconazole, bitertanol, bromuconazole, cyproconazole, difenoconazole, epoxyconazole, fenbuconazole, fluquinconazole, flusilazole, flutriafol, hexaconazole, imazalil, imibenconazole, ipconazole, ipfentrifluconazole, mefentrifluconazole, metconazole, myclobutanil, penconazole, propiconazole, prochloraz, prothioconazole, simeconazole , tebuconazole, tetraconazole, triadimefon, triadimenol, tricyclazole, triflumizole, triticonazole;
b) ammine inibitrici della biosintesi dell?ergosterolo scelte tra aldimorph, dodemorph, fenpropimorph, fenpropidin, spiroxamine, tridemorph; b) amines inhibiting ergosterol biosynthesis selected from aldimorph, dodemorph, fenpropimorph, fenpropidin, spiroxamine, tridemorph;
c) inibitori della succinatodeidrogenasi (SDHI) scelti tra benzovindiflupyr, bixafen, boscalid, carboxin, fluindapyr, fluopyram, flutolanil, fluxapyroxad, furametpyr, inpyrfluxam, isopyrazam, oxycarboxin, penflufen, penthiopyrad, sedaxane, thifluzamide. c) succinatodehydrogenase inhibitors (SDHI) chosen from benzovindiflupyr, bixafen, boscalid, carboxin, fluindapyr, fluopyram, flutolanil, fluxapyroxad, furametpyr, inpyrfluxam, isopyrazam, oxycarboxin, penflufen, sedifluzamide, thaxiopyr.
d) strobilurine scelte tra azoxystrobin, coumoxystrobin, dimoxystrobin, enoxastrobin, fluoxastrobin, kresoxim-methyl, metominostrobin, orysastrobin, picoxystrobin, pyraclostrobin, pyrametostrobin, pyraoxostrobin, trifloxystrobin; e) antioidici specifici scelti tra cyflufenamid, flutianil, metrafenone, proquinazid, pyriofenone, quinoxyfen; d) strobilurins selected from azoxystrobin, coumoxystrobin, dimoxystrobin, enoxastrobin, fluoxastrobin, kresoxim-methyl, metominostrobin, orysastrobin, picoxystrobin, pyraclostrobin, pyrametostrobin, pyraoxostrobin, trifloxystrobin; e) specific antioids selected from cyflufenamid, flutianil, metrafenone, proquinazid, pyriofenone, quinoxyfen;
f) anilinopirimidine scelte tra pyrimethanil, mepanipyrim, cyprodinil; g) benzimidazoli ed analoghi scelti tra carbendazim, benomyl, thiabendazole, thiophanate-methyl; f) anilinopyrimidines selected from pyrimethanil, mepanipyrim, cyprodinil; g) benzimidazoles and analogues selected from carbendazim, benomyl, thiabendazole, thiophanate-methyl;
h) dicarbossimmidi scelte tra iprodione, procymidone; h) dicarboximides selected from iprodione, procymidone;
i) ftalimmidi scelte tra captafol, captan, folpet; i) phthalimides selected from captafol, captan, folpet;
l) induttori di SAR (resistenza sistemica acquisita) scelti tra acibenzolar, probenazole, isotianil, tiadinil; l) inducers of SAR (acquired systemic resistance) selected from acibenzolar, probenazole, isothianil, thiadinil;
m) fenilpirroli scelti tra fenpiclonil, fludioxonil; m) phenylpyrroles selected from phenpiclonyl, fludioxonil;
n) acilalanine scelte tra benalaxyl, benalaxyl-M, furalaxyl, metalaxyl, metalaxyl-M; n) acylalanines selected from benalaxyl, benalaxyl-M, furalaxyl, metalaxyl, metalaxyl-M;
o) altri antiperonosporici specifici scelti tra ametoctradin, amisulbrom, benthiavalicarb, cyazofamid, cymoxanil, dimethomorph, ethaboxam, famoxadone, fenamidone, flumetover, flumorph, fluopicolide, iprovalicarb, mandipropamid, oxathiapiproline, valifenalate, zoxamide. o) other specific antiperonosporics chosen from among ametoctradin, amisulbrom, benthiavalicarb, cyazofamid, cymoxanil, dimethomorph, ethaboxam, famoxadone, fenamidone, flumetover, flumorph, fluopicolide, iprovalicarb, mandipropamid, oxathiaxalamide, valamide.
p) ditiocarbammati scelti tra maneb, mancozeb, propineb, zineb, metiram; q) acido fosforoso e suoi sali inorganici od organici, fosetyl-aluminium; r) composti rameici scelti tra poltiglia bordolese, carpropamid, copper hydroxide, copper oxychloride, copper sulphate, copper salicylate; p) dithiocarbamates selected from maneb, mancozeb, propineb, zineb, metiram; q) phosphorous acid and its inorganic or organic salts, fosetyl-aluminum; r) cupric compounds selected from Bordeaux mixture, carpropamid, copper hydroxide, copper oxychloride, copper sulphate, copper salicylate;
s) altri fungicidi scelti tra chlorothalonil, fenhexamid, fenpyrazamine, fluazinam, silthiofam, tebufloquin, zoxamide, dodine, guazatine, iminoctadine, tolclofos-metile. s) other fungicides selected from chlorothalonil, fenhexamid, fenpyrazamine, fluazinam, silthiofam, tebufloquin, zoxamide, dodine, guazatine, iminoctadine, tolclofos-methyl.
I composti fungicidi sono indicati nella presente descrizione con il loro nome internazionale ISO; le strutture chimiche e i loro nomi CAS e IUPAC sono riportati in Alan Wood?s Website (www.alanwood.net), Compendium of Pesticide Common Names; i dati chimico-fisici e le caratteristiche biologiche della maggior parte di questi composti sono riportati nel ?Pesticide Manual?, C.D.S. Tomlin, 15a Edizione, 2009, British Crop Production Council. Fungicidal compounds are indicated in this description with their international ISO name; the chemical structures and their CAS and IUPAC names are listed in Alan Wood? s Website (www.alanwood.net), Compendium of Pesticide Common Names; the chemical-physical data and the biological characteristics of most of these compounds are reported in the? Pesticide Manual ?, C.D.S. Tomlin, 15th Edition, 2009, British Crop Production Council.
Composizioni preferite contenenti almeno un composto di formula (I) (componente A) e almeno un altro fungicida noto sono quelle costituite da: Preferred compositions containing at least one compound of formula (I) (component A) and at least one other known fungicide are those consisting of:
C1: composto 433 tetraconazole; C1: compound 433 tetraconazole;
C2: composto 433 tebuconazole; C2: compound 433 tebuconazole;
C3: composto 433 epoxyconazole; C3: compound 433 epoxyconazole;
C4: composto 433 prothioconazole; C4: compound 433 prothioconazole;
C5: composto 433 difenoconazole; C5: compound 433 diphenoconazole;
C6: composto 433 penconazole; C6: compound 433 penconazole;
C7: composto 433 prochloraz; C7: compound 433 prochloraz;
C8: composto 433 fenpropimorph; C8: compound 433 fenpropimorph;
C9: composto 433 spiroxamine; C9: compound 433 spiroxamine;
C10: composto 433 bixafen; C10: compound 433 bixafen;
C11: composto 433 boscalid; C11: compound 433 boscalid;
C12: composto 433 carboxin; C12: composed 433 carboxin;
C13: composto 433 fluopyram; C13: compound 433 fluopyram;
C14: composto 433 fluxapyroxad; C14: compound 433 fluxapyroxad;
C15: composto 433 isopyrazam; C15: compound 433 isopyrazam;
C16: composto 433 penthiopyrad; C16: compound 433 penthiopyrad;
C17: composto 433 sedaxane; C17: compound 433 sedaxane;
C18: composto 433 azoxystrobin; C18: compound 433 azoxystrobin;
C19: composto 433 dimoxystrobin; C19: compound 433 dimoxystrobin;
C20: composto 433 fluoxastrobin; C20: compound 433 fluoxastrobin;
C21: composto 433 kresoxim-methyl; C22 composto 433 picoxystrobin; C21: compound 433 kresoxim-methyl; C22 compound 433 picoxystrobin;
C23: composto 433 pyraclostrobin; C23: compound 433 pyraclostrobin;
C24: composto 433 trifloxystrobin; C24: compound 433 trifloxystrobin;
C25: composto 433 metrafenone; C25: compound 433 metrafenone;
C26: composto 433 proquinazid; C26: compound 433 proquinazid;
C27: composto 433 mepanipyrim; C27: compound 433 mepanipyrim;
C28: composto 433 cyprodinil; C28: compound 433 cyprodinil;
C29: composto 433 iprodione; C29: compound 433 iprodione;
C30: composto 433 procymidone; C30: compound 433 procymidone;
C31: composto 433 carbendazim; C31: compound 433 carbendazim;
C32: composto 433 thiophanate-methyl; C33: composto 433 fluindapyr; C32: compound 433 thiophanate-methyl; C33: compound 433 fluindapyr;
C34: composto 433 benalaxyl-M; C34: compound 433 benalaxyl-M;
C35: composto 433 fenpyrazamine; C35: compound 433 fenpyrazamine;
C36: composto 433 fluazinam; C36: compound 433 fluazinam;
C37: composto 433 tolclofos-metile; C38: composto 433 mandipropamid; C39: composto 433 copper oxychloride; C40: composto 433 copper salicylate; C41: composto 433 chlorothalonil; C37: compound 433 tolclofos-methyl; C38: compound 433 mandipropamid; C39: compound 433 copper oxychloride; C40: compound 433 copper salicylate; C41: compound 433 chlorothalonyl;
C42: composto 433 cimoxanil; C42: compound 433 cimoxanil;
C43: composto 433 dimetomorph; C43: compound 433 dimetomorph;
C44: composto 433 oxathiopiproline; C45: composto 426 fluopicolide; C44: compound 433 oxathiopiproline; C45: compound 426 fluopicolide;
C46: composto 426 tetraconazole; C46: compound 426 tetraconazole;
C47: composto 426 tebuconazole; C47: compound 426 tebuconazole;
C48: composto 426 epoxyconazole; C48: compound 426 epoxyconazole;
C49: composto 426 prothioconazole; C49: compound 426 prothioconazole;
C50: composto 426 difenoconazole; C50: compound 426 diphenoconazole;
C51: composto 426 penconazole; C51: compound 426 penconazole;
C52: composto 426 prochloraz; C52: compound 426 prochloraz;
C53: composto 426 fenpropimorph; C53: compound 426 fenpropimorph;
C54: composto 426 spiroxamine; C54: compound 426 spiroxamine;
C55: composto 426 bixafen; C55: compound 426 bixafen;
C56: composto 426 boscalid; C56: compound 426 boscalid;
C57: composto 426 carboxin; C57: composed 426 carboxin;
C58: composto 426 fluopyram; C58: compound 426 fluopyram;
C59: composto 426 fluxapyroxad; C59: compound 426 fluxapyroxad;
C60: composto 426 isopyrazam; C60: compound 426 isopyrazam;
C61: composto 426 penthiopyrad; C61: compound 426 penthiopyrad;
C62: composto 426 sedaxane; C62: compound 426 sedaxane;
C63: composto 426 azoxystrobin; C63: compound 426 azoxystrobin;
C64: composto 426 dimoxystrobin; C64: compound 426 dimoxystrobin;
C65: composto 426 fluoxastrobin; C65: compound 426 fluoxastrobin;
C66: composto 426 kresoxim-methyl; C67: composto 426 picoxystrobin; C66: compound 426 kresoxim-methyl; C67: compound 426 picoxystrobin;
C68: composto 426 pyraclostrobin; C68: compound 426 pyraclostrobin;
C69: composto 426 trifloxystrobin; C70: composto 426 metrafenone; C69: compound 426 trifloxystrobin; C70: compound 426 metrafenone;
C71: composto 426 proquinazid; C71: compound 426 proquinazid;
C72: composto 426 mepanipyrim; C72: compound 426 mepanipyrim;
C73: composto 426 cyprodinil; C73: compound 426 cyprodinil;
C74: composto 426 iprodione; C74: compound 426 iprodione;
C75: composto 426 procymidone; C75: compound 426 procymidone;
C76: composto 426 carbendazim; C76: compound 426 carbendazim;
C77: composto 426 thiophanate-methyl; C78: composto 426 fluindapyr; C77: compound 426 thiophanate-methyl; C78: compound 426 fluindapyr;
C79: composto 426 benalaxyl-M; C79: compound 426 benalaxyl-M;
C80: composto 426 fenpyrazamine; C80: compound 426 fenpyrazamine;
C81: composto 426 fluazinam; C81: compound 426 fluazinam;
C82: composto 426 tolclofos-metile; C82: compound 426 tolclofos-methyl;
C83: composto 426 mandipropamid; C83: compound 426 mandipropamid;
C84: composto 426 copper oxychloride; C85: composto 426 copper salicylate; C86: composto 426 chlorothalonil; C84: compound 426 copper oxychloride; C85: compound 426 copper salicylate; C86: compound 426 chlorothalonyl;
C87: composto 426 cimoxanil; C87: compound 426 cimoxanil;
C88: composto 426 dimetomorph; C88: compound 426 dimetomorph;
C89: composto 426+ oxathiopiproline; C89: compound 426+ oxathiopiproline;
C90: composto 426 fluopicolide; C90: compound 426 fluopicolide;
C91: composto 330 tetraconazole; C91: compound 330 tetraconazole;
C92: composto 330 tebuconazole; C92: compound 330 tebuconazole;
C93: composto 330 epoxyconazole; C93: compound 330 epoxyconazole;
C94: composto 330 prothioconazole; C94: compound 330 prothioconazole;
C95: composto 330 difenoconazole; C95: compound 330 diphenoconazole;
C96: composto 330 penconazole; C96: compound 330 penconazole;
C97: composto 330 prochloraz; C97: compound 330 prochloraz;
C98: composto 330 fenpropimorph; C98: compound 330 fenpropimorph;
C99: composto 330 spiroxamine; C99: compound 330 spiroxamine;
C100: composto 330 bixafen; C101: composto 330 boscalid; C100: compound 330 bixafen; C101: compound 330 boscalid;
C102: composto 330 carboxin; C102: composed of 330 carboxins;
C103: composto 330 fluopyram; C103: compound 330 fluopyram;
C104: composto 330 fluxapyroxad; C104: compound 330 fluxapyroxad;
C105: composto 330 isopyrazam; C105: compound 330 isopyrazam;
C106: composto 330 penthiopyrad; C106: compound 330 penthiopyrad;
C107: composto 330+ sedaxane; C107: compound 330+ sedaxane;
C108: composto 330 azoxystrobin; C108: compound 330 azoxystrobin;
C109: composto 330 dimoxystrobin; C109: compound 330 dimoxystrobin;
C110: composto 330 fluoxastrobin; C110: compound 330 fluoxastrobin;
C111: composto 330 kresoxim-methyl; C112: composto 330 picoxystrobin; C111: compound 330 kresoxim-methyl; C112: compound 330 picoxystrobin;
C113: composto 330 pyraclostrobin; C113: compound 330 pyraclostrobin;
C114: composto 330 trifloxystrobin; C114: compound 330 trifloxystrobin;
C115: composto 330 metrafenone; C115: compound 330 metrafenone;
C116: composto 330 proquinazid; C116: compound 330 proquinazid;
C117: composto 330 mepanipyrim; C117: compound 330 mepanipyrim;
C118: composto 330 cyprodinil; C118: compound 330 cyprodinil;
C119: composto 330 iprodione; C119: compound 330 iprodione;
C120: composto 330 procymidone; C120: compound 330 procymidone;
C121: composto 330 carbendazim; C121: compound 330 carbendazim;
C122: composto 330 thiophanate-methyl; C123: composto 330 fluindapyr; C122: compound 330 thiophanate-methyl; C123: compound 330 fluindapyr;
C124: composto 330 benalaxyl-M; C124: compound 330 benalaxyl-M;
C125: composto 330 fenpyrazamine; C125: compound 330 fenpyrazamine;
C125: composto 330 fluazinam; C125: compound 330 fluazinam;
C126: composto 330 tolclofos-metile; C126: compound 330 tolclofos-methyl;
C127: composto 330 mandipropamid; C127: compound 330 mandipropamid;
C128: composto 330 copper oxychloride; C129: composto 330 copper salicilate; C128: compound 330 copper oxychloride; C129: compound 330 copper salicylate;
C130: composto 330 chlorothalonil; C131: composto 330 cymoxanil; C130: compound 330 chlorothalonyl; C131: compound 330 cymoxanil;
C132: composto 330 dimetomorph; C132: compound 330 dimetomorph;
C133: composto 330 oxathiapiproline; C133: compound 330 oxathiapiproline;
C134: composto 330 fluopicolide; C134: compound 330 fluopicolide;
C135: composto 330 pyrachlostrobin; C135: compound 330 pyrachlostrobin;
C136: composto 330 zoxamide; C136: compound 330 zoxamide;
C137: composto 330 ametoctradin; C137: compound 330 ametoctradin;
C138: composto 330 metiram; C138: compound 330 metiram;
C139: composto 330 fosfito di potassio; C139: compound 330 potassium phosphite;
C140: composto 433+ tetraconazole azoxystrobin, C140: compound 433+ tetraconazole azoxystrobin,
C141: composto 433 pyraclostrobin tetraconazole; C141: compound 433 pyraclostrobin tetraconazole;
C142: composto 433 epoxyconazole azoxystrobin; C142: compound 433 epoxyconazole azoxystrobin;
C143: composto 433 pyraclostrobin epoxyconazole; C143: compound 433 pyraclostrobin epoxyconazole;
C144: composto 433 azoxystrobin fluindapyr; C144: compound 433 azoxystrobin fluindapyr;
C145: composto 433 pyraclostrobin fluindapyr; C145: compound 433 pyraclostrobin fluindapyr;
C146: composto 433 fosetyl-aluminium copper oxychloride; C146: compound 433 fosetyl-aluminum copper oxychloride;
C147: composto 433 fosetyl-aluminium copper salicylate; C147: compound 433 fosetyl-aluminum copper salicylate;
C148: composto 433 fluindapyr+ tetraconazole; C148: compound 433 fluindapyr + tetraconazole;
C149: composto 330 tetraconazole azoxystrobin; C149: compound 330 tetraconazole azoxystrobin;
C150: composto 330 pyraclostrobin tetraconazole; C150: compound 330 pyraclostrobin tetraconazole;
C151: composto 330 azoxystrobin fluindapyr; C151: compound 330 azoxystrobin fluindapyr;
C152: composto 330 fluindapyr tetraconazole C152: compound 330 fluindapyr tetraconazole
La componente A, cio? i composti di formula generale (I), delle precedenti composizioni C1-C152 sono descritti ed esemplificati nella Tabella 1 e precisamente si tratta dei seguenti composti di formula generale (I) in cui i sostituenti assumono i significati sotto riportati: The component A, that is? the compounds of general formula (I), of the previous compositions C1-C152 are described and exemplified in Table 1 and precisely they are the following compounds of general formula (I) in which the substituents have the meanings reported below:
L?effetto sinergico delle composizioni contenenti un composto di formula generale (I) (componente A) e un fungicida noto (componente B), pu? essere valutato applicando la formula di Colby (?Weeds, 1967, 15, pag. 20-22): The synergistic effect of compositions containing a compound of general formula (I) (component A) and a known fungicide (component B), can be evaluated by applying Colby's formula (? Weeds, 1967, 15, pp. 20-22):
Et = EA + EB ? (EA x EB):100 Et = EA + EB? (EA x EB): 100
in cui Et ? la percentuale di efficacia attesa per la composizione contenente i composti A e B alle dosi dA + dB, EA ? la percentuale d?efficacia osservata per il componente A alla dose dA, EB ? la percentuale d?efficacia osservata per il componente B alla dose dB. in which Age? the expected efficacy percentage for the composition containing compounds A and B at doses dA + dB, EA? the observed efficacy rate for component A at dose dA, EB? the observed efficacy percentage for component B at dose dB.
Quando l?efficacia osservata per la composizione A B (EA+B) ? superiore all?efficacia attesa secondo la formula di Colby (EA+B/Et > 1), si ? in presenza di un effetto sinergico. When is the observed efficacy for composition A B (EA + B)? higher than the expected efficacy according to the Colby formula (EA + B / Et> 1), yes? in the presence of a synergistic effect.
Nel caso di combinazioni ternarie, la formula di Colby assume la forma: In the case of ternary combinations, the Colby formula takes the form:
Et = EA + EB1 + EB2 ? (EAxEB1 + EAxEB2 + EB1xEB2)/100 Et = EA + EB1 + EB2? (EAxEB1 + EAxEB2 + EB1xEB2) / 100
in cui Et ? la percentuale di efficacia attesa per la composizione contenente i composti A, B1 e B2 alle dosi dA + dB1 + dB2, EA ? la percentuale d?efficacia osservata per il componente A alla dose dA, EB1 ? la percentuale d?efficacia osservata per il componente B1 alla dose dB1, EB2 ? la percentuale d?efficacia osservata per il componente B2 alla dose dB2. in which Age? the expected efficacy percentage for the composition containing compounds A, B1 and B2 at doses dA + dB1 + dB2, EA? the observed efficacy rate for component A at dose dA, EB1? the observed efficacy percentage for component B1 at dose dB1, EB2? the percentage of efficacy observed for component B2 at the dB2 dose.
Quando l?efficacia osservata per la composizione A B1 B2 (EA+B1+B2) ? superiore all?efficacia attesa secondo la formula di Colby (EA+B1+B2/Et > 1), si ? in presenza di un effetto sinergico. When is the observed efficacy for composition A B1 B2 (EA + B1 + B2)? higher than the expected efficacy according to the Colby formula (EA + B1 + B2 / Et> 1), yes? in the presence of a synergistic effect.
E? quindi ulteriore oggetto della presente invenzione l?uso delle composizioni comprendenti almeno un composto di formula generale (I) per il controllo di funghi fitopatogeni in colture agricole. AND? therefore a further object of the present invention is the use of compositions comprising at least one compound of general formula (I) for the control of phytopathogenic fungi in agricultural crops.
Le principali colture che possono essere protette con le composizioni comprendenti almeno un composto di formula (I), da solo o in combinazione con almeno un altro principio attivo noto, comprendono cereali (grano, orzo, segale, avena, riso, mais, sorgo, ecc.), fruttiferi (melo, pero, susino, pesco, mandorlo, ciliegio banano, vite, fragola, lampone, mora, ecc.), agrumi (arancio, limone, mandarino, pompelmo, ecc.), leguminose (fagiolo, pisello, lenticchia, soia, ecc.), orticole (spinacio, lattuga, asparago, cavolo, carota, cipolla, pomodoro, patata, melanzana, peperone, ecc.), cucurbitacee (zucca, zucchina, cetriolo, melone, anguria, ecc.), piante oleoginose (girasole, colza, arachide, ricino, cocco, ecc.), tabacco, caff?, t?, cacao, barbabietola da zucchero, canna da zucchero, cotone, frutta in guscio. The main crops that can be protected with compositions comprising at least one compound of formula (I), alone or in combination with at least another known active ingredient, include cereals (wheat, barley, rye, oats, rice, corn, sorghum, etc.), fruit trees (apple, pear, plum, peach, almond, cherry, banana, vine, strawberry, raspberry, blackberry, etc.), citrus fruits (orange, lemon, mandarin, grapefruit, etc.), legumes (bean, pea , lentil, soy, etc.), vegetables (spinach, lettuce, asparagus, cabbage, carrot, onion, tomato, potato, eggplant, pepper, etc.), cucurbits (pumpkin, courgette, cucumber, melon, watermelon, etc.) , oil plants (sunflower, rapeseed, peanut, castor, coconut, etc.), tobacco, coffee, tea, cocoa, sugar beet, sugar cane, cotton, nuts.
In particolare, le composizioni della presente invenzione si sono dimostrate notevolmente efficaci nel controllo di Plasmopara viticola su vite, Phytophtora infestans e Botrytis cinerea su pomodoro, Phytophtora infestans su patata, Puccinia recondita, Erysiphe graminis, Helminthosporium teres, Septoria spp e Fusarium spp. su cereali, nel controllo di Phakopsora pachyrhizi su soia, nel controllo di Uromyces appendiculatus su fagiolo, nel controllo di Venturia inaequalis su melo, nel controllo di Sphaerotheca fuliginea su cetriolo. In particular, the compositions of the present invention have proved remarkably effective in the control of Plasmopara viticola on grapevine, Phytophtora infestans and Botrytis cinerea on tomato, Phytophtora infestans on potato, Puccinia recondita, Erysiphe graminis, Helminthosporium teres, Septoria spp and Fusarium spp. on cereals, in the control of Phakopsora pachyrhizi on soybeans, in the control of Uromyces appendiculatus on beans, in the control of Venturia inaequalis on apple trees, in the control of Sphaerotheca fuliginea on cucumber.
Inoltre le composizioni della presente invenzione sono efficaci anche nel controllo dei funghi del terreno, quali ad esempio Rhizoctonia solani, Sclerotinia spp, Pythium ultimum su orticole. Furthermore, the compositions of the present invention are also effective in the control of soil fungi, such as for example Rhizoctonia solani, Sclerotinia spp, Pythium ultimum on horticultural crops.
Ancora, le composizioni della presente invenzione sono efficaci nel controllo di batteri e virus fitopatogeni, quali ad esempio Xanthomonas spp., Pseudomonas spp., Erwinia amylovora, il virus del mosaico del tabacco. Furthermore, the compositions of the present invention are effective in the control of phytopathogenic bacteria and viruses, such as for example Xanthomonas spp., Pseudomonas spp., Erwinia amylovora, the tobacco mosaic virus.
Le composizioni oggetto della presente invenzione sono in grado di esplicare un?azione fungicida che pu? essere a carattere curativo, preventivo o eradicante, e, in generale, esibiscono una fitotossicit? molto bassa o nulla sulle colture trattate. Nel caso in cui le composizioni comprendano un composto di formula generale (Ic) e almeno un principio attivo noto, i rapporti in peso nelle suddette composizioni variano a seconda dei composti prescelti e possono essere di norma compresi tra 1:100 a 100:1, preferibilmente tra 1:10 a 10:1. The compositions object of the present invention are capable of carrying out a fungicidal action which can? be curative, preventive or eradicating, and, in general, exhibit a phytotoxicity? very little or no on treated crops. In the case in which the compositions comprise a compound of general formula (Ic) and at least one known active principle, the weight ratios in the aforementioned compositions vary according to the selected compounds and can normally be between 1: 100 and 100: 1, preferably between 1:10 to 10: 1.
La concentrazione totale dei componenti attivi nelle suddette composizioni pu? variare entro un ampio intervallo; in generale essa varia dall'1% al 99% in peso rispetto al peso totale della composizione, preferibilmente dal 5 al 90% in peso rispetto al peso totale della composizione. The total concentration of the active components in the above compositions can? vary over a wide range; in general it ranges from 1% to 99% by weight with respect to the total weight of the composition, preferably from 5 to 90% by weight with respect to the total weight of the composition.
L?applicazione di queste composizioni pu? avvenire su ogni parte della pianta, per esempio su foglie, steli, rami e radici, oppure sui semi stessi prima della semina, oppure sul terreno in cui cresce la pianta. The application of these compositions can? take place on every part of the plant, for example on leaves, stems, branches and roots, or on the seeds themselves before sowing, or on the ground where the plant grows.
Ulteriore oggetto della presente invenzione ? quindi un metodo per il controllo di funghi fitopatogeni in colture agricole, che consiste nell?applicare su una parte qualsiasi delle piante da proteggere o sul terreno dosi efficaci e non fitotossiche di composizioni comprendenti almeno un composto di formula generale (I) e, opzionalmente, uno o pi? principi attivi noti con esso compatibili. Further object of the present invention? therefore a method for the control of phytopathogenic fungi in agricultural crops, which consists in applying on any part of the plants to be protected or on the soil effective and non-phytotoxic doses of compositions comprising at least one compound of general formula (I) and, optionally, one or more? active ingredients known to be compatible with it.
La concentrazione dei composti ammidici di formula generale (I) nelle suddette composizioni pu? variare entro un ampio intervallo; in generale essa ? compresa tra 1% e 90% in peso rispetto al peso totale della composizione, preferibilmente tra 5 e 50% in peso rispetto al peso totale della composizione. The concentration of the amide compounds of general formula (I) in the above compositions can? vary over a wide range; in general it? between 1% and 90% by weight with respect to the total weight of the composition, preferably between 5 and 50% by weight with respect to the total weight of the composition.
L?applicazione di queste composizioni pu? avvenire su ogni parte della pianta, per esempio su foglie, steli, rami e radici, oppure sui semi stessi prima della semina, oppure sul terreno in cui cresce la pianta. The application of these compositions can? take place on every part of the plant, for example on leaves, stems, branches and roots, or on the seeds themselves before sowing, or on the ground where the plant grows.
Ulteriore oggetto della presente invenzione ? quindi un metodo per il controllo di funghi fitopatogeni in colture agricole, che consiste nell?applicazione di dosi efficaci dei composti di formula (I), utilizzati come tali o formulati in composizioni fungicide come sopra descritte. Further object of the present invention? therefore a method for the control of phytopathogenic fungi in agricultural crops, which consists in the application of effective doses of the compounds of formula (I), used as such or formulated in fungicidal compositions as described above.
La quantit? di composto da applicare per ottenere l?effetto desiderato pu? variare in funzione di diversi fattori quali, ad esempio, il composto utilizzato, la coltura da preservare, il tipo di patogeno, il grado di infezione, le condizioni climatiche, il metodo di applicazione, la formulazione adottata. The quantity of compound to be applied to obtain the desired effect can? vary according to various factors such as, for example, the compound used, the crop to be preserved, the type of pathogen, the degree of infection, the climatic conditions, the method of application, the formulation adopted.
Dosi di composto comprese tra 10 g e 5 kg per ettaro di coltura agricola forniscono, in genere, un controllo sufficiente. Compost doses ranging from 10g to 5kg per hectare of agricultural crop generally provide sufficient control.
Allo scopo di meglio illustrare l?invenzione vengono ora forniti i seguenti esempi che sono da ritenersi illustrativi e non limitativi della stessa. In order to better illustrate the invention, the following examples are now provided which are to be considered illustrative and not limitative thereof.
ESEMPIO 1 EXAMPLE 1
Preparazione di (2R)-2-(3-idrossi-4-metossipicolinammido)-3-metiltiopropionato di (1S)-2,2-bis(4-fluorofenil)-1-metiletanolo (composto n? 426) a) Preparazione di (2R)-2-(3-idrossi-4-metossipicolinammido)-3-metiltiopropionato di metile (composto n?477) Preparation of (2R) -2- (3-hydroxy-4-methoxycolinamido) -3-methylthiopropionate of (1S) -2,2-bis (4-fluorophenyl) -1-methylethanol (compound No. 426) a) Preparation of (2R) -2- (3-hydroxy-4-methoxycolinamido) -3-methylthiopropionate (compound No. 477)
A una soluzione di 5,3 g dell?estere metilico della S-metil-L-cisteina cloridrata (29 mmol), 11,2 g (87 mmol) di diisopropiletilammina e 15,08 g (29 mmol) di PyBOP [(1-Benzotriazolilossi) tripirrolidinofosfonio esafluorofosfato] in 90 ml di CH2Cl2 sono stati aggiunti a 0?C 5,0 g (29 mmol) di acido 3-idrossi-4-metossipiridin-2-carbossilico. La miscela di reazione ? stata mantenuta in agitazione a questa temperatura per 2 ore, poi lasciata risalire a valori ambientali e in agitazione per altre 8 ore. Dopo controllo con LC-MS la miscela di reazione ? stata lavata con acqua e le fasi sono state separate. La fase acquosa ? stata estratta con CH2Cl2 (3 x 15 ml) e le fasi organiche riunite sono state lavate con acqua (1 x 30ml) e con una soluzione satura di NaCl (1 x 30 ml). Queste sono state poi anidrificate su Na2SO4, filtrate e concentrate. Sono stati ottenuti 18 g di un grezzo che ? stato lavato con etere etilico e filtrato per eliminare i sottoprodotti dell?agente condensante. La fase eterea ? stata quindi concentrata al rotavapor e purificata per cromatografia su gel di silice mediante separatore automatico Biotage. Sono stati ottenuti 6,2 g del prodotto desiderato. Resa 72% To a solution of 5.3 g of the methyl ester of S-methyl-L-cysteine hydrochloride (29 mmol), 11.2 g (87 mmol) of diisopropylethylamine and 15.08 g (29 mmol) of PyBOP [(1 -Benzotriazolyloxy) tripyrrolidinophosphonium hexafluorophosphate] in 90 ml of CH2Cl2 was added to 0? C 5.0 g (29 mmol) of 3-hydroxy-4-methoxypyridine-2-carboxylic acid. The reaction mixture? it was kept under stirring at this temperature for 2 hours, then allowed to rise to ambient values and under stirring for a further 8 hours. After checking the reaction mixture with LC-MS? was washed with water and the phases were separated. The aqueous phase? was extracted with CH2Cl2 (3 x 15 ml) and the combined organic phases were washed with water (1 x 30 ml) and with a saturated solution of NaCl (1 x 30 ml). These were then dried on Na2SO4, filtered and concentrated. 18 g of a crude were obtained which? been washed with ethyl ether and filtered to eliminate the by-products of the condensing agent. The ethereal phase? it was then concentrated in the rotavapor and purified by chromatography on silica gel using an automatic Biotage separator. 6.2 g of the desired product were obtained. Yield 72%
LC-MS: M<+ >= 300 LC-MS: M <+> = 300
b) Preparazione dell?acido (2R)-2-(3-idrossi-4-metossipicolinammido)-3-metiltiopropanoico (composto n?518) b) Preparation of (2R) -2- (3-hydroxy-4-methoxycolinamido) -3-methylthiopropanoic acid (compound No. 518)
A una soluzione di 6,2 g (20,7 mmol) di (2R)-2-(3-idrossi-4-metossipicolinammido)-3-metiltiopropionato di metile in 60 ml di CH2Cl2 sono stati addizionati 60 ml di acido trifluoroacetico e si ? lasciato in agitazione per tutta la notte. Dopo controllo in LC-MS la miscela di reazione ? stata concentrata al rotavapor fino a secchezza. Resa quantitativa 60 ml of trifluoroacetic acid was added to a solution of 6.2 g (20.7 mmol) of methyl (2R) -2- (3-hydroxy-4-methoxycolinamido) -3-methylthiopropionate in 60 ml of CH2Cl2 and yes ? left to shake overnight. After checking the reaction mixture in LC-MS? was concentrated in the rotavapor until dryness. Quantitative yield
LC-MS: M<- >= 286 LC-MS: M <-> = 286
c) Preparazione di (2R)-2-(3-idrossi-4-metossipicolinammido)-3-metiltiopropionato di (1S)-2,2-bis(4-fluorofenil)-1-metiletile c) Preparation of (2R) -2- (3-hydroxy-4-methoxycolinamido) -3-methylthiopropionate of (1S) -2,2-bis (4-fluorophenyl) -1-methylethyl
A una soluzione di 5,9 g (20,7 mmol) dell?acido (2R)-2-(3-idrossi-4-metossipicolinammido)-3-metiltiopropanoico in 230 ml di CH2Cl2 sono stati aggiunti sotto agitazione su bagno di ghiaccio 6,16 g (24,8 mmol) di 2,2-bis(4-fluorofenil)-1-metiletanolo e di seguito 7,9 g (41,4 mmol) di EDCI [N-(3-dimetilamminopropil)-N?-etilcarbodiimmide cloridrata] e 3,03 g (24,8 mmol) di DMAP (dimetilamminopiridina). La soluzione cos? ottenuta ? stata agitata 1 ora a circa 0?C e a temperatura ambiente per 3 ore. Dopo controllo con TLC (eluente esano/etil acetato 6/4) la miscela di reazione ? stata lavata con acqua e le fasi sono state separate. La fase acquosa ? stata estratta con CH2Cl2 (3 x 15 ml) e le fasi organiche riunite sono state lavate con acqua (1 x 30ml), poi con una soluzione 1M di HCl ed infine con una soluzione satura di NaCl (1 x 30 ml). Queste sono state poi anidrificate su Na2SO4, filtrate e concentrate. Dopo purificazione per cromatografia su gel di silice mediante separatore automatico Biotage sono stati ottenuti 10,0 g di prodotto desiderato. Resa 94% To a 5.9 g (20.7 mmol) solution of (2R) -2- (3-hydroxy-4-methoxycolinamido) -3-methylthiopropanoic acid in 230 ml of CH2Cl2 were added under stirring on an ice bath 6.16 g (24.8 mmol) of 2,2-bis (4-fluorophenyl) -1-methylethanol and then 7.9 g (41.4 mmol) of EDCI [N- (3-dimethylaminopropyl) -N ? -ethylcarbodiimide hydrochloride] and 3.03 g (24.8 mmol) of DMAP (dimethylaminopyridine). The solution cos? obtained? was stirred for 1 hour at about 0 ° C and at room temperature for 3 hours. After checking with TLC (eluent hexane / ethyl acetate 6/4) the reaction mixture? was washed with water and the phases were separated. The aqueous phase? was extracted with CH2Cl2 (3 x 15 ml) and the combined organic phases were washed with water (1 x 30 ml), then with a 1M solution of HCl and finally with a saturated solution of NaCl (1 x 30 ml). These were then dried on Na2SO4, filtered and concentrated. After purification by chromatography on silica gel by means of an automatic Biotage separator, 10.0 g of the desired product were obtained. Yield 94%
LC-MS: M<+ >= 516 LC-MS: M <+> = 516
ESEMPIO 2 EXAMPLE 2
Preparazione di (2R)-2-(3-isoprossicarbossicarbetossimetossi-4-metossipicolinammido)-3-metiltiopropionato di (1S)-2,2-bis(4-fluorofenil)-1-metiletile (composto n?433) Preparation of (2R) -2- (3-isoproxycarboxycarbetoxymethoxy-4-methoxycolinamido) -3-methylthiopropionate of (1S) -2,2-bis (4-fluorophenyl) -1-methylethyl (compound n? 433)
A una soluzione di 5,0 g (9,7 mmol) di (2R)-2-(3-idrossi-4-metossipicolinammido)-3-metiltiopropionato di (1S)-2,2-bis(4-fluorofenil)-1-metiletile in 100 ml di acetone sono stati aggiunti sotto agitazione 2,7 g (19,4 mmol) di carbonato di potassio e 3,55 g (14,5 mmol) di iodometil-isopropilcarbonato e la miscela di reazione ? stata scaldata a 55?C per 2 ore. Dopo controllo in LC-MS si ? concentrata la miscela di reazione al rotavapor e si ? purificata per cromatografia su gel di silice mediante separatore automatico Biotage. Sono stati ottenuti 4,35 g di prodotto desiderato. Resa 71% To a 5.0 g (9.7 mmol) solution of (2R) -2- (3-hydroxy-4-methoxycolinamido) -3-methylthiopropionate of (1S) -2.2-bis (4-fluorophenyl) - 1-methylethyl in 100 ml of acetone 2.7 g (19.4 mmol) of potassium carbonate and 3.55 g (14.5 mmol) of iodomethyl-isopropyl carbonate were added under stirring and the reaction mixture? been heated at 55 ° C for 2 hours. After checking in LC-MS yes? concentrated the reaction mixture to the rotavapor and yes? purified by chromatography on silica gel using Biotage automatic separator. 4.35 g of desired product were obtained. Yield 71%
LC-MS: M<+ >= 632 LC-MS: M <+> = 632
ESEMPIO 3 EXAMPLE 3
Preparazione di (2R)-2-(4-formilamminosalicilammido)-3-metiltiopropionato di (1S)-2,2-bis(4-fluorofenil)-1-metiletile (composto n?425) Preparation of (2R) -2- (4-formylaminosalicylamido) -3-methylthiopropionate of (1S) -2,2-bis (4-fluorophenyl) -1-methylethyl (compound n? 425)
a) Preparazione di (2R)-2-(3-benzilossi-4-nitrobenzammido)-3-metiltiopropionato di metile (composto n?481) a) Preparation of methyl (2R) -2- (3-benzyloxy-4-nitrobenzamido) -3-methylthiopropionate (compound no? 481)
A una soluzione di 5,0 g (18,3 mmol) di acido O-benzil-nitrosalicilico in 50 ml di CH2Cl2 sono stati aggiunti 3,4 g (18,3 mmol) dell?estere metilico della S-metil-L-cisteina cloridrata, si ? raffreddata la miscela di reazione a 0?C e sono stati aggiunti 3,64 g di HOBT (N-idrossibenzotriazolo) (23,8 mmol). Mediante gocciolamento ? stata addizionata la soluzione ottenuta sciogliendo 4,56 g (23,8 mmol) di EDCI [N-(3-dimetilamminopropil)-N?-etilcarbodiimmide cloridrata] e 4,82 g (47,6 mmol) di trietilammina in 100 ml di CH2Cl2, la temperatura ? stata lascata risalire a valori ambientali e si ? mantenuta in agitazione per 24 ore. Dopo controllo con LC-MS la miscela di reazione ? stata lavata con acqua e le fasi vengono separate. La fase acquosa viene estratta con CH2Cl2 (3 x 15 ml) e le fasi organiche riunite sono state lavate con acqua (1 x 30ml) e con una soluzione satura di NaCl (1 x 30 ml). Queste sono poi state anidrificate su Na2SO4, filtrate e concentrate. Sono stati ottenuti 7 g di grezzo che ? stato purificato per cromatografia su gel di silice mediante separatore automatico Biotage. Sono stati ottenuti 5,54 g del prodotto desiderato. Resa 75% 3.4 g (18.3 mmol) of the S-methyl-L-methyl ester was added to a solution of 5.0 g (18.3 mmol) of O-benzyl-nitrosalicylic acid in 50 ml of CH2Cl2. cysteine hydrochloride, yes? the reaction mixture was cooled to 0 ° C and 3.64 g of HOBT (N-hydroxybenzotriazole) (23.8 mmol) was added. By dripping? the solution obtained by dissolving 4.56 g (23.8 mmol) of EDCI [N- (3-dimethylaminopropyl) -N? -ethylcarbodiimide hydrochloride] and 4.82 g (47.6 mmol) of triethylamine in 100 ml of CH2Cl2, the temperature? been left to go back to environmental values and yes? kept under agitation for 24 hours. After checking the reaction mixture with LC-MS? been washed with water and the phases are separated. The aqueous phase is extracted with CH2Cl2 (3 x 15 ml) and the combined organic phases were washed with water (1 x 30 ml) and with a saturated solution of NaCl (1 x 30 ml). These were then dried on Na2SO4, filtered and concentrated. 7 g of crude were obtained which? was purified by chromatography on silica gel using an automatic Biotage separator. 5.54 g of the desired product were obtained. Yield 75%
LC-MS: M<+ >= 404 LC-MS: M <+> = 404
b) Preparazione dell?acido (2R)-2-(3-benzilossi-4-nitrobenzammido)-3-metiltiopropionico (composto n?530) b) Preparation of (2R) -2- (3-benzyloxy-4-nitrobenzamido) -3-methylthiopropionic acid (compound n? 530)
A una soluzione di 5,54 g (13,7 mmol) di (2R)-2-(3-benzilossi-4-nitrobenzammido)-3-metiltiopropionato di metile in 60 ml di CH2Cl2 sono stati addizionati 55 ml di acido trifluoroacetico e si ? lasciato in agitazione per tutta la notte. Dopo controllo in LC-MS la miscela di reazione ? stata concentrata al rotavapor fino a secchezza. Resa quantativa 55 ml of trifluoroacetic acid were added to a solution of 5.54 g (13.7 mmol) of methyl (2R) -2- (3-benzyloxy-4-nitrobenzamido) -3-methylthiopropionate in 60 ml of CH2Cl2. yes ? left to shake overnight. After checking the reaction mixture in LC-MS? was concentrated in the rotavapor until dryness. Quantative yield
LC-MS: M<- >= 390 LC-MS: M <-> = 390
c) Preparazione di (2R)-2-(3-benzilossi-4-nitrobenzammido)-3-metiltiopropionato di (1S)-2,2-bis(4-fluorofenil)-1-metiletile c) Preparation of (2R) -2- (3-benzyloxy-4-nitrobenzamido) -3-methylthiopropionate of (1S) -2,2-bis (4-fluorophenyl) -1-methylethyl
A una soluzione di 5,34 g (13,7 mmol) dell?acido (2R)-2-(3-benzilossi-4-nitrobenzammido)-3-metiltiopropionico in 200 ml di CH2Cl2 sono stati aggiunti sotto agitazione su bagno di ghiaccio 3,4 g (13,7 mmol) di 2,2-bis(4-fluorofenil)-1-metiletanolo e di seguito 5,25 g (27,4 mmol) di EDCI [N-(3-dimetilamminopropil)-N?-etilcarbodiimmide cloridrata] e 2,0 g (16,44 mmol) di DMAP (dimetilamminopiridina). La soluzione cos? ottenuta ? stata agitata 1 ora a circa 0?C e a temperatura ambiente per 3 ore. Dopo controllo con TLC (eluente esano/etil acetato 6/4) la miscela di reazione ? stata lavata con acqua e le fasi sono state separate, la fase acquosa ? stata estratta con CH2Cl2 (3 x 15 ml) e le fasi organiche riunite sono state lavate con acqua (1 x 30ml), poi con una soluzione 1M di HCl ed infine con una soluzione satura di NaCl (1 x 30 ml). Queste sono state poi anidrificate su Na2SO4, filtrate e concentrate. Dopo purificazione per cromatografia su gel di silice mediante separatore automatico Biotage sono stati ottenuti 7,6 g di prodotto desiderato. Resa 89% To a solution of 5.34 g (13.7 mmol) of (2R) -2- (3-benzyloxy-4-nitrobenzamido) -3-methylthiopropionic acid in 200 ml of CH2Cl2 were added under stirring on an ice bath 3.4 g (13.7 mmol) of 2,2-bis (4-fluorophenyl) -1-methylethanol and then 5.25 g (27.4 mmol) of EDCI [N- (3-dimethylaminopropyl) -N ? -ethylcarbodiimide hydrochloride] and 2.0 g (16.44 mmol) of DMAP (dimethylaminopyridine). The solution cos? obtained? was stirred for 1 hour at about 0 ° C and at room temperature for 3 hours. After checking with TLC (eluent hexane / ethyl acetate 6/4) the reaction mixture? washed with water and the phases separated, the aqueous phase? was extracted with CH2Cl2 (3 x 15 ml) and the combined organic phases were washed with water (1 x 30 ml), then with a 1M solution of HCl and finally with a saturated solution of NaCl (1 x 30 ml). These were then dried on Na2SO4, filtered and concentrated. After purification by chromatography on silica gel by means of an automatic Biotage separator, 7.6 g of the desired product were obtained. Yield 89%
LC-MS: M<+ >= 620 LC-MS: M <+> = 620
d) Preparazione di (2R)-2-(4-amminosalicilammido)-3-metiltiopropionato di (1S)-2,2-bis(4-fluorofenil)-1-metiletile d) Preparation of (2R) -2- (4-aminosalicylamido) -3-methylthiopropionate of (1S) -2,2-bis (4-fluorophenyl) -1-methylethyl
Una soluzione 0,05 M in metanolo di 7,6 g del prodotto ottenuto nel passaggio precedente ? stata flussata nell?apparecchiatura per riduzioni catalitiche H-Cube Thalesnano<? >attraverso una cartuccia di Pd/C 10% con 15 bar di H2 a 60?C. La soluzione di raccolta ? stata quindi concentrata a dare il prodotto desiderato. Resa quantitativa A 0.05 M solution in methanol of 7.6 g of the product obtained in the previous step? flowed into the H-Cube Thalesnano <? > through a 10% Pd / C cartridge with 15 bar of H2 at 60 ° C. The collection solution? was then concentrated to give the desired product. Quantitative yield
LC-MS: M<- >= 500 LC-MS: M <-> = 500
e) Preparazione (2R)-2-(4-formilamminosalicilammido)-3-metiltio propanoato di (1S)-2,2-bis(4-fluorofenil)-1-metiletile e) Preparation (2R) -2- (4-formylaminosalicylamido) -3-methylthio propanoate of (1S) -2,2-bis (4-fluorophenyl) -1-methylethyl
Una sospensione di 6,1 g (12,2 mmol) (2R)-2-(4-amminosalicilammido)-3-metiltiopropionato di (1S)-2,2-bis(4-fluorofenil)-1-metiletile in 25 ml di THF ? stata addizionata di 3,54 ml (94 mmol) di acido formico e 0,49 g (6,1 mmol) di ossido di zinco e mantenuta in agitazione alla temperatura di 70 ?C per 1 ora. Dopo controllo in LC-MS la miscela di reazione ? stata filtrata per eliminare il metallo ed evaporata fino a secchezza, azeotropando l?acido formico in eccesso con esano. Il grezzo co? ottenuto ? stato purificato per cromatografia su gel di silice mediante separatore automatico Biotage e sono stati ottenuti 4,5 g del prodotto desiderato. Resa 70% A suspension of 6.1 g (12.2 mmol) (2R) -2- (4-aminosalicylamido) -3-methylthiopropionate of (1S) -2.2-bis (4-fluorophenyl) -1-methylethyl in 25 ml of THF? 3.54 ml (94 mmol) of formic acid and 0.49 g (6.1 mmol) of zinc oxide was added and kept under stirring at a temperature of 70 ° C for 1 hour. After checking the reaction mixture in LC-MS? filtered to remove the metal and evaporated to dryness, azeotroping the excess formic acid with hexane. The raw co? obtained ? was purified by chromatography on silica gel by means of an automatic Biotage separator and 4.5 g of the desired product were obtained. Yield 70%
LC-MS: M<- >= 528 LC-MS: M <-> = 528
ESEMPIO 4 EXAMPLE 4
Preparazione di (2R)-2-(3-idrossi-4-metossipicolinammido)-3-metiltiopropionato di (1S)-2,2-bis(4-fluoro-2-metilfenil)-1-metiletile (composto n?438) Preparation of (2R) -2- (3-hydroxy-4-methoxycolinamido) -3-methylthiopropionate of (1S) -2,2-bis (4-fluoro-2-methylphenyl) -1-methylethyl (compound No. 438)
a) (2R)-2-ter-butossicarbonilammino-3-metiltiopropionato di (1S)-2,2-bis(4-fluoro-2-metilfenil)-1-metiletile (composto n?164) a) (2R) -2-tert-butoxycarbonylamino-3-methylthiopropionate of (1S) -2,2-bis (4-fluoro-2-methylphenyl) -1-methylethyl (compound No. 164)
A una soluzione di 5,0 g (21,3 mmol) di t-butossicarbonilammino-S-metil-L-cisteina in 50 ml di CH2Cl2 sono stati aggiunti sotto agitazione su bagno di ghiaccio 5,88 g di (1S)-2,2-bis(4-fluoro-2-metilfenil)-1-metiletanolo e di seguito 8,16 g (21,3 mmol) di EDCI [N-(3-dimetilamminopropil)-N?-etilcarbodiimmide cloridrata] (42,6 mmol) e 2,6 g (21,3 mmol) di DMAP (dimetilamminopiridina). La soluzione cos? ottenuta ? stata agitata 1 ora a circa 0?C e a temperatura ambiente per 8 ore. Dopo controllo con TLC (eluente esano/etil acetato 7/3) la miscela di reazione ? stata lavata con acqua e le fasi sono state separate, la fase acquosa ? stata estratta con CH2Cl2 (3 x 15 ml) e le fasi organiche riunite sono state lavate con acqua (1 x 30ml), ed infine con una soluzione satura di NaCl (1 x 30 ml). Queste sono state poi anidrificate su Na2SO4, filtrate e concentrate. Dopo purificazione per cromatografia su gel di silice mediante separatore automatico Biotage sono stati ottenuti 8,6 g di prodotto desiderato. Resa 82% 5.88 g of (1S) -2 were added under stirring on an ice bath to a solution of 5.0 g (21.3 mmol) of t-butoxycarbonylamino-S-methyl-L-cysteine in 50 ml of CH2Cl2. , 2-bis (4-fluoro-2-methylphenyl) -1-methylethanol and then 8.16 g (21.3 mmol) of EDCI [N- (3-dimethylaminopropyl) -N? -Ethylcarbodiimide hydrochloride] (42, 6 mmol) and 2.6 g (21.3 mmol) of DMAP (dimethylaminopyridine). The solution cos? obtained? was stirred for 1 hour at about 0 ° C and at room temperature for 8 hours. After checking with TLC (eluent hexane / ethyl acetate 7/3) the reaction mixture? washed with water and the phases separated, the aqueous phase? was extracted with CH2Cl2 (3 x 15 ml) and the combined organic phases were washed with water (1 x 30ml), and finally with a saturated solution of NaCl (1 x 30 ml). These were then dried on Na2SO4, filtered and concentrated. After purification by chromatography on silica gel by means of Biotage automatic separator, 8.6 g of desired product were obtained. Yield 82%
GC-MS: M<+ >= 493 GC-MS: M <+> = 493
b) Preparazione del cloridrato di (2R)-2-ammino-3-metiltiopropionato di (1S)-2,2-bis(4-fluoro-2-metilfenil)-1-metiletile (composto n?300) b) Preparation of (2R) -2-amino-3-methylthiopropionate of (1S) -2,2-bis (4-fluoro-2-methylphenyl) -1-methylethyl hydrochloride (compound n? 300)
A una soluzione di 8,6 g (17,4 mmol) di (2R)-2-ter-butossicarbonilammino-3-metiltiopropionato di 2,2-bis(4-fluoro-2-metilfenil)-1-metiletanolo in 100 ml di CH2Cl2 sono stati aggiunti sotto agitazione a temperatura ambiente 21,7 ml (87 mmol) di una soluzione 4 N di HCl in diossano. Dopo 4 ore si controlla in LC-MS, il solvente ? stato svaporato e l?acidit? residua ? stata allontanata strippando 3 volte con etere etilico. Sono stati ottenuti 6,5 g del prodotto desiderato. To a solution of 8.6 g (17.4 mmol) of (2R) -2-tert-butoxycarbonylamino-3-methylthiopropionate of 2,2-bis (4-fluoro-2-methylphenyl) -1-methylethanol in 100 ml of CH2Cl2 were added under stirring at room temperature 21.7 ml (87 mmol) of a 4 N solution of HCl in dioxane. After 4 hours, the solvent? been evaporated and the acidity? residual? removed by stripping 3 times with ethyl ether. 6.5 g of the desired product were obtained.
Resa 95% Yield 95%
GC-MS: M<+ >= 393 GC-MS: M <+> = 393
c) Preparazione di (2R)-2-(3-idrossi-4-metossipicolinammido)-3-metiltiopropionato di (1S)-2,2-bis(4-fluoro-2-metilfenil)-1-metiletile (composto n?436) c) Preparation of (2R) -2- (3-hydroxy-4-methoxycolinamido) -3-methylthiopropionate of (1S) -2,2-bis (4-fluoro-2-methylphenyl) -1-methylethyl (compound n? 436)
A una soluzione di 6,5 g (16,5 mmol) del cloridrato di (2R)-2-ammino-3-metiltiopropionato di (1S)-2,2-bis(4-fluoro-2-metilfenil)-1-metiletile sono stati aggiunti a 0?C e in sequenza 6,39 g (49,6 mmol) di diisopropiletilammina e 8,58 g (16,5 mmol) di PyBOP [(1-Benzotriazolilossi)-tripirrolidinofosfonio esafluorofosfato] in 150 ml di CH2Cl2 e infine 2,79 g (16,5 mmol) di acido 3-idrossi-4-metossipiridin-2-carbossilico. La miscela di reazione ? stata mantenuta in agitazione a questa temperatura per 2 ore, poi lasciata risalire a valori ambientali e in agitazione per altre 24 ore. Dopo controllo con LC-MS la miscela di reazione ? stata lavata con acqua e le fasi sono state separate. La fase acquosa ? stata estratta con CH2Cl2 (3 x 15 ml) e le fasi organiche riunite sono state lavate con acqua (1 x 30ml) e con una soluzione satura di NaCl (1 x 30 ml). Queste sono state poi anidrificate su Na2SO4, filtrate e concentrate. Sono stati ottenuti 18 g di un grezzo che ? stato lavato con etere etilico e filtrato per eliminare i sottoprodotti dell?agente condensante. La fase eterea ? stata quindi concentrata al rotavapor e purificata per cromatografia su gel di silice mediante separatore automatico Biotage. Si sono ottenuti 6,1 g del prodotto desiderato. To a solution of 6.5 g (16.5 mmol) of (2R) -2-amino-3-methylthiopropionate hydrochloride of (1S) -2.2-bis (4-fluoro-2-methylphenyl) -1- methylethyl were added at 0 ° C and in sequence 6.39 g (49.6 mmol) of diisopropylethylamine and 8.58 g (16.5 mmol) of PyBOP [(1-Benzotriazolyloxy) -tripyrrolidinophosphonium hexafluorophosphate] in 150 ml of CH2Cl2 and finally 2.79 g (16.5 mmol) of 3-hydroxy-4-methoxypyridine-2-carboxylic acid. The reaction mixture? it was kept under stirring at this temperature for 2 hours, then allowed to rise to ambient values and under stirring for another 24 hours. After checking the reaction mixture with LC-MS? was washed with water and the phases were separated. The aqueous phase? was extracted with CH2Cl2 (3 x 15 ml) and the combined organic phases were washed with water (1 x 30 ml) and with a saturated solution of NaCl (1 x 30 ml). These were then dried on Na2SO4, filtered and concentrated. 18 g of a crude were obtained which? been washed with ethyl ether and filtered to eliminate the by-products of the condensing agent. The ethereal phase? it was then concentrated in the rotavapor and purified by chromatography on silica gel using an automatic Biotage separator. 6.1 g of the desired product were obtained.
Resa 68% Yield 68%
LC-MS: M<+ >= 544 LC-MS: M <+> = 544
ESEMPIO 5 EXAMPLE 5
Preparazione di (2R)-2-(3-isobutirrilossimetossi-4-metossipicolinammido)-3-metiltiopropionato di (1S)-2,2-bis(4-fluoro-2-metilfenil)-1-metiletile (composto n?439) Preparation of (2R) -2- (3-isobutyryloxymethoxy-4-methoxycolinamido) -3-methylthiopropionate of (1S) -2,2-bis (4-fluoro-2-methylphenyl) -1-methylethyl (compound n? 439)
A una soluzione di 3,0 g (5,5 mmol) di (2R)-2-(3-idrossi-4-metossipicolinammido)-3-metiltiopropionato di (1S)-2,2-bis(4-fluoro-2-metilfenil)-1-metiletile in 60 ml di acetone sono stati aggiunti sotto agitazione 1,52 g (11,0 mmol) di carbonato di potassio e 1,88 g (8,25 mmol) di iodometilisobutirrato e la miscela di reazione ? stata scaldata a 55?C per 2 ore. Dopo controllo in LC-MS si ? concentrata la miscela di reazione al rotavapor e si ? purificata per cromatografia su gel di silice mediante separatore automatico Biotage. Sono stati ottenuti 2,48 g di prodotto desiderato. To a solution of 3.0 g (5.5 mmol) of (2R) -2- (3-hydroxy-4-methoxycolinamido) -3-methylthiopropionate of (1S) -2.2-bis (4-fluoro-2 -methylphenyl) -1-methylethyl in 60 ml of acetone were added under stirring 1.52 g (11.0 mmol) of potassium carbonate and 1.88 g (8.25 mmol) of iodomethyl isobutyrate and the reaction mixture? been heated at 55 ° C for 2 hours. After checking in LC-MS yes? concentrated the reaction mixture to the rotavapor and yes? purified by chromatography on silica gel using Biotage automatic separator. 2.48 g of desired product were obtained.
Resa 70% Yield 70%
LC-MS: M<+ >= 644 LC-MS: M <+> = 644
ESEMPIO 6 EXAMPLE 6
Preparazione di (2R)-2-(4-formilamminosalicilammido)-3-metiltiopropanoato di 6-metil-2-eptile (composto n?330) Preparation of (2R) -2- (4-formylaminosalicylamido) -3-methylthiopropanoate of 6-methyl-2-heptyl (compound No. 330)
a) Preparazione di (2R)-2-[(9H-fluoren-9-il)metossi]carbonilammino-3-metiltiopropionato di 6-metil-2-eptile (composto n?25) a) Preparation of (2R) -2 - [(9H-fluoren-9-yl) methoxy] carbonylamino-3-methylthiopropionate of 6-methyl-2-heptyl (compound No. 25)
A una soluzione di 5,0 g (14,0 mmol) di acido (R)-2-[(9H- fluoren-9-il)metossi]carbonilammino-3-metiltiopropionico in 50 ml di CH2Cl2 sono stati aggiunti sotto agitazione su bagno di ghiaccio 1,8 g (14,0 mmol) di alcool 6-metil-2-eptanolo e di seguito 5,4 g (28 mmol) di EDCI [N-(3-dimetilamminopropil)-N?-etilcarbodiimmide cloridrata] e 0,17 g (1,4 mmol) di DMAP (dimetilamminopiridina). La soluzione cos? ottenuta ? stata agitata 1 ora a circa 0?C e a temperatura ambiente per 3 ore. Dopo controllo con TLC (eluente esano/etil acetato 7/3) la miscela di reazione ? stata lavata con acqua e le fasi sono state separate, la fase acquosa ? stata estratta con CH2Cl2 (3 x 15 ml) e le fasi organiche riunite sono state lavate con acqua (1 x 30ml), poi con una soluzione 1M di HCl ed infine con una soluzione satura di NaCl (1 x 30 ml). Queste sono state poi anidrificate su Na2SO4, filtrate e concentrate. Dopo purificazione per cromatografia su gel di silice mediante separatore automatico Biotage, sono stati ottenuti 5,9 g di prodotto desiderato. Resa 90% To a solution of 5.0 g (14.0 mmol) of (R) -2 - [(9H- fluoren-9-yl) methoxy] carbonylamino-3-methylthiopropionic acid in 50 ml of CH2Cl2 were added under stirring on ice bath 1.8 g (14.0 mmol) of 6-methyl-2-heptanol alcohol and then 5.4 g (28 mmol) of EDCI [N- (3-dimethylaminopropyl) -N? -ethylcarbodiimide hydrochloride] and 0.17 g (1.4 mmol) of DMAP (dimethylaminopyridine). The solution cos? obtained? was stirred for 1 hour at about 0 ° C and at room temperature for 3 hours. After checking with TLC (eluent hexane / ethyl acetate 7/3) the reaction mixture? washed with water and the phases separated, the aqueous phase? was extracted with CH2Cl2 (3 x 15 ml) and the combined organic phases were washed with water (1 x 30 ml), then with a 1M solution of HCl and finally with a saturated solution of NaCl (1 x 30 ml). These were then dried on Na2SO4, filtered and concentrated. After purification by chromatography on silica gel by means of Biotage automatic separator, 5.9 g of desired product were obtained. Yield 90%
GC-MS: M<+ >= 469 GC-MS: M <+> = 469
b) Preparazione di (2R)-2-ammino-3-metiltiopropionato di 6-metil-2-eptile (composto n?187) b) Preparation of (2R) -2-amino-3-methylthiopropionate of 6-methyl-2-heptyl (compound No. 187)
A una soluzione di 5,9 g (12,5 mmol) di (2R)-2-[(9H-fluoren-9-il)metossi]carbonilammino-3-metiltiopropionato di 6-metil-2-eptile in 126 ml di DMF sono stati aggiunti 9,2 g di trietilammina (10 equiv) e il tutto ? stato lasciato in agitazione 2 ore. Dopo controllo in GC-MS si ? concentrata la miscela di reazione sotto vuoto spinto per allontanare il pi? possibile il solvente e si ? purificata velocemente su un piede di silice per eliminare il sottoprodotto dibenzofulvene. Il prodotto ottenuto ? stato utilizzato tal quale per la reazione successiva. To a solution of 5.9 g (12.5 mmol) of (2R) -2 - [(9H-fluoren-9-yl) methoxy] carbonylamino-3-methylthiopropionate of 6-methyl-2-heptyl in 126 ml of DMF 9.2 g of triethylamine (10 equiv) was added and the whole? was left under stirring for 2 hours. After checking in GC-MS yes? concentrated the reaction mixture under high vacuum to remove the pi? can the solvent and yes? quickly purified on a silica foot to eliminate the dibenzofulvene by-product. The product obtained? was used as it is for the subsequent reaction.
GC-MS: M<+>= 261 GC-MS: M <+> = 261
c) Preparazione di (2R)-2-(3-benzilossi-4-nitrobenzammido)-3-metiltiopropionato di 6-metil-2-eptile c) Preparation of (2R) -2- (3-benzyloxy-4-nitrobenzamido) -3-methylthiopropionate of 6-methyl-2-heptyl
A una soluzione di 3,8 g (14 mmol) di acido O-benzil-nitrosalicilico in 50 ml di CH2Cl2 ? stato aggiunto l?amminoestere ottenuto nel passaggio precedente, si ? raffreddata la miscela di reazione a 0?C e sono stati aggiunti 3,2 g (21 mmol) di HOBT (N-idrossibenzotriazolo). Mediante gocciolamento ? stata poi addizionata la soluzione ottenuta sciogliendo 4,03 g (21 mmol) di EDCI [N-(3-dimetilamminopropil)-N?-etilcarbodiimmide cloridrata] e 2,13 g (21 mmol) di trietilammina in 100 ml di CH2Cl2, si ? lasciata risalire la temperatura a valori ambientali e si ? mantenuta in agitazione per 24 ore. Dopo controllo con LC-MS la miscela di reazione ? stata lavata con acqua e le fasi sono state separate. La fase acquosa ? stata estratta con CH2Cl2 (3 x 15 ml) e le fasi organiche riunite sono state lavate con acqua (1 x 30ml) e con una soluzione satura di NaCl (1 x 30 ml). Queste sono state poi anidrificate su Na2SO4, filtrate e concentrate. Sono stati ottenuti 8 g di grezzo che ? stato purificato per cromatografia su gel di silice mediante separatore automatico Biotage. Sono stati ottenuti 4,57 g del prodotto desiderato. To a solution of 3.8 g (14 mmol) of O-benzyl-nitrosalicylic acid in 50 ml of CH2Cl2? the aminoester obtained in the previous step was added, yes? the reaction mixture was cooled to 0 ° C and 3.2 g (21 mmol) of HOBT (N-hydroxybenzotriazole) was added. By dripping? The solution obtained by dissolving 4.03 g (21 mmol) of EDCI [N- (3-dimethylaminopropyl) -N? -ethylcarbodiimide hydrochloride] and 2.13 g (21 mmol) of triethylamine in 100 ml of CH2Cl2 was then added. ? let the temperature rise to environmental values and yes? kept under agitation for 24 hours. After checking the reaction mixture with LC-MS? was washed with water and the phases were separated. The aqueous phase? was extracted with CH2Cl2 (3 x 15 ml) and the combined organic phases were washed with water (1 x 30 ml) and with a saturated solution of NaCl (1 x 30 ml). These were then dried on Na2SO4, filtered and concentrated. 8 g of crude was obtained which? was purified by chromatography on silica gel using an automatic Biotage separator. 4.57 g of the desired product were obtained.
Resa 65% Yield 65%
LC-MS: M<+ >= 502 LC-MS: M <+> = 502
d) Preparazione di (2R)-2-(4-amminosalicilammido)-3-metiltiopropionato di 6-metil-2-eptile d) Preparation of (2R) -2- (4-aminosalicylamido) -3-methylthiopropionate of 6-methyl-2-heptyl
Una soluzione 0,05 M in metanolo di 4,57 g (19,1 mmol) (2R)-2-(3-benzilossi-4-nitrobenzammido)-3-metiltiopropanoato di 6-metil-2-eptile ? stata flussata nell?apparecchiatura per riduzioni catalitiche H-Cube Thalesnano<? >attraverso una cartuccia di Pd/C 10% con 15 bar di H2 a 60?C. La soluzione di raccolta ? stata quindi concentrata a dare il prodotto desiderato. A 0.05 M solution in methanol of 4.57 g (19.1 mmol) (2R) -2- (3-benzyloxy-4-nitrobenzamido) -3-methylthiopropanoate of 6-methyl-2-heptyl? flowed into the H-Cube Thalesnano <? > through a 10% Pd / C cartridge with 15 bar of H2 at 60 ° C. The collection solution? was then concentrated to give the desired product.
Resa quantitativa Quantitative yield
LC-MS: M<- >= 382 LC-MS: M <-> = 382
e) Preparazione di (2R)-2-(4-formilamminosalicilammido)-3-metiltiopropionato di 6-metil-2-eptile e) Preparation of (2R) -2- (4-formylaminosalicylamido) -3-methylthiopropionate of 6-methyl-2-heptyl
Una sospensione di 3,48 g (9,1 mmol) (2R)-2-(4-amminosalicilammido)-3-metiltiopropanoato di 6-metil-2-eptile in 15 ml di THF ? stata addizionata di 2,64 ml (70 mmol) di acido formico e 0,37 g (4,55 mmol) di ossido di zinco e mantenuta in agitazione alla temperatura di 70 ?C per 1 ora. Dopo controllo in LC-MS la miscela di reazione ? stata filtrata per eliminare il metallo ed evaporata fino a secchezza, azeotropando l?acido formico in eccesso con esano. Dopo purificazione per cromatografia su gel di silice mediante separatore automatico Biotage sono stati ottenuti 2,72 g del prodotto desiderato. A suspension of 3.48 g (9.1 mmol) (2R) -2- (4-aminosalicylamido) -3-methylthiopropanoate of 6-methyl-2-heptyl in 15 ml of THF? 2.64 ml (70 mmol) of formic acid and 0.37 g (4.55 mmol) of zinc oxide were added and kept under stirring at a temperature of 70 ° C for 1 hour. After checking the reaction mixture in LC-MS? filtered to remove the metal and evaporated to dryness, azeotroping the excess formic acid with hexane. After purification by chromatography on silica gel by means of Biotage automatic separator 2.72 g of the desired product were obtained.
Resa 73% Yield 73%
LC-MS: M<- >= 410 LC-MS: M <-> = 410
ESEMPIO 7 EXAMPLE 7
Preparazione del cloridrato di (2R)-2-ammino-3-benziltio-propionato di 6-metil-2-eptile (composto n?206) Preparation of 6-methyl-2-heptyl (2R) -2-amino-3-benzylthio-propionate hydrochloride (compound No. 206)
a) Preparazione di (2R)-2-t-butossicarbonilammino-3-benziltio propionato di 6-metil-2-eptile (composto n?61) a) Preparation of (2R) -2-t-butoxycarbonylamino-3-benzylthio propionate of 6-methyl-2-heptyl (compound No. 61)
A una soluzione di 5,9 g (19,0 mmol) di t-butossicarbonil-S-benzil-L-cisteina in 50 ml di CH2Cl2 sono stati aggiunti sotto agitazione su bagno di ghiaccio 2,46 g (19,0 mmol) di 6-metil-2-eptanolo e di seguito 7,2 g (38 mmol) di EDCI [N-(3-dimetilamminopropil)-N?-etilcarbodiimmide cloridrata] e 0,23 g (1,9 mmol) di DMAP (dimetilamminopiridina). La soluzione cos? ottenuta ? stata agitata 1 ora a circa 0?C e a temperatura ambiente per 3 ore. Dopo controllo con TLC (eluente esano/etil acetato 7/3) la miscela di reazione ? stata lavata con acqua e le fasi sono state separate, la fase acquosa ? stata estratta con CH2Cl2 (3 x 15 ml) e le fasi organiche riunite sono state lavate con acqua (1 x 30ml), poi con una soluzione 1M di HCl ed infine con una soluzione satura di NaCl (1 x 30 ml). Queste sono state poi anidrificate su Na2SO4, filtrate e concentrate. Dopo purificazione per cromatografia su gel di silice mediante separatore automatico Biotage, sono stati ottenuti 8,1 g di prodotto desiderato. To a solution of 5.9 g (19.0 mmol) of t-butoxycarbonyl-S-benzyl-L-cysteine in 50 ml of CH2Cl2 was added under stirring on an ice bath 2.46 g (19.0 mmol) of 6-methyl-2-heptanol and subsequently 7.2 g (38 mmol) of EDCI [N- (3-dimethylaminopropyl) -N? -ethylcarbodiimide hydrochloride] and 0.23 g (1.9 mmol) of DMAP ( dimethylaminopyridine). The solution cos? obtained? was stirred for 1 hour at about 0 ° C and at room temperature for 3 hours. After checking with TLC (eluent hexane / ethyl acetate 7/3) the reaction mixture? washed with water and the phases separated, the aqueous phase? was extracted with CH2Cl2 (3 x 15 ml) and the combined organic phases were washed with water (1 x 30 ml), then with a 1M solution of HCl and finally with a saturated solution of NaCl (1 x 30 ml). These were then dried on Na2SO4, filtered and concentrated. After purification by chromatography on silica gel by means of Biotage automatic separator, 8.1 g of desired product were obtained.
Resa quantitativa Quantitative yield
GC-MS: M<+ >= 423 GC-MS: M <+> = 423
b) Preparazione del (2R)-2-ammino-3-benziltio-propionato di 6-metil-2-eptile b) Preparation of 6-methyl-2-heptyl (2R) -2-amino-3-benzylthio-propionate
A una soluzione di 8,5 g (19,0 mmol)di (2R)-2-t-butossicarbonilammino-3-benziltiopropionato di 6-metil-2-eptile in 100 ml di CH2Cl2 sono stati aggiunti sotto agitazione a temperatura ambiente 23 ml (95 mmol) di una soluzione 4 N di HCl in diossano. Dopo 4 ore si ? controllata la reazione in LC-MS, il solvente ? stato svaporato e l?acidit? residua ? stata allontanata strippando 3 volte con etere etilico. Sono stati ottenuti 6,5 g del prodotto desiderato. A solution of 8.5 g (19.0 mmol) of (2R) -2-t-butoxycarbonylamino-3-benzylthiopropionate of 6-methyl-2-heptyl in 100 ml of CH2Cl2 was added under stirring at room temperature 23 ml (95 mmol) of a 4 N solution of HCl in dioxane. After 4 hours, yes? controlled the reaction in LC-MS, the solvent? been evaporated and the acidity? residual? removed by stripping 3 times with ethyl ether. 6.5 g of the desired product were obtained.
Resa 95% Yield 95%
GC-MS: M<+ >= 459 GC-MS: M <+> = 459
ESEMPIO 8 EXAMPLE 8
Preparazione di (R)-2-[(9H-fluoren-9-il)metossi]carbonilammino-3-metiltiopropionato di (S)-2-nonile (composto n?24) Preparation of (R) -2 - [(9H-fluoren-9-yl) methoxy] carbonylamino-3-methylthiopropionate of (S) -2-nonyl (compound No. 24)
A una soluzione di 5,0 g (14,0 mmol) di acido (R)-2-[(9H- fluoren-9-il)metossi]carbonilammino-3-metiltiopropionico in 50 ml di CH2Cl2 sono stati aggiunti sotto agitazione su bagno di ghiaccio 2,02 g (14,0 mmol) di alcool (S)-2nonanolo e di seguito 5,4 g (28 mmol) di EDCI [N-(3-dimetilamminopropil)-N?-etilcarbodiimmide cloridrata] e 0,17 g (1,4 mmol) di DMAP (dimetilamminopiridina). La soluzione cos? ottenuta ? stata agitata 1 ora a circa 0?C e a temperatura ambiente per 16 ore. Dopo controllo con TLC (eluente esano/etil acetato 7/3) la miscela di reazione ? stata lavata con acqua e le fasi sono state separate. La fase acquosa ? stata estratta con CH2Cl2 (3 x 15 ml) e le fasi organiche riunite sono state lavate con acqua (1 x 30ml), poi con una soluzione 1M di HCl ed infine con una soluzione satura di NaCl (1 x 30 ml). Queste sono state poi anidrificate su Na2SO4, filtrate e concentrate. Dopo purificazione per cromatografia su gel di silice mediante separatore automatico Biotage sono stati ottenuti 6,5 g di prodotto desiderato . Resa 96% To a solution of 5.0 g (14.0 mmol) of (R) -2 - [(9H- fluoren-9-yl) methoxy] carbonylamino-3-methylthiopropionic acid in 50 ml of CH2Cl2 were added under stirring on ice bath 2.02 g (14.0 mmol) of alcohol (S) -2nonanol and then 5.4 g (28 mmol) of EDCI [N- (3-dimethylaminopropyl) -N? -ethylcarbodiimide hydrochloride] and 0 , 17 g (1.4 mmol) of DMAP (dimethylaminopyridine). The solution cos? obtained? was stirred for 1 hour at about 0 ° C and at room temperature for 16 hours. After checking with TLC (eluent hexane / ethyl acetate 7/3) the reaction mixture? was washed with water and the phases were separated. The aqueous phase? was extracted with CH2Cl2 (3 x 15 ml) and the combined organic phases were washed with water (1 x 30 ml), then with a 1M solution of HCl and finally with a saturated solution of NaCl (1 x 30 ml). These were then dried on Na2SO4, filtered and concentrated. After purification by chromatography on silica gel by means of an automatic Biotage separator, 6.5 g of the desired product were obtained. Yield 96%
GC-MS: M<+ >= 483 GC-MS: M <+> = 483
ESEMPIO 9 EXAMPLE 9
a) Preparazione di (2R)-2-t-butossicarbonilammino-3-t-butiltio propionato di 2,2-bis(3-fluoro-4-metilfenil)-1-metiletile (composto n?169) a) Preparation of (2R) -2-t-butoxycarbonylamino-3-t-butylthio propionate of 2,2-bis (3-fluoro-4-methylphenyl) -1-methylethyl (compound No. 169)
A una soluzione di 5,0 g (18 mmol) di N-(t-butossicarbonilammino)-S-t-butil-L-cisteina in 50 ml di CH2Cl2 sono stati aggiunti sotto agitazione su bagno di ghiaccio 4,98 g di 2,2-bis(3-fluoro-4-metilfenil)-1-metiletanolo (18 mmol) e di seguito 6,9 g (36 mmol) di EDCI [N-(3-dimetilamminopropil)-N?-etilcarbodiimmide cloridrata] e 2,2 g (18 mmol) di DMAP (dimetilamminopiridina). La soluzione cos? ottenuta ? stata agitata 1 ora a circa 0?C e a temperatura ambiente per 8 ore. Dopo controllo con TLC (eluente esano/etil acetato 7/3) la miscela di reazione ? stata lavata con acqua e le fasi sono state separate, la fase acquosa ? stata estratta con CH2Cl2 (3 x 15 ml) e le fasi organiche riunite sono state lavate con acqua (1 x 30ml), ed infine con una soluzione satura di NaCl (1 x 30 ml). Queste sono state poi anidrificate su Na2SO4, filtrate e concentrate. Dopo purificazione per cromatografia su gel di silice mediante separatore automatico Biotage, sono stati ottenuti 8,2 g di prodotto desiderato. Resa 85% 4.98 g of 2.2 were added under stirring on an ice bath to a solution of 5.0 g (18 mmol) of N- (t-butoxycarbonylamino) -S-t-butyl-L-cysteine in 50 ml of CH2Cl2. -bis (3-fluoro-4-methylphenyl) -1-methylethanol (18 mmol) and then 6.9 g (36 mmol) of EDCI [N- (3-dimethylaminopropyl) -N? -ethylcarbodiimide hydrochloride] and 2, 2 g (18 mmol) of DMAP (dimethylaminopyridine). The solution cos? obtained? was stirred for 1 hour at about 0 ° C and at room temperature for 8 hours. After checking with TLC (eluent hexane / ethyl acetate 7/3) the reaction mixture? washed with water and the phases separated, the aqueous phase? was extracted with CH2Cl2 (3 x 15 ml) and the combined organic phases were washed with water (1 x 30ml), and finally with a saturated solution of NaCl (1 x 30 ml). These were then dried on Na2SO4, filtered and concentrated. After purification by chromatography on silica gel by means of Biotage automatic separator, 8.2 g of desired product were obtained. Yield 85%
GC-MS: M<+ >= 535 GC-MS: M <+> = 535
ESEMPIO 10 EXAMPLE 10
Preparazione di (2R)-2-t-butossicarbonilammino-4-metiltiobutirrato di 2,2-bis(4-fluorofenil)-1-metiletile (composto n?160) Preparation of (2R) -2-t-butoxycarbonylamino-4-methylthiobutyrate of 2,2-bis (4-fluorophenyl) -1-methylethyl (compound n? 160)
A una soluzione di 5,0 g (20 mmol) di N-(t-butossicarbonilammino)-L-metionina in 50 ml di CH2Cl2 sono stati aggiunti sotto agitazione su bagno di ghiaccio 4,98 g (20 mmol) di 2,2-bis(4-fluorofenil)-1-metiletanolo e di seguito 6,7 g (40 mmol) di EDCI [N-(3-dimetilamminopropil)-N?-etilcarbodiimmide cloridrata] e 2,44 g (20 mmol). di DMAP (dimetilamminopiridina). La soluzione cos? ottenuta ? stata agitata 1 ora a circa 0?C e a temperatura ambiente per 8 ore. Dopo controllo con TLC (eluente esano/etil acetato 7/3) la miscela di reazione ? stata lavata con acqua e le fasi sono state separate. La fase acquosa ? stata estratta con CH2Cl2 (3 x 15 ml) e le fasi organiche riunite sono state lavate con acqua (1 x 30ml), ed infine con una soluzione satura di NaCl (1 x 30 ml). Queste sono state poi anidrificate su Na2SO4, filtrate e concentrate. Dopo purificazione per cromatografia su gel di silice mediante separatore automatico Biotage, sono stati ottenuti 7,7 g di prodotto desiderato. 4.98 g (20 mmol) of 2.2 were added under stirring on an ice bath to a solution of 5.0 g (20 mmol) of N- (t-butoxycarbonylamino) -L-methionine in 50 ml of CH2Cl2. -bis (4-fluorophenyl) -1-methylethanol and subsequently 6.7 g (40 mmol) of EDCI [N- (3-dimethylaminopropyl) -N? -ethylcarbodiimide hydrochloride] and 2.44 g (20 mmol). of DMAP (dimethylaminopyridine). The solution cos? obtained? was stirred for 1 hour at about 0 ° C and at room temperature for 8 hours. After checking with TLC (eluent hexane / ethyl acetate 7/3) the reaction mixture? was washed with water and the phases were separated. The aqueous phase? was extracted with CH2Cl2 (3 x 15 ml) and the combined organic phases were washed with water (1 x 30ml), and finally with a saturated solution of NaCl (1 x 30 ml). These were then dried on Na2SO4, filtered and concentrated. After purification by chromatography on silica gel by means of Biotage automatic separator, 7.7 g of desired product were obtained.
Resa 81% Yield 81%
GC-MS: M<+ >= 479 GC-MS: M <+> = 479
Operando analogamente a quanto riportato nei precedenti esempi, sono stati ottenuti i composti 317, 330, 331, 339, 340, 345, 348, 350, 353, 355, 357, 359, 361, 412, 413, 414, 415, 427, 428, 429, 430, 431, 432, 434, 435, 436, 437, 440, 441, 442, 443, 446, 447, 448, 449, 450, 451, 452, 453, 454, 455, 456, 457, 458, 459, 460 di formula generale (Ic) riportati in Tabella 11. Operating similarly to what reported in the previous examples, the compounds 317, 330, 331, 339, 340, 345, 348, 350, 353, 355, 357, 359, 361, 412, 413, 414, 415, 427, were obtained. 428, 429, 430, 431, 432, 434, 435, 436, 437, 440, 441, 442, 443, 446, 447, 448, 449, 450, 451, 452, 453, 454, 455, 456, 457, 458, 459, 460 of general formula (Ic) shown in Table 11.
Tabella 11 Table 11
In Tabella 12 sono stati riportati i risultati delle analisi GC-MS condotte sui composti 317, 330, 331, 339, 340, 345, 348, 350, 353, 355, 357, 359, 361, 412, 413, 414, 415, 427, 428, 429, 430, 431, 432, 434, 435, 436, 437, 440, 441, 442, 443, 446, 447, 448, 449, 450, 451, 452, 453, 454, 455, 456, 457, 458, 459, 460 di formula generale (Ic). Table 12 shows the results of the GC-MS analyzes conducted on compounds 317, 330, 331, 339, 340, 345, 348, 350, 353, 355, 357, 359, 361, 412, 413, 414, 415, 427, 428, 429, 430, 431, 432, 434, 435, 436, 437, 440, 441, 442, 443, 446, 447, 448, 449, 450, 451, 452, 453, 454, 455, 456, 457, 458, 459, 460 of general formula (Ic).
Tabella 12 Table 12
ESEMPIO 11 EXAMPLE 11
Determinazione dell?attivit? fungicida dei composti di Formula (I) nei confronti di Zymoseptoria tritici su foglia staccata di frumento Determination of the activity? fungicide of the compounds of Formula (I) against Zymoseptoria tritici on detached wheat leaf
La parte centrale della prima foglia vera delle piante di frumento della variet? Bologna alla fase fenologica BBCH12 ? stata staccata e disposta in piastre Petri con un foglio di carta bibula imbevuto con 2ml di chinetina al 5%. Le molecole da saggiare sono state distribuite omogeneamente sulla superficie fogliare attraverso torre di Potter (Burkard Manufacturing Co Ltd). La superficie fogliare ? stata infettata utilizzando un inoculo preparato con due ceppi di Z. tritici cresciuti in liquido ad una concentrazione di conidi pari a 3*10<6 >UFC/ml. L?inoculo ? stato distribuito omogeneamente utilizzando la torre di Potter. Le piastre Petri sono state poste ad incubare con cicli di temperatura luce: 20?C/ 16 ore di luce e 14?C/8 ore di buio. La stima dei sintomi di septoriosi del grano ? stata eseguita dopo 21 giorni dall?inizio del test utilizzando una scala d?infezione basata sulla superfice fogliare ricoperta da picnidi riportata in letteratura (Eyal et al., 1987; ISBN 968-612 7-06-2). E? stata infine calcolata l?efficacia semplice secondo la formula di Abbott. The central part of the first true leaf of the wheat plants of the variety? Bologna at the phenological phase BBCH12? was peeled off and placed in Petri dishes with a sheet of bibulous paper soaked in 2ml of 5% kinetin. The molecules to be tested were homogeneously distributed on the leaf surface through a Potter tower (Burkard Manufacturing Co Ltd). The leaf surface? was infected using an inoculum prepared with two strains of Z. tritici grown in liquid at a conidia concentration equal to 3 * 10 <6> CFU / ml. The inoculum? was evenly distributed using the Potter tower. The Petri dishes were placed to incubate with light temperature cycles: 20 ° C / 16 hours of light and 14 ° C / 8 hours of dark. Estimating wheat septoria symptoms? was performed 21 days after the start of the test using an infection scale based on the leaf surface covered by pycnidia reported in the literature (Eyal et al., 1987; ISBN 968-612 7-06-2). AND? Finally, the simple efficacy was calculated according to the Abbott formula.
Tutti i composti N? 426, 429, 433, 430 hanno evidenziato attivit? maggiore dell'80% alla dose di 125mg/l. All compounds N? 426, 429, 433, 430 have highlighted activities? greater than 80% at the dose of 125mg / l.
In Tabella 13 sono stati riportati i risultati ottenuti con i composti N? 426, 429, 433 e 430. Table 13 shows the results obtained with compounds N? 426, 429, 433 and 430.
Tabella 13 Table 13
ESEMPIO 12 EXAMPLE 12
Determinazione dell?attivit? fungicida dei composti di Formula (I) nei confronti di Phakopsora pachyrhizi su foglia staccata di soia Determination of the activity? fungicide of the compounds of Formula (I) against Phakopsora pachyrhizi on detached soybean leaf
I saggi ex vivo nei confronti della ruggine asiatica della soia (ASR) sono stati effettuatiti prelevando dalle piante di soia della variet? Zora alla fase fenologica BBCH12 la prima trifoliata e ponendola in piastre Petri contenenti cotone imbevuto da chinetina al 5%. I prodotti sperimentali (IR) sono stati applicati sulla foglia mediante torre di Potter. La superficie fogliare ? stata infettata 24 ore dopo il trattamento utilizzando un inoculo costituito da uredospore di P. pachyrhiz sospese in acqua alla concentrazione di 3 x 10<5 >spore/ml usando nebulizzatore DeVilbiss jet. Le piastre Petri sono state poste ad incubare con cicli di temperatura luce: 26?C/ 16 ore di luce e 23?C/8 ore di buio. La stima dei sintomi di ASR della soia ? stata eseguita dopo 12 giorni dall?inizio del test utilizzando una scala d?infezione basata sulla superfice fogliare ricoperta da lesioni riportata in letteratura (Godoy et al., 2006; Fitopatologia Brasileira, 31(1), 63-68). ? stata infine a calcolata l?efficacia semplice secondo la formula di Abbott. The ex vivo tests against Asian soybean rust (ASR) were carried out by taking from soybean plants of the variety? Zora to the phenological phase BBCH12 the first trifoliate and placing it in Petri dishes containing cotton soaked in 5% kinetin. Experimental products (IR) were applied to the leaf using a Potter tower. The leaf surface? was infected 24 hours after treatment using an inoculum consisting of P. pachyrhiz uredospores suspended in water at a concentration of 3 x 10 <5> spores / ml using DeVilbiss jet nebulizer. The Petri dishes were placed to incubate with light temperature cycles: 26 ° C / 16 hours of light and 23 ° C / 8 hours of dark. Estimating Soy ASR Symptoms? was performed 12 days after the start of the test using an infection scale based on the leaf surface covered by lesions reported in the literature (Godoy et al., 2006; Fitopatologia Brasileira, 31 (1), 63-68). ? Finally, the simple efficacy was calculated according to the Abbott formula.
Tutti i composti N? 428, 425, 427, 426, 431, 430, 317 hanno evidenziato attivit? maggiore dell? 80% alla dose di 30mg/l All compounds N? 428, 425, 427, 426, 431, 430, 317 have highlighted activities? greater than? 80% at a dose of 30mg / l
In Tabella 14 sono stati riportati i risultati ottenuti effettuando il test descritto con i composti N? 428, 425, 427, 426, 431, 430 e 317. Table 14 shows the results obtained by carrying out the test described with compounds N? 428, 425, 427, 426, 431, 430 and 317.
Tabella 14 Table 14
ESEMPIO 13 EXAMPLE 13
Determinazione dell?attivit? fungicida preventiva (3 giorni) dei composti di Formula (I) contro Phytophthora infestans su pomodoro. Determination of the activity? preventive fungicide (3 days) of the compounds of Formula (I) against Phytophthora infestans on tomato.
Foglie di piante di pomodoro di variet? Marmande, allevate in vaso in ambiente condizionato a 20? C e al 70% di U.R. (Umidit? Relativa), sono state trattate per irrorazione di ambedue le pagine con il composto sotto esame disperso in soluzione idroacetonica al 20% in volume di acetone. Variety tomato plant leaves Marmande, grown in pots in a conditioned environment at 20? C and 70% of R.H. (Relative humidity), were treated by spraying both pages with the compound under examination dispersed in a hydroacetonic solution at 20% by volume of acetone.
Dopo 1 giorno di permanenza in ambiente condizionato, le piante sono state irrorate su entrambe le pagine fogliari con una sospensione acquosa di conidi di Phytophthora infestans (50.000 spore per 1 ml di sospensione per infezione). After 1 day in a conditioned environment, the plants were sprayed on both leaves with an aqueous suspension of Phytophthora infestans conidia (50,000 spores per 1 ml of suspension for infection).
Dopo l?irrorazione, le piante sono state mantenute in ambiente saturo di umidit? e a 15?C per il periodo di incubazione del fungo (7 giorni). After spraying, the plants were kept in an environment saturated with humidity. and at 15? C for the mushroom incubation period (7 days).
Trascorso questo periodo di tempo, sono comparsi i sintomi esteriori del patogeno ed ? stato quindi possibile procedere alla valutazione visiva dell?intensit? dell?infezione. After this period of time, the external symptoms of the pathogen appeared and? was therefore possible to proceed with the visual assessment of the intensity? of the infection.
L?attivit? fungicida ? stata espressa come percentuale di riduzione, rispetto a piantine non trattate (testimone), dell?area fogliare colpita dalla malattia (100 = completa efficacia; 0 = efficacia nulla). The activity fungicide? was expressed as a percentage of reduction, compared to untreated seedlings (witness), of the leaf area affected by the disease (100 = complete efficacy; 0 = null efficacy).
Tutti i composti N?425, 330, 317di formula generale (I) hanno evidenziato attivit? maggiore dell? 80% alla dose di 125 ppm. All compounds N? 425, 330, 317 of general formula (I) have shown activity? greater than? 80% at the dose of 125 ppm.
In Tabella 15 sono stati riportati i risultati ottenuti effettuando il test descritto con i composti N?425, 330, 317 in confronto con il composto CR1 descritto in WO2016109257 (N? 145) Table 15 shows the results obtained by carrying out the test described with compounds N? 425, 330, 317 in comparison with the compound CR1 described in WO2016109257 (N? 145)
CR1: Florypicoxamid CR1: Florypicoxamid
Tabella 15 Table 15
ESEMPIO 14 EXAMPLE 14
Determinazione dell?attivit? antifungina in vitro dei composti di Formula (I) Le molecole di formula generale (I) sono state saggiate per valutare la loro attivit? antifungina in vitro nei confronti dei seguenti funghi e straminipila: Alternaria alternata, Botrytis cinerea, Cercospora beticola, Colletotrichum lindemuthianum, Drechslera graminea, Fusarium graminearum, Magnaporthe oryzae, Monilia fructigena, Parastagonospora nodorum, Phytophthora infestans, Pythium ultimum, Rhizoctonia solani, Sclerotinia sclerotiorum, Ustilago maydis, Venturia inaequalis e Zymoseptoria tritici. Determination of the activity? in vitro antifungal of the compounds of Formula (I) The molecules of general formula (I) have been tested to evaluate their activity? in vitro antifungal against the following fungi and straminipila: Alternaria alternata, Botrytis cinerea, Cercospora beticola, Colletotrichum lindemuthianum, Drechslera graminea, Fusarium graminearum, Magnaporthe oryzae, Monilia fructigena, Parastagonospora nodorum, Solimumytophiorum, Scythimum sc Ustilago maydis, Venturia inaequalis and Zymoseptoria tritici.
Gli isolati in coltura pura sono stati mantenuti e conservati a 4?C in frigorifero su substrati nutritivi agarizzati adatti per ciascuno di loro. Per l?esecuzione dei saggi di attivit? si ? preparato l?inoculo che a seconda della specie del patogeno poteva essere una sospensione di conidi oppure un omogenato miceliare. Per i ceppi non facilmente sporulanti in vitro, sei-otto tasselli di micelio sono stati trasferiti in un ovetto di macinazione contenente 6 ml di Potato Dextrose Broth (PDB) 2x e alcune sfere di metallo. La sospensione ? stata omogeneizzata con un mini-mulino Pulverisette 23 (Fritsch GmbH). The pure culture isolates were maintained and stored at 4 ° C in a refrigerator on agar nutrient substrates suitable for each of them. For the execution of the activity tests? yes ? prepared the inoculum which, depending on the species of the pathogen, could be a suspension of conidia or a mycelial homogenate. For strains not readily sporulating in vitro, six to eight patches of mycelium were transferred to a grinding egg containing 6 ml of 2x Potato Dextrose Broth (PDB) and some metal balls. The suspension ? was homogenized with a Pulverisette 23 mini-mill (Fritsch GmbH).
Per tutti i ceppi sporulanti in vitro la sospensione conidica ? stata preparata a partire da una coltura cresciuta su apposito terreno agarizzato e in adatte condizioni per stimolarne la sporulazione. I conidi sono stati raccolti in 1 ml di PDB2x e contati al microscopio con una camera di conta al fine di ottenere un inoculo finale di 2 x 10<4 >conidi/ml. For all in vitro sporulating strains the conidic suspension? was prepared starting from a culture grown on a suitable agar medium and in suitable conditions to stimulate sporulation. The conidia were collected in 1 ml of PDB2x and counted under the microscope with a counting chamber in order to obtain a final inoculum of 2 x 10 <4> conidia / ml.
Le concentrazioni saggiate per ogni molecola attiva sono state 0.001, 0.01, 0.1, 1, 5 e 10 mg/l. Per ogni molecola da saggiare, ? stata preparata una soluzione madre in dimetilsolfossido (DMSO) a 80000 mg/l che ? stata poi serialmente diluita in acqua demineralizzata sterile per ottenere le soluzioni da saggiare a concentrazioni doppia rispetto alle dosi finali. I saggi di inibizione sono stati effettuati in piastre da 96 pozzetti: 50 ?l di inoculo viene miscelato con 50 ?l di soluzione della molecola attiva in ciascun pozzetto utilizzando il dispensatore seriale Eppendorf Multipette? System E3. Quattro pozzetti sono stati utilizzati come repliche per ciascuna concentrazione di principio attivo. Tutti i ceppi dei patogeni sono stati fatti crescere in pozzetti di controllo non trattato contenenti 50 ?l di sospensione fungina e 50 ?l di acqua demineralizzata sterile. Le piastre multipozzetto inoculate vengono incubate a 20?C per 72 ore (96 o 120 ove necessario). The concentrations tested for each active molecule were 0.001, 0.01, 0.1, 1, 5 and 10 mg / l. For each molecule to be tested,? was prepared a stock solution in dimethyl sulfoxide (DMSO) at 80000 mg / l which? It was then serially diluted in sterile demineralized water to obtain the solutions to be tested at twice the concentrations of the final doses. Inhibition assays were performed in 96-well plates: 50µl of inoculum is mixed with 50µl of active molecule solution in each well using the Eppendorf Multipette serial dispenser. System E3. Four wells were used as replicates for each concentration of active ingredient. All strains of the pathogens were grown in untreated control wells containing 50 µl of fungal suspension and 50 µl of sterile demineralized water. The inoculated multiwell plates are incubated at 20 ° C for 72 hours (96 or 120 if necessary).
La sensibilit? alle molecole ? stata valutata come inibizione di crescita del fungo e misurata in termini di assorbanza subito prima e dopo il periodo d?incubazione. L?assorbanza ? stata misurata per ciascun pozzetto mediante lo spettrofotometro Infinite? F50 Absorbance Reader (Tecan Group Ltd) a 405 nm (per gli inoculi miceliari) e a 492 nm (per gli inoculi conidici). The sensitivity? to the molecules? was evaluated as growth inhibition of the fungus and measured in terms of absorbance just before and after the incubation period. The absorbance? been measured for each well by the Infinite spectrophotometer? F50 Absorbance Reader (Tecan Group Ltd) at 405 nm (for mycelial inocula) and at 492 nm (for conidial inocula).
Per ogni ceppo la percentuale d?inibizione di crescita (GIP) causata da ciascuna delle concentrazioni di principio attivo ? stata calcolata mediante la seguente formula: For each strain, the percentage of growth inhibition (GIP) caused by each of the concentrations of the active ingredient? was calculated using the following formula:
dove At72-120 e At0 sono rispettivamente le assorbanze del pozzetto trattato e controllo non trattato misurate alla fine e all?inizio del periodo di incubazione. I dati di GIP sono stati utilizzati per calcolare EC50 le quali sono, rispettivamente, le concentrazioni effettive (mg/l) di molecola attiva che riducono la crescita miceliare al 50% rispetto al controllo non trattato. where At72-120 and At0 are respectively the absorbances of the treated well and the untreated control measured at the end and at the beginning of the incubation period. GIP data were used to calculate EC50 which are, respectively, the actual concentrations (mg / l) of the active molecule that reduce mycelial growth by 50% compared to the untreated control.
In particolare tutti i composti testati hanno mostrato una EC50 minore di 2mg/l su Zymoseptoria tritici e Parastagonospora nodorum. In particular, all the compounds tested showed an EC50 lower than 2mg / l on Zymoseptoria tritici and Parastagonospora nodorum.
In Tabella 16 sono stati riportati i risultati ottenuti effettuando il test descritto con i composti N? 428, 425, 427, 426, 331, 330, 340, 431, 339, 429, 430, 433 e 317. Tabella 16 Table 16 shows the results obtained by carrying out the test described with compounds N? 428, 425, 427, 426, 331, 330, 340, 431, 339, 429, 430, 433 and 317. Table 16
Tutti i prodotti saggiati hanno registrato un?elevata attivit? antifungina nei confronti della maggioranza dei ceppi fungini fitopatogeni. Come si evince dalla Tabella 16, da un punto di vista di efficacia, ossia inferiore dose efficace al 50 % (EC50), molte molecole saggiate hanno riportato dosi efficaci contenute inferiori a 1 mg/l. All the products tested showed a high level of activity. antifungal against the majority of phytopathogenic fungal strains. As can be seen from Table 16, from an efficacy point of view, i.e. lower effective dose than 50% (EC50), many molecules tested reported effective doses lower than 1 mg / l.
I composti pi? attivi, su almeno un fungo fitopatogeno, sono stati: N?428, 425, 426, 427, 331, 330, 340, 431, 339 e 433. The compounds pi? active, on at least one phytopathogenic fungus, were: N? 428, 425, 426, 427, 331, 330, 340, 431, 339 and 433.
In particolare, i ceppi fungini relativamente pi? sensibili ai composti saggiati sono stati M. oryzae, P. nodorum, Z. tritici. In particular, relatively more fungal strains? sensitive to the compounds tested were M. oryzae, P. nodorum, Z. tritici.
In aggiunta B. cinerea, B. sorokiniana, C. beticola, C. lindemuthianum e S. sclerotiorum sono risultati patogeni fungini con valori di EC50 contenuti per i composti N?425, 426, 431, 429. In addition B. cinerea, B. sorokiniana, C. beticola, C. lindemuthianum and S. sclerotiorum were found to be fungal pathogens with low EC50 values for compounds N? 425, 426, 431, 429.
Prendendo in considerazione lo spettro d?azione, i composti N? 428, 425, 330, 317 hanno riportato un ampio spettro comprendente non solo gli agenti fitopatogeni fungini ma anche agenti afferenti al regno degli Straminipila come P. infestans e P. ultimum. Taking into consideration the spectrum of action, the compounds N? 428, 425, 330, 317 reported a broad spectrum including not only fungal phytopathogens but also agents afferent to the Straminipila kingdom such as P. infestans and P. ultimum.
Claims (14)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT102020000007234A IT202000007234A1 (en) | 2020-04-06 | 2020-04-06 | Compounds with fungicidal activity, relative agronomic compositions and use for the control of phytopathogenic fungi |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT102020000007234A IT202000007234A1 (en) | 2020-04-06 | 2020-04-06 | Compounds with fungicidal activity, relative agronomic compositions and use for the control of phytopathogenic fungi |
Publications (1)
Publication Number | Publication Date |
---|---|
IT202000007234A1 true IT202000007234A1 (en) | 2021-10-06 |
Family
ID=71170736
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT102020000007234A IT202000007234A1 (en) | 2020-04-06 | 2020-04-06 | Compounds with fungicidal activity, relative agronomic compositions and use for the control of phytopathogenic fungi |
Country Status (1)
Country | Link |
---|---|
IT (1) | IT202000007234A1 (en) |
Citations (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1035855B (en) * | 1957-06-29 | 1958-08-07 | Hans Schwarzkopf Chem Fab | Skin and hair care products |
SU126975A1 (en) * | 1959-05-05 | 1959-11-30 | С.Д. Кустова | A method of processing Chinese citronella oil |
US4036984A (en) * | 1974-04-30 | 1977-07-19 | Nissan Chemical Industries, Ltd. | Soil fungi inhibiting agent |
FR2345077A1 (en) * | 1976-03-24 | 1977-10-21 | Philagro Sa | NEW REGULATORY COMPOSITIONS OF PLANT GROWTH BASED ON N-ACYL METHIONINE DERIVATIVES |
JPS5387370A (en) * | 1977-01-08 | 1978-08-01 | Yoshitomi Pharmaceut Ind Ltd | Preparation of penicillamine derivative |
US4782086A (en) * | 1985-06-13 | 1988-11-01 | Bayer Aktiengesellschaft | E-isomers of N.sup.α -(2-cyano-2-alkoximinoacetyl)-amino acid derivatives, compositions and fungicidal use |
JPS63275566A (en) * | 1987-05-08 | 1988-11-14 | Nippon Kayaku Co Ltd | N-(2-chloroisonicotinoyl)amino acid derivative and agricultural and horticultural fungicide containing said derivative as active component |
EP0652229A2 (en) | 1993-10-05 | 1995-05-10 | ISAGRO S.p.A. | Oligopeptides with fungicidal activity |
WO1999027783A1 (en) | 1997-12-04 | 1999-06-10 | Dow Agrosciences Llc | Fungicidal compositions and methods, and compounds and methods for the preparation thereof |
WO2001005769A2 (en) | 1999-07-20 | 2001-01-25 | Dow Agrosciences Llc | Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
US20100184730A1 (en) * | 2008-07-08 | 2010-07-22 | Vu Chi B | Fatty Acid Acylated Salicylates and Their Uses |
WO2012000587A1 (en) | 2010-06-28 | 2012-01-05 | Amphenol-Tuchel Electronics Gmbh | Screened plug connector |
WO2014000339A1 (en) | 2012-06-25 | 2014-01-03 | 广州毅昌科技股份有限公司 | Combined toy |
WO2014009759A2 (en) | 2012-07-13 | 2014-01-16 | Leptrex Ltd | Improvements in or relating to allium extracts |
WO2015008019A1 (en) | 2013-07-15 | 2015-01-22 | Leptrex Ltd | Improvements in or relating to allium extracts |
WO2015092412A1 (en) * | 2013-12-20 | 2015-06-25 | Isis Innovation Limited | Chemical compounds |
WO2016109257A1 (en) | 2014-12-30 | 2016-07-07 | Dow Agrosciences Llc | Use of picolinamide compounds as fungicides |
-
2020
- 2020-04-06 IT IT102020000007234A patent/IT202000007234A1/en unknown
Patent Citations (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1035855B (en) * | 1957-06-29 | 1958-08-07 | Hans Schwarzkopf Chem Fab | Skin and hair care products |
SU126975A1 (en) * | 1959-05-05 | 1959-11-30 | С.Д. Кустова | A method of processing Chinese citronella oil |
US4036984A (en) * | 1974-04-30 | 1977-07-19 | Nissan Chemical Industries, Ltd. | Soil fungi inhibiting agent |
FR2345077A1 (en) * | 1976-03-24 | 1977-10-21 | Philagro Sa | NEW REGULATORY COMPOSITIONS OF PLANT GROWTH BASED ON N-ACYL METHIONINE DERIVATIVES |
JPS5387370A (en) * | 1977-01-08 | 1978-08-01 | Yoshitomi Pharmaceut Ind Ltd | Preparation of penicillamine derivative |
US4782086A (en) * | 1985-06-13 | 1988-11-01 | Bayer Aktiengesellschaft | E-isomers of N.sup.α -(2-cyano-2-alkoximinoacetyl)-amino acid derivatives, compositions and fungicidal use |
JPS63275566A (en) * | 1987-05-08 | 1988-11-14 | Nippon Kayaku Co Ltd | N-(2-chloroisonicotinoyl)amino acid derivative and agricultural and horticultural fungicide containing said derivative as active component |
EP0652229A2 (en) | 1993-10-05 | 1995-05-10 | ISAGRO S.p.A. | Oligopeptides with fungicidal activity |
WO1999027783A1 (en) | 1997-12-04 | 1999-06-10 | Dow Agrosciences Llc | Fungicidal compositions and methods, and compounds and methods for the preparation thereof |
WO2001005769A2 (en) | 1999-07-20 | 2001-01-25 | Dow Agrosciences Llc | Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
US20100184730A1 (en) * | 2008-07-08 | 2010-07-22 | Vu Chi B | Fatty Acid Acylated Salicylates and Their Uses |
WO2012000587A1 (en) | 2010-06-28 | 2012-01-05 | Amphenol-Tuchel Electronics Gmbh | Screened plug connector |
WO2014000339A1 (en) | 2012-06-25 | 2014-01-03 | 广州毅昌科技股份有限公司 | Combined toy |
WO2014009759A2 (en) | 2012-07-13 | 2014-01-16 | Leptrex Ltd | Improvements in or relating to allium extracts |
WO2015008019A1 (en) | 2013-07-15 | 2015-01-22 | Leptrex Ltd | Improvements in or relating to allium extracts |
WO2015092412A1 (en) * | 2013-12-20 | 2015-06-25 | Isis Innovation Limited | Chemical compounds |
WO2016109257A1 (en) | 2014-12-30 | 2016-07-07 | Dow Agrosciences Llc | Use of picolinamide compounds as fungicides |
Non-Patent Citations (61)
Title |
---|
AIK, WEISHEN, ET AL.: "Structural Basis for Inhibition of the Fat Mass and Obesity Associated", JOURNAL OF MEDICINAL CHEMISTRY, vol. 56, no. 9, 2013 - 2013, pages 3680 - 3688, ISSN: 0022-2623, DOI: 10.1021/jm400193d * |
BERGERON, RAYMOND J. ET AL: "An Investigation of Desferrithiocin Metabolism", JOURNAL OF MEDICINAL CHEMISTRY, vol. 37, no. 18, 1994 - 1994, pages 2889 - 2895, ISSN: 0022-2623, DOI: 10.1021/JM00044A009 * |
BERGERON, RAYMOND J., ET AL.: "An Investigation of Desferrithiocin Metabolism", JOURNAL OF MEDICINAL CHEMISTRY, vol. 37, no. 18, 1994 - 1994, pages 2889 - 2895, ISSN: 0022-2623, DOI: 10.1021/jm00044a009 * |
BOEHMER, ANKE ET AL: "Potential pitfalls with the use of acetoxy (CH3COO) drugs in studies on nitric oxide synthase in platelets", NITRIC OXIDE, vol. 28, 2013 - 2013, pages 14 - 16, ISSN: 1089-8603, DOI: 10.1016/J.NIOX.2012.09.002 * |
BURDICK, DANIEL J., ET AL.: "N-Benzoyl amino acids as LFA-1/ICAM inhibitors 1: amino acid structure-activity relationship", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 13, no. 6, 2003 - 2003, pages 1015 - 1018, ISSN: 0960-894X, DOI: 10.1016/S0960-894X(03)00084-2 * |
C.D.S. TOMLIN: "Pesticide Manual", 2009, BRITISH CROP PRODUCTION COUNCIL. |
CHURUSOVA, SVETLANA G. ET AL: "Non-classical N-metalated Pd(II) pincer complexes featuring amino acid pendant arms: Synthesis and biological activity", POLYHEDRON, vol. 143, 2018 - 2018, pages 70 - 82, ISSN: 0277-5387, DOI: 10.1016/J.POLY.2017.08.019 * |
COLBY, WEEDS, vol. 15, 1967, pages 20 - 22 |
DANNAN, H., ET AL.: "S-Acylation of cysteine by O-acetylsalicylic anhydride: a possible mechanism for aspirin hypersensitivity?", JOURNAL OF PHARMACEUTICAL SCIENCES, vol. 75, no. 11, 1986 - 1986, pages 1081 - 1084, ISSN: 0022-3549, DOI: 10.1002/jps.2600751112 * |
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 1987, DANNAN, H., ET AL.: "S-Acylation of cysteine by O-acetylsalicylic anhydride: a possible mechanism for aspirin hypersensitivity?", XP002801061, Database accession no. 1987:85014 * |
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 1989, MUKHERJEE, SOMA, ET AL: "Cysteine, a chelating moiety for synthesis of technetium-99m-labeled radiopharmaceuticals. Part I. Benzoyl cysteine and derivatives", XP002801060, Database accession no. 1990:94625 * |
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 1994, BERGERON, RAYMOND J. ET AL: "An Investigation of Desferrithiocin Metabolism", XP002801025, retrieved from STN Database accession no. 1994:580145 * |
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 1996, INO, AKIRA ET AL: "Chemical structure and total synthesis of new antimycoplasma antibiotic micacocidin", XP002801024, retrieved from STN Database accession no. 1996:703670 * |
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 1998, KIM, YOUNG RO, ET AL.: "Properties and hair-growth effect of N-salicylamido-S-benzyl-L-cysteine", XP002801058, Database accession no. 1998:714328 * |
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 2003, BURDICK, DANIEL J., ET AL.: "N-Benzoyl amino acids as LFA-1/ICAM inhibitors 1: amino acid structure-activity relationship", XP002801057, Database accession no. 2003:215759 * |
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 2005, GRAVES, ALAN P., ET AL.: "Decoys for Docking", XP002801055, Database accession no. 2005:396035 * |
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 2005, SUO, ZUCAI: "Thioesterase Portability and Peptidyl Carrier Protein Swapping in Yersiniabactin Synthetase from Yersinia pestis", XP002801056, Database accession no. 2005:179894 * |
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 2010, VU, CHI B. ET AL: "Preparation of fatty acid acylated salicylates for the treatment of inflammatory disorders", XP002801020, retrieved from STN Database accession no. 2010:913898 * |
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 2012, WOON, ESTHER C. Y. ET AL: "Dynamic Combinatorial Mass Spectrometry Leads to Inhibitors of a 2-Oxoglutarate-Dependent Nucleic Acid Demethylase", XP002801019, retrieved from STN Database accession no. 2012:108583 * |
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 2013, AIK, WEISHEN, ET AL.: "Structural Basis for Inhibition of the Fat Mass and Obesity Associated", XP002801054, Database accession no. 2013:509474 * |
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 2013, BOEHMER, ANKE ET AL: "Potential pitfalls with the use of acetoxy (CH3COO) drugs in studies on nitric oxide synthase in platelets", XP002801016, retrieved from STN Database accession no. 2013:68836 * |
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 2013, DULLA, BALAKRISHNA ET AL: "Synthesis and evaluation of 3-amino/guanidine substituted phenyl oxazoles as a novel class of LSD1 inhibitors with anti-proliferative properties", XP002801014, retrieved from STN Database accession no. 2013:634364 * |
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 2013, DULLA, BALAKRISHNA, ET AL.: "Synthesis and evaluation of 3-amino/guanidine substituted phenyl oxazoles as a novel class of LSD1 inhibitors with anti-proliferative properties", XP002801053, Database accession no. 2013:634364 * |
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 2014, RYDZIK, ANNA M. ET AL: "Modulating carnitine levels by targeting its biosynthesis - selective inhibition of .gamma.-butyrobetaine hydroxylase", XP002801013, retrieved from STN Database accession no. 2014:557902 * |
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 2014, RYDZIK, ANNA M., ET AL.: "Modulating carnitine levels by targeting its biosynthesis - selective inhibition of .gamma.-butyrobetaine hydroxylase", XP002801052, Database accession no. 2014:557902 * |
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 2015, SCHOFIELD, CHRISTOPHER JOSEPH ET AL: "Preparation of pyridine or isoquinoline derivatives as .gamma.-butyrobetaine hydroxylase inhibitors", XP002801011, retrieved from STN Database accession no. 2015:1047294 * |
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 2016, ESCOBAR, ZILMA ET AL: "Preclinical Characterization of 3.beta.-(N-Acetyl L-cysteine methyl ester)-2a.beta.,3-dihydrogaliellalactone (GPA512), a Prodrug of a Direct STAT3 Inhibitor for the Treatment of Prostate Cancer", XP002801009, retrieved from STN Database accession no. 2016:665996 * |
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 2016, WANG, QIQIN ET AL.: "Chiral separation of acidic compounds using an O-9-(tert-butylcarbamoyl)quinidine functionalized monolith in micro-liquid chromatography", XP002801051, Database accession no. 2016:467953 * |
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 2018, CHURUSOVA, SVETLANA G. ET AL: "Non-classical N-metalated Pd(II) pincer complexes featuring amino acid pendant arms: Synthesis and biological activity", XP002801007, retrieved from STN Database accession no. 2017:1437697 * |
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 2018, VADIVEL, K., ET AL.: "UV spectroscopic method for estimation of 2-(2-acetoxy benzamido)-3-(allylthio) propanoate sodium", XP002801050, Database accession no. 2018:2263617 * |
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; CLAPOT, CLAUDE ET AL: "N-Acylmethionine derivatives useful in plant growth regulating compositions", XP002801028, retrieved from STN Database accession no. 1978:23395 * |
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; KAVALA, VEERABABURAO ET AL: "Synthesis of fused isoquinolinone and iminoisoindolinone derivatives via a copper-catalyzed regioselective switching process", XP002801012, retrieved from STN Database accession no. 2014:1257273 * |
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; KIM, HEEJUNG ET AL: "Synthesis and Properties of N,N'-Bis(5-Aminosalicyl)-L-Cystine as a Colon-Specific Deliverer of 5-Aminosalicylic Acid and Cystine", XP002801022, retrieved from STN Database accession no. 2008:60398 * |
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; KUSTOVA, S. D.: "Treating Chinese citronella oil", XP002801029, retrieved from STN Database accession no. 1960:99541 * |
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; ORLICK, GERHARD: "Solubilization of amino acids for use in cosmetics", XP002801030, retrieved from STN Database accession no. 1960:99540 * |
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; SHIROKI, MASAMI ET AL: "Penicillamines", XP002801027, retrieved from STN Database accession no. 1979:457031 * |
DATABASE CA CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 1994, BERGERON, RAYMOND J., ET AL.: "An Investigation of Desferrithiocin Metabolism", XP002801059, Database accession no. 1994:580145 * |
DULLA, BALAKRISHNA ET AL: "Synthesis and evaluation of 3-amino/guanidine substituted phenyl oxazoles as a novel class of LSD1 inhibitors with anti-proliferative properties", ORGANIC & BIOMOLECULAR CHEMISTRY, vol. 11, no. 19, 2013 - 2013, pages 3103 - 3107, ISSN: 1477-0520, DOI: 10.1039/C3OB40217G * |
DULLA, BALAKRISHNA, ET AL.: "Synthesis and evaluation of 3-amino/guanidine substituted phenyl oxazoles as a novel class of LSD1 inhibitors with anti-proliferative properties", ORGANIC & BIOMOLECULAR CHEMISTRY, vol. 11, no. 19, 2013 - 2013, pages 3103 - 3107, ISSN: 1477-0520, DOI: 10.1039/c3ob40217g * |
E. TADASHIU. NORICHIKAY. MASATAKA ET AL., TETRAHEDRON, vol. 65, 2009, pages 9583 - 9591 |
ESCOBAR, ZILMA ET AL: "Preclinical Characterization of 3.beta.-(N-Acetyl L-cysteine methyl ester)-2a.beta.,3-dihydrogaliellalactone (GPA512), a Prodrug of a Direct STAT3 Inhibitor for the Treatment of Prostate Cancer", JOURNAL OF MEDICINAL CHEMISTRY, vol. 59, no. 10, 2016 - 2016, pages 4551 - 4562, ISSN: 0022-2623, DOI: 10.1021/ACS.JMEDCHEM.5B01814 * |
GODOY ET AL., FITOPATHOLOGY BRASILEIRA, vol. 31, no. 1, 2006, pages 63 - 68 |
GRAVES, ALAN P., ET AL.: "Decoys for Docking", JOURNAL OF MEDICINAL CHEMISTRY, vol. 48, no. 11, 2005 - 2005, pages 3714 - 3728, ISSN: 0022-2623, DOI: 10.1021/jm0491187 * |
HOSSEINI-SARVARI MONASHARGHI HASHEM, JOURNAL OF ORGANIC CHEMISTRY, vol. 71, no. 17, 2006, pages 6652 - 6654 |
INO, AKIRA ET AL: "Chemical structure and total synthesis of new antimycoplasma antibiotic micacocidin", TENNEN YUKI KAGOBUTSU TORONKAI KOEN YOSHISHU , 38TH, 1996 - 1996, pages 121 - 126 * |
JOHN JANETZKOROBERT A. BATEY, JOURNAL OF ORGANIC CHEMISTRY, vol. 79, 2014, pages 7415 - 7424 |
KAVALA, VEERABABURAO ET AL: "Synthesis of fused isoquinolinone and iminoisoindolinone derivatives via a copper-catalyzed regioselective switching process", ADVANCED SYNTHESIS & CATALYSIS, vol. 356, no. 11-12, 2014, pages 2609 - 2626, ISSN: 1615-4150, DOI: 10.1002/ADSC.201301105 * |
KIM, HEEJUNG ET AL: "Synthesis and Properties of N,N'-Bis(5-Aminosalicyl)-L-Cystine as a Colon-Specific Deliverer of 5-Aminosalicylic Acid and Cystine", DRUG DELIVERY, vol. 15, no. 1, 2008, pages 37 - 42, ISSN: 1071-7544, DOI: 10.1080/10717540701828806 * |
KIM, YOUNG RO, ET AL.: "Properties and hair-growth effect of N-salicylamido-S-benzyl-L-cysteine", SOUL TAEHAKKYO YAKHAK NONMUNJIP, vol. 1997, no. 22, 1997 - 1997, pages 10 - 18, ISSN: 0250-3336 * |
KRISHNAMURTHY S., TETRAHEDRON LETTERS, vol. 23, 1982, pages 3315 - 3318 |
LOGINOVARUBTSOVAKUCHIN, CHEMISTRY OF NATURAL COMPOUNDS, vol. 44, 2008, pages 752 - 754 |
M. MATTEUCCIG. BHALAYM. BRADLEY, ORG. LETTER, vol. 5, no. 3, 2003, pages 235 - 237 |
MUKHERJEE, SOMA, ET AL: "Cysteine, a chelating moiety for synthesis of technetium-99m-labeled radiopharmaceuticals. Part I. Benzoyl cysteine and derivatives", NUCLEAR MEDICINE AND BIOLOGY, vol. 16, no. 7, 1989 - 1989, pages 715 - 720, ISSN: 0883-2897, DOI: 10.1016/0883-2897(89)90144-X * |
R.BUNTROCK: "Review of heterocyclic Chemistry", 2012, COPYRIGHT @ 2012 THE AMERICAN CHEMICAL SOCIETY |
RYDZIK, ANNA M. ET AL: "Modulating carnitine levels by targeting its biosynthesis - selective inhibition of .gamma.-butyrobetaine hydroxylase", CHEMICAL SCIENCE, vol. 5, no. 5, 2014 - 2014, pages 1765 - 1771, ISSN: 2041-6520, DOI: 10.1039/C4SC00020J * |
RYDZIK, ANNA M., ET AL.: "Modulating carnitine levels by targeting its biosynthesis - selective inhibition of .gamma.-butyrobetaine hydroxylase", CHEMICAL SCIENCE, vol. 5, no. 5, 2014 - 2014, pages 1765 - 1771 * |
SAJADI S. MOHAMMAD ET AL., LETTERS IN ORGANIC CHEMISTRY, vol. 1, no. 1, 2014, pages 49 - 54 |
SUO, ZUCAI: "Thioesterase Portability and Peptidyl Carrier Protein Swapping in Yersiniabactin Synthetase from Yersinia pestis", BIOCHEMISTRY, vol. 44, no. 12, 2005 - 2005, pages 4926 - 4938, ISSN: 0006-2960, DOI: 10.1021/bi047538s * |
VADIVEL, K., ET AL.: "UV spectroscopic method for estimation of 2-(2-acetoxybenzamido)-3-(allylthio) propanoate sodium", EUROPEAN JOURNAL OF BIOMEDICAL AND PHARMACEUTICAL SCIENCES, vol. 5, no. 6, 2018 - 2018, pages 1 - 3, ISSN: 2349-8870 * |
WANG, QIQIN ET AL.: "Chiral separation of acidic compounds using an O-9-(tert-butylcarbamoyl)quinidine functionalized monolith in micro-liquid chromatography", JOURNAL OF CHROMATOGRAPHY A, vol. 2016, no. 1444, 2016 - 2016, pages 64 - 73, DOI: 10.1016/j.chroma.2016.03.047 * |
WOON, ESTHER C. Y. ET AL: "Dynamic Combinatorial Mass Spectrometry Leads to Inhibitors of a 2-Oxoglutarate-Dependent Nucleic Acid Demethylase", JOURNAL OF MEDICINAL CHEMISTRY, vol. 55, no. 5, 2012 - 2012, pages 2173 - 2184, ISSN: 0022-2623, DOI: 10.1021/JM201417E * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10149473B2 (en) | Aminoindanes amides having a high fungicidal activity and their phytosanitary compositions | |
US9040457B2 (en) | Phenylamidines having a high fungicidal activity and use thereof | |
US7598395B2 (en) | Heterocyclocarboxamide derivatives | |
US7332518B2 (en) | Carboxamides as fungicides in agriculture | |
US8084613B2 (en) | Tetrazoyloxime derivative and plant disease control agent | |
AU2011347585A1 (en) | Aminoindanes amides having a high fungicidal activity and their phytosanitary compositions | |
WO2010109301A1 (en) | Benzamidic compounds having fungicidal activity and relative use | |
ITMI20120405A1 (en) | "SYNERGIC COMPOSITIONS WITH FUNGICIDAL ACTIVITY AND RELATED USE" | |
CN103339104A (en) | Decahydro-1,4-methanonaphthalen carboxamides | |
IT201900006543A1 (en) | Compounds with fungicidal activity, relative agronomic compositions and use for the control of phytopathogenic fungi | |
IT202000007234A1 (en) | Compounds with fungicidal activity, relative agronomic compositions and use for the control of phytopathogenic fungi | |
WO2018178848A1 (en) | Pyridyl-formamidines having a fungicidal activity, their agronomic compositions ans use thereof | |
IT201900011127A1 (en) | Compounds with fungicidal activity, relative agronomic compositions and use for the control of phytopathogenic fungi | |
US20040082477A1 (en) | Pyrrolecarboxamides for the use as fungicdes | |
US20060287328A1 (en) | Silicon compounds with microbiocidal activity | |
US11365175B2 (en) | Aromatic amides having a fungicidal activity, their agronomic compositions and relative preparation method | |
DE60211018T2 (en) | FUNGICIDE THIAZONE DERIVATIVES | |
TW201841902A (en) | Novel triazolethione derivatives | |
BR112019019096B1 (en) | PYRIDYL-FORMAMIDINES, FUNGICIDAL COMPOSITION, USE OF COMPOUNDS, AND METHOD TO CONTROL PHYTOPATHOGENIC FUNGI IN AGRICULTURAL CROPS | |
ITMI20101575A1 (en) | PHENYLAMIDINE WITH HIGH FUNGICIDAL ACTIVITY AND RELATED USE |